🔗

Mappings

MONDO

MONDO:0018709 X-linked intellectual disability-hypotonia-movement disorder syndrome Not Yet Curated

MONDO:0018709 names the syndromic concept this entry actually curates - intellectual disability with hypotonia and movement disorder - and is the term the deep-research report proposed. It is recorded as a closeMatch rather than an exactMatch because the two terms are separate MONDO concepts sitting under different parents, and MONDO:0010497 remains the disease_term for the reasons set out in the non_syndromic_label_mismatch discussion. A closeMatch is a cross-reference and deliberately does not retire MONDO:0018709 from the curation queue.

👪

Inheritance

3

X-linked inheritance HP:0001417

DDX3X sits at Xp11.4 and the disorder is X-linked, but neither the dominant nor the recessive label alone describes it. Most recognised probands are females with a de novo heterozygous allele; a minority are hemizygous males with a missense or splice allele that is often maternally inherited from an unaffected or only mildly affected carrier.

X-linked inheritance

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"Our data show that variants in DDX3X can cause an X-linked neurodevelopmental disorder in males, with unaffected or mildly affected carrier females."

States the X-linked mode and the carrier-female pattern that distinguishes the male families from the de novo female majority.

X-linked dominant inheritance HP:0001423

The female presentation behaves dominantly: a single heterozygous allele is sufficient, and because DDX3X escapes X-inactivation the wild-type allele on the active X does not rescue dosage.

X-linked dominant inheritance De novo rate: Nearly all reported female probands carry a de novo allele; 22 of 22 female variants in a 2,317-proband Chinese exome cohort were de novo.

Show evidence (2 references)

PMID:26235985 SUPPORT Human Clinical

"we present 35 unique deleterious de novo mutations in DDX3X identified by whole exome sequencing in 38 females with ID and various other features including hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy"

The founding cohort establishes de novo heterozygous alleles in females as the dominant-acting mechanism.

PMID:35392274 SUPPORT Human Clinical

"A total of 17 DDX3X variants were novel and 22 were de novo."

Quantifies the de novo rate in an independent diagnostic cohort of 23 patients (22 female, 1 male).

X-linked recessive inheritance HP:0001419

Families with an inherited hypomorphic missense allele segregate in an apparently X-linked recessive pattern: hemizygous males are affected while the transmitting heterozygous mother is unaffected or only mildly affected. This is not a separate disease but the same locus seen through a residual-function allele. A carrier mother transmits the allele to half her pregnancies; sons who inherit it are affected, and daughters who inherit it become heterozygotes who are not expected to manifest a neurodevelopmental phenotype.

X-linked recessive inheritance

Show evidence (3 references)

PMID:26235985 SUPPORT Human Clinical

"we present three families with segregating missense mutations in DDX3X, suggestive of an X-linked recessive inheritance pattern. In these families, all males with the DDX3X variant had ID, whereas carrier females were unaffected."

Documents the segregating male families and the unaffected carrier mothers.

PMID:32852922 SUPPORT Human Clinical

"If the mother of an affected male has a DDX3X pathogenic variant, the chance of transmitting it in each pregnancy is 50%"

Gives the per-pregnancy transmission risk from a carrier mother, which is the quantitative content of the X-linked recessive recurrence risk.

PMID:32852922 SUPPORT Human Clinical

"Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be heterozygotes and are not expected to manifest a neurodevelopmental phenotype"

States the sex-dependent outcome of inheriting a male-associated allele, which is what makes these families read as recessive despite the same locus acting dominantly in de novo female probands.

◆

Subtypes

2

Female heterozygous DDX3X-related neurodevelopmental disorder

DDX3X hgnc:2745

The majority presentation. A de novo heterozygous allele of any class - nonsense, frameshift, canonical or non-canonical splice, missense, in-frame indel - in a female. Protein-truncating alleles act by haploinsufficiency; severe helicase-domain missense alleles behave differently and mark the polymicrogyria/severe-outcome group.

Show evidence (1 reference)

PMID:32135084 SUPPORT Human Clinical

"demonstrating a striking correlation between recurrent dominant missense mutations, polymicrogyria, and the most severe clinical outcomes"

The 107-individual cohort separates the severe missense group from the rest of the female presentation.

Male hemizygous DDX3X-related neurodevelopmental disorder

DDX3X hgnc:2745 X-linked recessive inheritance

Hemizygous males carrying a missense or splice allele with retained partial function, either de novo or inherited from a carrier mother. No germline truncating allele has been reported in a male. Recurrent substitutions p.(Arg351Gln) and p.(Arg488Cys) account for part of the reported cohort.

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"The vast majority of males have missense variants, including two recurrent variants (p.(Arg351Gln) and p.(Arg488Cys)). No truncating variants have been reported, consistent with the presumed embryonic lethality of complete loss-of-function of DDX3X in males."

Defines the male allelic architecture and the absence of truncating male alleles that motivates curating this stratum separately.

?

Discussions and Knowledge Gaps

4

Does the Y-linked paralog DDX3Y compensate for DDX3X in the developing male brain?

CONTROVERSY OPEN ddx3y_compensation_conflict

Attached to

pathophysiology#Hemizygous Partial Loss of DDX3X Function in Males pathophysiology#Partial Escape from X-Chromosome Inactivation

Two mouse studies reach opposite conclusions. The conditional neural-progenitor knockout reports that Ddx3y compensates for Ddx3x in the developing male neocortex, making the phenotype sexually dimorphic. The haploinsufficient mouse paper argues DDX3Y cannot compensate because it is translated only in spermatocytes. The answer matters: if DDX3Y compensates in the developing brain, it is a second reason - alongside escape from X-inactivation - that hemizygous males tolerate an allele that a female does not, and it changes how a hemizygous variant of uncertain significance in a male should be interpreted.

Both statements are about mouse. Neither has been tested in human fetal cortex, which is where the question would have to be settled.

Show evidence (2 references)

PMID:35762573 SUPPORT Model Organism

"In addition, Ddx3x loss is sexually dimorphic, as its paralog, Ddx3y, compensates for Ddx3x in the developing male neocortex."

The position that Ddx3y does compensate, demonstrated in conditional knockout neocortex.

PMID:34344536 REFUTE Model Organism

"The DDX3X paralog on the Y chromosome (DDX3Y) does not appear to compensate for this dosage imbalance as it is translated only in spermatocytes"

The opposing position, on the grounds that DDX3Y translation is restricted to spermatocytes.

Why does MONDO:0010497 classify this disorder as non-syndromic X-linked intellectual disability when the published phenotype is syndromic?

INTERPRETATION OPEN non_syndromic_label_mismatch

Attached to

disease#Intellectual Disability X-linked 102 phenotypes#Corpus Callosum Hypoplasia phenotypes#Polymicrogyria

MONDO:0010497 is a child of MONDO:0019181, non-syndromic X-linked intellectual disability, and carries synonyms including "DDX3X non-syndromic X-linked intellectual disability" generated by the disease-series-by-gene design pattern. The same term also carries the synonym "intellectual developmental disorder, X-linked, syndrome, Snijders Blok type", which is the opposite claim. The literature is unambiguous: the founding cohort reported hypotonia, movement disorders, behaviour problems, corpus callosum hypoplasia and epilepsy alongside the intellectual disability, and later series added polymicrogyria, ventriculomegaly, delayed myelination, feeding difficulty, ophthalmologic problems and scoliosis. The "non-syndromic" placement is an artefact of an automated gene-series pattern, not a curatorial claim about the phenotype. This entry curates the syndromic phenotype and flags the term for upstream correction rather than trimming the phenotype to fit the label.

Show evidence (2 references)

PMID:30936465 SUPPORT Human Clinical

"De novo DDX3X variants account for 1-3% of syndromic intellectual disability (ID) in females and have been occasionally reported in males."

Describes the same 1-3% population as syndromic intellectual disability, directly contradicting the non-syndromic placement.

PMID:26235985 SUPPORT Human Clinical

"we present 35 unique deleterious de novo mutations in DDX3X identified by whole exome sequencing in 38 females with ID and various other features including hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy"

The founding cohort itself reports extra-cognitive features, so the disorder was never described as non-syndromic.

Is the excitatory/inhibitory neuronal imbalance seen in ddx3x-deficient zebrafish present in human DDX3X-related neurodevelopmental disorder, and is the glutamatergic rescue translatable?

HUMAN MODEL MISMATCH OPEN ei_imbalance_human_translation

Attached to

pathophysiology#Excitatory-Inhibitory Neuronal Differentiation Imbalance pathophysiology#Reduced CREBBP mRNA Stability and Notch Signalling

The zebrafish work supplies the only mechanistic route from DDX3X loss to a pharmacologically reversible phenotype: crebbp mRNA destabilisation, reduced Notch signalling, an excitatory/inhibitory differentiation imbalance, and partial behavioural rescue with L-glutamate or a glutamate receptor agonist. Every step of that chain is untested in human cells or tissue. The mismatch is substantive rather than routine because it is the only current candidate for a disease-modifying target, so the translational gap is what stands between a model result and a therapeutic hypothesis. Zebrafish forebrain development also lacks the mammalian cortical architecture in which the human phenotype arises.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"the supplementation of L-glutamate or glutamate receptor agonist ly404039 could partly rescue the adaptation and social deficits"

The rescue result whose human translatability is the open question.

What is the population prevalence or birth incidence of DDX3X-related neurodevelopmental disorder?

KNOWLEDGE GAP OPEN no_population_prevalence

Attached to

prevalence#Worldwide

Every quantitative statement about how common this disorder is comes from diagnostic sequencing cohorts of already-ascertained intellectual disability, or from counts of diagnosed individuals. Neither supports a population rate. Ascertainment is additionally sex-biased, so even the observed sex ratio among diagnosed individuals cannot be read as the true one: males with hypomorphic alleles are under-recognised, and the male cohort's median age at diagnosis was 8 years with a range extending to 47.

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"DDX3X-related neurodevelopmental disorder is one of the most common monogenic causes of intellectual disability in females, with currently >1000 females diagnosed worldwide."

A diagnosed-case count, which is the best available figure and is not a prevalence.

⚙

Pathophysiology

11

Partial Escape from X-Chromosome Inactivation

DDX3X partially escapes X-chromosome inactivation, so both alleles are transcribed in a heterozygous female. The usual protection that functional mosaicism or wild-type-favouring skewing gives a female carrier of an X-linked allele therefore does not apply here, which is the structural reason the recognised patient population is female-biased rather than male-biased as it is for most X-linked intellectual disability genes.

DDX3X hgnc:2745

Downstream

DDX3X RNA Helicase Deficiency Because the variant allele continues to be expressed from the inactive X, a heterozygous female retains a substantial mutant transcript fraction and the functional deficiency is established despite skewing.

Show evidence (2 references)

PMID:40164730 SUPPORT Human Clinical

"DDX3X is an essential gene located on the X-chromosome (Xp11.4), that partially escapes X-inactivation"

States the escape-from-inactivation property that the sex-dependent architecture rests on.

PMID:36299587 SUPPORT Human Clinical

"It was discovered that XCI in the mutant allele was insufficient to reverse the phenotype of DDX3X-related neurodevelopmental disorder."

A symptomatic female with extreme inactivation of the mutant X shows directly that skewing does not rescue the phenotype.

Hemizygous Partial Loss of DDX3X Function in Males

A male has one DDX3X allele and no functional somatic backup, so complete loss of function is not compatible with a liveborn phenotype; every reported germline male allele is missense or splice-altering and retains partial activity. This is the male entry point into the same downstream chain, and it is why the male allelic spectrum is narrower than the female one rather than simply rarer.

DDX3X hgnc:2745

Genetic context variant_origin: GERMLINE zygosity: HEMIZYGOUS functional_impact_category: PARTIAL_LOSS_OF_FUNCTION

Hemizygous germline missense or splice-altering alleles with retained residual helicase function. The p.Arg79Lys allele, which lies outside the core helicase domain, was shown to be hypomorphic in a zebrafish functional assay.

Animal models

p.Arg79Lys zebrafish rescue assay Danio rerio measures Quantifies residual DDX3X activity for a specific male allele, which is the property this pathophysiology node asserts.

Downstream

DDX3X RNA Helicase Deficiency A hemizygous hypomorphic allele produces the same helicase deficiency, at a severity set by how much activity the allele retains.

Show evidence (2 references)

PMID:29490693 SUPPORT Model Organism

"found that this allele causes a partial loss of DDX3X function and thus represents a hypomorphic variant"

A zebrafish rescue assay establishes partial rather than complete loss of function for the inherited male allele.

PMID:29490693 SUPPORT Human Clinical

"consistent with the hypothesis that haploinsufficiency at this locus on the X-chromosome is likely to be lethal in males"

States the viability constraint that restricts the male allelic spectrum to residual-function alleles.

DDX3X RNA Helicase Deficiency

Mechanism confidence: Established

Reduced ATP-dependent RNA-helicase activity of DDX3X, arising either from reduced dosage (protein-truncating alleles, haploinsufficiency) or from direct impairment of the catalytic machinery by helicase-domain missense alleles. This is the shared lesion that the female and male routes converge on.

DDX3X hgnc:2745

Genetic context variant_origin: GERMLINE functional_impact_category: LOSS_OF_FUNCTION

Germline alleles spanning nonsense, frameshift, canonical and non-canonical splice, missense and in-frame indel classes. Truncating female alleles are consistent with haploinsufficiency; severe helicase-domain missense alleles impair catalysis directly and additionally seed ectopic granules, so they are not simply stronger null alleles.

RNA helicase activity GO:0003724 ↓ DECREASED

Downstream

Impaired Translation of Structured Transcripts Loss of unwinding activity leaves structured 5' untranslated regions unresolved, so the transcripts that depend on DDX3X for initiation are under-translated.

Ectopic RNA-Protein Granule Formation Severe-missense branch. Mutant DDX3X protein nucleates ectopic ribonucleoprotein granules in neural progenitors and neurons, a behaviour the truncating alleles do not have.

Reduced CREBBP mRNA Stability and Notch Signalling DDX3X loss destabilises crebbp mRNA and thereby lowers Notch signalling. Shown in zebrafish; not yet demonstrated in human tissue.

Attenuated Canonical Wnt Signalling Every de novo allele tested reduced canonical Wnt output in a zebrafish assay. The assay was used as a surrogate readout of DDX3X function rather than as a demonstration that Wnt is the route to the human brain phenotype, so the intermediates between this node and corticogenesis are not established.

Show evidence (1 reference)

PMID:32135084 SUPPORT In Vitro

"Severe DDX3X missense mutations profoundly disrupt RNA helicase activity, induce ectopic RNA-protein granules in neural progenitors and neurons, and impair translation."

Biochemical and cell-based assays show the missense alleles reduce helicase activity itself rather than only protein amount.

Impaired Translation of Structured Transcripts

DDX3X is required for cap-dependent initiation on messages with structured 5' untranslated regions. When helicase activity falls, that subset of the neural translatome is selectively under-produced; ribosome profiling in vivo identifies the DDX3X-dependent transcripts and shows several are required for neurogenesis.

cortical neural progenitor cell CL:0011020

translational initiation GO:0006413 ↓ DECREASED RNA processing GO:0006396 ↕ DYSREGULATED

Downstream

Altered Neural Progenitor Cell Cycle and Neurogenic Division Translational control of the progenitor transcriptome is one of the two arms by which DDX3X sets cortical neuron output in the mouse model.

Show evidence (1 reference)

PMID:35762573 SUPPORT Model Organism

"Finally, we use ribosome profiling in vivo to discover the repertoire of translated transcripts in neural progenitors, including those which are DDX3X-dependent and essential for neurogenesis."

Identifies the DDX3X-dependent translated transcripts in progenitors and links them to neurogenesis.

Ectopic RNA-Protein Granule Formation

Mechanism confidence: Established

Severe missense DDX3X protein assembles into ectopic cytoplasmic ribonucleoprotein granules in neural progenitors and neurons, sequestering message and further disturbing translation. This is the mechanistic feature that separates the severe missense group from simple dosage loss and tracks with polymicrogyria and the worst clinical outcomes.

cortical neural progenitor cell CL:0011020 neuron CL:0000540

ectopic cytoplasmic ribonucleoprotein granule GO:0035770

Downstream

Impaired Translation of Structured Transcripts Granule formation is reported together with aberrant translation in the same cells, so the severe missense branch reaches the translational defect by a second route beyond loss of catalytic activity.

Polymicrogyria The alleles that produce granules are the alleles that correlate with polymicrogyria in the 107-individual clinical cohort. The correlation is genotype-phenotype, so the steps between granule formation and the cortical malformation are inferred rather than demonstrated.

Show evidence (1 reference)

PMID:32135084 SUPPORT In Vitro

"Severe DDX3X missense mutations profoundly disrupt RNA helicase activity, induce ectopic RNA-protein granules in neural progenitors and neurons, and impair translation."

Direct demonstration of ectopic granules in the relevant cell types.

Reduced CREBBP mRNA Stability and Notch Signalling

Mechanism confidence: Provisional

DDX3X deficiency destabilises crebbp mRNA, and the resulting fall in CREBBP lowers Notch signalling in the developing brain. Demonstrated in a ddx3x-deficient zebrafish with single-nucleus transcriptomics and biological validation; the human counterpart has not been shown.

Notch signaling pathway GO:0007219 ↓ DECREASED

Animal models

ddx3x-deficient zebrafish Danio rerio recapitulates The molecular arm of the mechanism - crebbp mRNA destabilisation and reduced Notch signalling - was demonstrated in this model.

Downstream

Neural Stem and Progenitor Pool Depletion Notch signalling maintains the neural stem cell pool; its loss reduces that pool in the ddx3x-deficient zebrafish.

Excitatory-Inhibitory Neuronal Differentiation Imbalance The same lesion shifts the ratio in which excitatory and inhibitory neurons are produced.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"Mechanistically, we reveal that the ddx3x deficiency attenuates the stability of the crebbp mRNA, which in turn causes downregulation of Notch signaling and defects in neurogenesis."

Establishes the mRNA-stability-to-Notch step in the zebrafish model.

Attenuated Canonical Wnt Signalling

Mechanism confidence: Provisional

Canonical Wnt output falls when DDX3X function is reduced. In the founding study this was a zebrafish surrogate assay of allele function, and the size of the effect differed between the female and male dosage contexts. It is retained here as a genuine but provisional arm: it grounds the sex-dependent dosage argument, and it has not been shown to be the route to any specific human brain phenotype.

canonical Wnt signaling pathway GO:0060070 ↓ DECREASED

Downstream

Altered Neural Progenitor Cell Cycle and Neurogenic Division Canonical Wnt is a standard regulator of cortical progenitor proliferation, so this edge is the plausible connection to the progenitor node. No study has demonstrated it for DDX3X, and the edge is drawn with unknown intermediates for that reason.

Show evidence (1 reference)

PMID:26235985 SUPPORT Model Organism

"We demonstrate a consistent loss-of-function effect of all tested de novo mutations on the Wnt pathway, and we further show a differential effect by gender."

Records both the Wnt effect and its sex dependence in the zebrafish assay.

Altered Neural Progenitor Cell Cycle and Neurogenic Division

Mechanism confidence: Established

Radial glial and neural progenitor cells lose precise control of cell-cycle duration and of the choice between self-renewing and neurogenic division. Live imaging of Ddx3x-deficient progenitors shows both parameters shift, and they together set how many neurons the cortex produces. This is the DDX3X substitution into the module's progenitor-division node: the perturbation reaching the cell cycle is translational rather than centrosomal.

cortical radial glial cell CL:0000681 cortical neural progenitor cell CL:0011020

mitotic cell cycle GO:0000278 ↕ DYSREGULATED asymmetric neurogenic division GO:0008356 ↕ DYSREGULATED

Animal models

Ddx3x conditional neural progenitor knockout mouse Mus musculus recapitulates Live imaging of progenitors demonstrates altered cell-cycle duration and a shifted balance of neurogenic divisions, and ribosome profiling identifies the DDX3X-dependent translated transcripts underlying it.

Downstream

Neural Stem and Progenitor Pool Depletion Altered division parameters change the size and composition of the progenitor pool, the module's next step.

Show evidence (2 references)

PMID:35762573 SUPPORT Model Organism

"we show that DDX3X promotes neuronal generation by regulating both cell cycle duration and neurogenic divisions"

Live imaging of progenitors demonstrates the two division parameters this node names.

PMID:32135084 SUPPORT Model Organism

"We show that Ddx3x controls cortical development by regulating neuron generation."

Independent demonstration that DDX3X acts on neuron generation during corticogenesis.

Neural Stem and Progenitor Pool Depletion

The cortical neural stem and progenitor pool is reduced, and with it the total number of neurons generated. Dosage-dependent: complete progenitor loss in females gives frank microcephaly, whereas the heterozygous female and hemizygous male states reduce neurogenesis without marked microcephaly, which matches the human observation that most patients are not microcephalic.

neural stem cell CL:0000047 cortical neural progenitor cell CL:0011020 cortical radial glial cell CL:0000681

neurogenesis GO:0022008 ↓ DECREASED progenitor population proliferation GO:0008283 ↕ DYSREGULATED maintenance of neural stem cell number GO:0098727 ↕ DYSREGULATED

Animal models

Ddx3x conditional neural progenitor knockout mouse Mus musculus recapitulates Reduced neurogenesis across the dosage series, with frank microcephaly only at complete female progenitor loss.

Downstream

Aberrant Cortical Neuron Output and Cortical Malformation Fewer and mistimed neurons produce an abnormally built cortex, the module's terminal developmental node.

Show evidence (1 reference)

PMID:35762573 SUPPORT Model Organism

"First, we show brain development is sensitive to Ddx3x dosage; complete Ddx3x loss from neural progenitors causes microcephaly in females, whereas hemizygous males and heterozygous females show reduced neurogenesis without marked microcephaly."

Establishes the dosage-graded reduction in neurogenesis that this node records.

Excitatory-Inhibitory Neuronal Differentiation Imbalance

Mechanism confidence: Provisional

The ratio in which excitatory and inhibitory neurons are produced is disturbed. In the zebrafish model this imbalance is what the behavioural deficits track, and partial rescue by glutamate or a glutamate receptor agonist argues the deficit is functional rather than purely structural. The human counterpart has not been measured.

cortical excitatory neuron CL:0000679 inhibitory interneuron CL:0000617

cerebral cortex neuron differentiation GO:0021895 ↕ DYSREGULATED

Animal models

ddx3x-deficient zebrafish Danio rerio recapitulates Single-nucleus transcriptomics shows imbalanced excitatory and inhibitory neuron differentiation, and glutamatergic supplementation partly rescues the behavioural consequence.

Downstream

Autistic Behaviour Social-interaction and adaptation deficits in the zebrafish model are attributed to the imbalance and are partly reversible by glutamatergic supplementation. Extrapolating from that to human autistic behaviour is an inference across species and across behavioural constructs.

Show evidence (2 references)

PMID:39471229 SUPPORT Model Organism

"ddx3x deficiency leads to reduced neural stem cell pool, decreased total neuron number, and imbalanced differentiation of excitatory and inhibitory neurons, which are responsible for the behavioral defects"

Single-nucleus transcriptomics plus validation in the zebrafish allele demonstrates the imbalance and attributes behaviour to it.

PMID:34344536 SUPPORT Model Organism

"Cortical thinning was accompanied by defective cortical lamination, indicating that Ddx3x regulates the balance of glutamatergic neurons in the developing cortex."

Independent mouse evidence that the excitatory neuron balance specifically is affected.

Aberrant Cortical Neuron Output and Cortical Malformation

The number, timing and laminar allocation of cortical neurons are abnormal, producing the structural findings seen on brain MRI: cortical thinning and defective lamination in the mouse; and in patients, polymicrogyria, callosal dysgenesis, ventriculomegaly, delayed myelination and reduced brain volume. Around two-thirds of one diagnostic cohort had a structural abnormality, so a normal MRI does not exclude the diagnosis.

cortical neuron CL:0000540

cerebral cortex development GO:0021987 ↕ DYSREGULATED neurogenesis GO:0022008 ↓ DECREASED

cerebral cortex UBERON:0000956

Animal models

Ddx3x heterozygous null mouse Mus musculus recapitulates Cortical thinning with defective lamination and reduced regional brain volume, the mouse counterpart of the human structural phenotype.

Downstream

Polymicrogyria Disordered cortical neuron output and lamination manifests radiologically as polymicrogyria in the severe end of the spectrum.

Corpus Callosum Hypoplasia Callosal hypoplasia or dysgenesis was in the founding cohort's phenotype list and recurs in every subsequent series.

Ventriculomegaly Lateral ventricle enlargement is among the recurrent structural findings.

Delayed Myelination Delayed myelination accompanies the malformation spectrum.

Intellectual Disability Abnormal cortical construction is the presumed substrate of the cognitive phenotype. The step from circuit abnormality to measured cognition is not demonstrated in humans and is drawn here as an inference.

Seizures Malformations of cortical development, polymicrogyria in particular, are an established epileptogenic substrate, and seizures occur in a minority of patients.

Show evidence (2 references)

PMID:35392274 SUPPORT Human Clinical

"A total of 15 individuals had notable brain anatomical disruption (15/23, 65.2%), including lateral ventricle enlargement, corpus callosum abnormalities, and delayed myelination."

Quantifies structural brain abnormality in a consecutive diagnostic cohort and names the recurrent findings.

PMID:30936465 SUPPORT Human Clinical

"a common brain malformative pattern characterized by malformations of cortical development, callosal dysgenesis, basal ganglia anomalies, and midbrain-hindbrain malformations"

Describes the recurrent malformation pattern, which extends beyond the cortex to callosal, basal ganglia and hindbrain structures.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

27

Cardiovascular 1

Congenital Heart Defect Abnormal heart morphology HP:0001627

No frequency band is recorded. GeneReviews gives no rate, and the only quantitative characterisation available calls the finding rare without reporting a denominator.

Show evidence (3 references)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews lists congenital heart defects among the recurrent findings.

PMID:30349862 SUPPORT Human Clinical

"Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline."

An independent phenotype-expansion series reporting congenital heart disease, and characterising it as a rare rather than a core feature.

PMID:32852922 SUPPORT Human Clinical

"Surveillance: Periodic evaluation by the multidisciplinary team regarding growth, developmental progress and educational needs, and psychiatric/behavioral issues; regular assessment of vision and hearing, of the spine for scoliosis, for seizure control (when relevant), and for cardiac and..."

GeneReviews directs ongoing cardiac assessment, confirming the finding is recurrent enough to warrant screening.

Digestive 1

Feeding Difficulties FREQUENT HP:0011968

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"intellectual disability (23/23, 100%) with varying degrees of severity, muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23, 56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)"

Gives the 56.5% feeding-difficulty rate supporting the frequent band.

Ear 1

Hearing Impairment HP:0000365

Show evidence (2 references)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews lists hearing impairment among the recurrent findings.

PMID:32852922 SUPPORT Human Clinical

"Surveillance: Periodic evaluation by the multidisciplinary team regarding growth, developmental progress and educational needs, and psychiatric/behavioral issues; regular assessment of vision and hearing, of the spine for scoliosis, for seizure control (when relevant), and for cardiac and..."

GeneReviews places hearing under regular assessment, which is the practical consequence of the finding being recurrent enough to screen for.

Endocrine 1

Hypothyroidism OCCASIONAL HP:0000821

Single-cohort finding awaiting independent replication; the frequency band is taken from that cohort and may not generalise.

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"Hypothyroidism was first noted as a novel clinical feature (6/23, 26.1%)."

Reports the 26.1% rate and, by describing it as novel, marks it as unreplicated.

Eye 1

Ophthalmologic Abnormality FREQUENT Abnormality of the eye HP:0000478

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"intellectual disability (23/23, 100%) with varying degrees of severity, muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23, 56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)"

Gives the 47.8% ophthalmologic-problem rate supporting the frequent band.

Musculoskeletal 4

Abnormal Muscle Tone FREQUENT HP:0003808

Show evidence (2 references)

PMID:35392274 SUPPORT Human Clinical

"intellectual disability (23/23, 100%) with varying degrees of severity, muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23, 56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)"

Gives the 73.9% tone-abnormality rate supporting the frequent band.

PMID:32852922 SUPPORT Human Clinical

"Hypotonia, a common finding, can be associated with feeding difficulty in infancy."

Identifies hypotonia specifically as the common tone abnormality and links it to the feeding phenotype.

Progressive Spasticity HP:0001257

Course: PROGRESSIVE

Show evidence (1 reference)

PMID:29490693 SUPPORT Human Clinical

"We evaluated two male siblings with syndromic features characterized by mild-to-moderate ID and progressive spasticity."

Documents progressive spasticity in the hemizygous male siblings.

Scoliosis HP:0002650

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews lists scoliosis among the recurrent findings.

Joint Hypermobility HP:0001382

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews lists joint laxity among the recurrent findings.

Nervous System 16

Intellectual Disability VERY_FREQUENT HP:0001249

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"intellectual disability (23/23, 100%) with varying degrees of severity, muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23, 56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)"

Reports intellectual disability in 23 of 23 individuals, supporting the very frequent band.

Global Developmental Delay HP:0001263

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"The phenotype in males is diverse, including intellectual disability, speech/language delays, behavioural challenges and structural brain abnormalities."

Documents the multi-domain developmental phenotype in the male cohort.

Delayed Speech and Language Development HP:0000750

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"The phenotype in males is diverse, including intellectual disability, speech/language delays, behavioural challenges and structural brain abnormalities."

Names speech and language delay as part of the core phenotype.

Absent Speech FREQUENT HP:0001344

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"about 50% of affected girls remain nonverbal after age five years"

GeneReviews gives the proportion remaining nonverbal, supporting the frequent band.

Speech Apraxia HP:0011098

Show evidence (1 reference)

PMID:32345733 SUPPORT Human Clinical

"In 11/34 (32%) probands, we identified highly plausible pathogenic single nucleotide (n = 10; CDK13, EBF3, GNAO1, GNB1, DDX3X, MEIS2, POGZ, SETBP1, UPF2, ZNF142) or copy number (n = 1; 5q14.3q21.1 locus) variants in novel genes or loci for CAS."

Identifies DDX3X among the genes with plausible pathogenic variants in a cohort ascertained for childhood apraxia of speech.

Movement Disorder Abnormality of movement HP:0100022

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews names dyskinesia, spasticity and abnormal gait as the movement phenotypes.

Seizures OCCASIONAL HP:0001250

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"intellectual disability (23/23, 100%) with varying degrees of severity, muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23, 56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)"

Gives the 26.1% seizure rate supporting the occasional band.

EEG Abnormality FREQUENT HP:0002353

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"Furthermore, 9 patients showed abnormal electroencephalogram results (9/23, 39.1%)."

Gives the 39.1% abnormal-EEG rate supporting the frequent band.

Polymicrogyria HP:0002126

Show evidence (1 reference)

PMID:32135084 SUPPORT Human Clinical

"demonstrating a striking correlation between recurrent dominant missense mutations, polymicrogyria, and the most severe clinical outcomes"

Establishes polymicrogyria as a phenotype of the disorder and ties it to the missense allele class.

Corpus Callosum Hypoplasia Aplasia/Hypoplasia of the corpus callosum HP:0007370

Show evidence (1 reference)

PMID:26235985 SUPPORT Human Clinical

"we present 35 unique deleterious de novo mutations in DDX3X identified by whole exome sequencing in 38 females with ID and various other features including hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy"

Names corpus callosum hypoplasia in the founding female cohort.

Ventriculomegaly HP:0002119

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"A total of 15 individuals had notable brain anatomical disruption (15/23, 65.2%), including lateral ventricle enlargement, corpus callosum abnormalities, and delayed myelination."

Names lateral ventricle enlargement among the recurrent structural findings.

Delayed Myelination HP:0012448

Show evidence (1 reference)

PMID:33789733 SUPPORT Human Clinical

"We report a 10-year-old girl affected by delayed psychomotor development, delayed myelination, and polymicrogyria (PMG)."

Patient-level documentation of delayed myelination together with polymicrogyria.

Autistic Behaviour Autistic behavior HP:0000729

Show evidence (2 references)

PMID:32852922 SUPPORT Human Clinical

"Behavioral issues can include autism spectrum disorder, attention-deficit/hyperactivity disorder and hyperactivity, self-injurious behavior, poor impulse control, and aggression."

Lists autism spectrum disorder among the behavioural features.

PMID:35536379 SUPPORT INDIRECT Human Clinical

"Autism characteristics did not differ between DDX3X and comparison groups, while levels of anxiety and self-injurious behaviour (SIB) were significantly higher in the DDX3X group."

Qualifies the autism phenotype: present, but not elevated relative to other genetic causes of intellectual disability.

Attention Deficit Hyperactivity Disorder HP:0007018

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Behavioral issues can include autism spectrum disorder, attention-deficit/hyperactivity disorder and hyperactivity, self-injurious behavior, poor impulse control, and aggression."

Lists ADHD and hyperactivity among the behavioural features.

Self-Injurious Behaviour Self-injurious behavior HP:0100716

Show evidence (1 reference)

PMID:35536379 SUPPORT Human Clinical

"Autism characteristics did not differ between DDX3X and comparison groups, while levels of anxiety and self-injurious behaviour (SIB) were significantly higher in the DDX3X group."

A controlled comparison showing self-injurious behaviour is significantly raised in the DDX3X group.

Anxiety HP:0000739

Show evidence (1 reference)

PMID:35536379 SUPPORT Human Clinical

"Autism characteristics did not differ between DDX3X and comparison groups, while levels of anxiety and self-injurious behaviour (SIB) were significantly higher in the DDX3X group."

A controlled comparison showing anxiety is significantly raised in the DDX3X group.

Respiratory 1

Respiratory Difficulties Abnormal respiratory system physiology HP:0002795

No frequency band is recorded, for the same reason as the cardiac record: neither source reports a rate.

Show evidence (3 references)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

GeneReviews lists respiratory difficulties among the recurrent findings.

PMID:30349862 SUPPORT Human Clinical

"Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline."

An independent phenotype-expansion series reporting respiratory problems, and characterising them as rare rather than core.

PMID:32852922 SUPPORT Human Clinical

"Surveillance: Periodic evaluation by the multidisciplinary team regarding growth, developmental progress and educational needs, and psychiatric/behavioral issues; regular assessment of vision and hearing, of the spine for scoliosis, for seizure control (when relevant), and for cardiac and..."

GeneReviews directs ongoing respiratory assessment, confirming the finding is recurrent enough to warrant screening.

Neoplasm 1

Neuroblastoma VERY_RARE HP:0003006

Show evidence (2 references)

PMID:32852922 SUPPORT Human Clinical

"Neuroblastoma has been observed in three individuals."

GeneReviews records the three observed neuroblastomas, supporting the very rare band.

PMID:30936465 SUPPORT INDIRECT Human Clinical

"A pilocytic astrocytoma was incidentally diagnosed in Patient 1 and trigonocephaly was found in Patient 2."

A second, different tumour type in a separate series; cited as indirect because it concerns a brain tumour rather than neuroblastoma and rests on an incidental finding in one patient.

🧬

Genetic Associations

1

DDX3X

Gene: DDX3X hgnc:2745 relationship_type: CAUSATIVE variant_origin: GERMLINE

Show evidence (3 references)

PMID:26235985 SUPPORT Human Clinical

"we present 35 unique deleterious de novo mutations in DDX3X identified by whole exome sequencing in 38 females with ID and various other features including hypotonia, movement disorders, behavior problems, corpus callosum hypoplasia, and epilepsy"

Establishes DDX3X as the causative gene in the founding cohort.

PMID:32135084 SUPPORT Human Clinical

"De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of unexplained intellectual disability (ID) cases in females and are associated with autism, brain malformations, and epilepsy."

Confirms the gene-disease relationship and its share of unexplained female intellectual disability.

PMID:30349862 SUPPORT Human Clinical

"Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline."

Documents the rarer systemic and late-onset features that widen the DDX3X-associated phenotype beyond the neurodevelopmental core.

💊

Medical Actions

9

Early Developmental Intervention

Category: Therapeutic Action: Early Intervention NCIT:C159524

Platform: Behavioral / lifestyle

Early, individualised developmental and special-educational intervention is the foundation of care. It does not modify the molecular lesion; the argument for starting early is developmental rather than mechanistic.

Target Phenotypes: Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Treatment is symptomatic and focuses on optimizing the individual's abilities using a multidisciplinary approach that should also include psychosocial support for family members."

GeneReviews states that management is symptomatic and multidisciplinary, which is what this treatment record implements.

Speech-Language Therapy and Augmentative Communication

Category: Therapeutic Action: speech-language therapy with augmentative and alternative communication Ontology label: Speech Language Therapy NCIT:C159273

Platform: Behavioral / lifestyle

Speech-language assessment with early introduction of augmentative and alternative communication. About half of affected girls remain nonverbal beyond age five, so waiting for speech to emerge before providing an alternative delays communication access for the group with the greatest need.

Target Phenotypes: Delayed speech and language development HP:0000750 Absent speech HP:0001344

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"about 50% of affected girls remain nonverbal after age five years"

Quantifies the nonverbal fraction that motivates early augmentative and alternative communication rather than speech therapy alone.

Physical Therapy

Category: Therapeutic Action: Physical Therapy NCIT:C15302

Platform: Behavioral / lifestyle

Physiotherapy for hypotonia, gait, posture and mobility, and for the spasticity and movement abnormalities that occur in a subset.

Target Phenotypes: Hypotonia HP:0001252

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Other findings can include seizures, movement disorders (dyskinesia, spasticity, abnormal gait), vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis."

Names the tone, movement and gait problems that physiotherapy addresses. GeneReviews states these are managed as per standard care; no DDX3X-specific efficacy data exist.

Occupational Therapy

Category: Therapeutic Action: Occupational Therapy NCIT:C121351

Platform: Behavioral / lifestyle

Occupational therapy for fine-motor skills, adaptive function, sensory processing and daily-living independence.

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Treatment is symptomatic and focuses on optimizing the individual's abilities using a multidisciplinary approach that should also include psychosocial support for family members."

Supports occupational therapy as part of the multidisciplinary symptomatic approach; there is no DDX3X-specific trial of it.

Antiseizure Pharmacotherapy

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: anticonvulsant agent NCIT:C264

Platform: Small molecule

Standard antiseizure medication selected by seizure type for the minority who develop epilepsy. No DDX3X-specific drug choice or response rate has been established.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Management of feeding difficulty, intellectual disability, behavioral issues, seizures, spasticity and other movement disorders, vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis as per standard care."

GeneReviews directs seizure management to standard care, which is the basis for this record and for the absence of any disorder-specific regimen.

Feeding and Nutritional Support

Category: Therapeutic Action: Nutritional Support NCIT:C15433

Feeding therapy and nutritional support for the infantile feeding difficulty that accompanies hypotonia, with attention to growth.

Target Phenotypes: Feeding difficulties HP:0011968

Show evidence (1 reference)

PMID:32852922 SUPPORT Human Clinical

"Management of feeding difficulty, intellectual disability, behavioral issues, seizures, spasticity and other movement disorders, vision and hearing impairment, congenital heart defects, respiratory difficulties, joint laxity, and scoliosis as per standard care."

Names feeding difficulty as a managed manifestation.

Behavioural and Mental-Health Management

Category: Therapeutic Action: Behavioral Intervention NCIT:C15184

Platform: Behavioral / lifestyle

Structured management of anxiety, self-injurious behaviour, ADHD, sleep disturbance and irritability. Anxiety and self-injury are raised relative to other genetic intellectual disability, so they warrant active attention rather than being treated as background features of intellectual disability.

Target Phenotypes: Anxiety HP:0000739 Self-injurious behavior HP:0100716

Show evidence (1 reference)

PMID:35536379 SUPPORT INDIRECT Human Clinical

"Autism characteristics did not differ between DDX3X and comparison groups, while levels of anxiety and self-injurious behaviour (SIB) were significantly higher in the DDX3X group."

Establishes that anxiety and self-injury are disproportionately raised, which is the case for targeting them. The study measured the phenotype, not a treatment, so the support for the intervention itself is indirect.

Genetic Counselling and Reproductive Testing

Category: Counseling / Informational Action: Genetic Counseling NCIT:C15240

Counselling covers de novo versus inherited status, the residual recurrence risk from parental gonadal mosaicism after an apparently de novo result, and cascade testing in families with an inherited male hypomorphic allele. Prenatal and preimplantation testing are options once the familial variant is known.

Show evidence (3 references)

PMID:40164730 SUPPORT Human Clinical

"In our novel cohort, 6/17 variants are de novo in the affected male and 3/17 variants are de novo in the mother."

Shows that de novo and maternally arising alleles both occur in male families, which is exactly the distinction counselling has to establish before quoting a recurrence risk. It bears on that first counselling step only; the recurrence-risk and reproductive-testing claims below are carried by the GeneReviews items that follow.

PMID:32852922 SUPPORT Human Clinical

"the risk to sibs is slightly greater than that of the general population (though still <1%) because of the possibility of parental germline mosaicism"

Quantifies the residual sib recurrence risk after an apparently de novo result, and names parental germline mosaicism as its cause. This is the source for that clause of the record's description.

PMID:32852922 SUPPORT Human Clinical

"Once the DDX3X pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic testing are possible"

States that prenatal and preimplantation genetic testing become available once the familial variant is known, which is the reproductive-testing half of this record.

Multidisciplinary Supportive Care

Category: Monitoring Action: Supportive Care NCIT:C15747

Coordinated multidisciplinary surveillance: development and education, behaviour and mental health, vision and hearing, spine, growth and nutrition, cardiac and respiratory status, seizures where relevant, and psychosocial support for the family. Almost all of this is generic developmental-disability care; the one disorder-specific instruction is to begin screening girls for precocious puberty at age eight. This is the whole of current management; there is no disease-modifying therapy.

Show evidence (2 references)

PMID:32852922 SUPPORT Human Clinical

"Surveillance: Periodic evaluation by the multidisciplinary team regarding growth, developmental progress and educational needs, and psychiatric/behavioral issues; regular assessment of vision and hearing, of the spine for scoliosis, for seizure control (when relevant), and for cardiac and..."

Sets out the surveillance schedule this record represents.

PMID:32852922 SUPPORT Human Clinical

"Starting at age eight years, assess girls for evidence of precocious puberty."

The one age-anchored, disorder-specific surveillance instruction in the chapter: screening girls for precocious puberty from age eight.

🔬

Diagnosis

1

Trio Exome or Genome Sequencing

Diagnosis requires a compatible neurodevelopmental phenotype plus a pathogenic or likely pathogenic germline DDX3X variant. Trio sequencing is preferred because it establishes de novo status, which is central to interpreting a female heterozygote, and because the differential for unexplained developmental delay is broad. Chromosomal microarray detects DDX3X-containing deletions but misses the single-nucleotide and small indel variants that account for nearly all cases. There is no biochemical biomarker.

Show evidence (2 references)

PMID:32852922 SUPPORT Human Clinical

"The diagnosis of DDX3X-NDD is established in a female proband with suggestive findings and a heterozygous de novo DDX3X pathogenic variant identified by molecular genetic testing and in a male proband with suggestive findings and a hemizygous DDX3X pathogenic variant."

States the diagnostic criteria, including the different zygosity requirement by sex.

PMID:35392274 SUPPORT Human Clinical

"A total of 23 Chinese patients (i.e., 22 female and 1 male) with 22 de novo DDX3X deleterious variants were detected among 2,317 probands with unexplained intellectual disability (ID) undertaking whole exome sequencing (WES)."

Demonstrates exome sequencing as the diagnostic route in an unselected unexplained-intellectual-disability cohort.

📊

Prevalence

2

Worldwide

Cases In Literature Unknown

More than 1,000 diagnosed females worldwide as of 2025. This is an ascertainment count from diagnostic laboratories and registries, not an epidemiological estimate, and no population prevalence or incidence has been established. Ascertainment is strongly female-biased because hemizygous complete loss of function is not viable in males.

Show evidence (1 reference)

PMID:40164730 SUPPORT Human Clinical

"DDX3X-related neurodevelopmental disorder is one of the most common monogenic causes of intellectual disability in females, with currently >1000 females diagnosed worldwide."

Gives the worldwide diagnosed-case count that this record reports.

Females with unexplained intellectual disability in diagnostic sequencing cohorts

Unknown Unknown

Germline DDX3X variants explain roughly 1-3% of unexplained intellectual disability in females. Recorded here for completeness because it is the most quoted number for this disorder, but it is a diagnostic-cohort fraction rather than any of the standard occurrence measures, so measure_type and prevalence_class are left UNKNOWN rather than forced into a band. The structured version of this quantity is the case_fractions record on the DDX3X genetic entry.

Show evidence (1 reference)

PMID:35392274 SUPPORT Human Clinical

"A total of 23 Chinese patients (i.e., 22 female and 1 male) with 22 de novo DDX3X deleterious variants were detected among 2,317 probands with unexplained intellectual disability (ID) undertaking whole exome sequencing (WES)."

Gives the denominator and numerator of one such diagnostic cohort, which is the kind of measurement the 1-3% figure comes from.

🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Intellectual Disability X-linked 102:

Cerebral palsy

Overlapping Features A static motor phenotype with intellectual disability is readily labelled cerebral palsy, and DDX3X-related disorder has been diagnosed after such a label. Unexplained intellectual disability with a static motor picture should prompt genomic testing rather than closing the diagnosis clinically.

Distinguishing Features

Cerebral palsy is a clinical description with a presumed acquired or perinatal cause, whereas DDX3X-related disorder is established by a pathogenic germline variant.
A cortical malformation on brain MRI points away from a purely clinical cerebral-palsy label and towards a genetic malformation syndrome.

Tubulinopathies and other malformations of cortical development

Overlapping Features The DDX3X brain malformation pattern - malformations of cortical development with callosal dysgenesis, basal ganglia anomalies and midbrain-hindbrain involvement - closely resembles the tubulinopathies on imaging.

Distinguishing Features

Resolution is molecular; the imaging pattern alone does not separate DDX3X from TUBA1A and the other tubulin genes.

Show evidence (1 reference)

PMID:30936465 SUPPORT Human Clinical

"These findings expand the phenotypic spectrum of DDX3X-related disorders, demonstrating unique neuroradiological features resembling those of the tubulinopathies, and support a role for DDX3X in neuronal development."

States the radiological resemblance to the tubulinopathies that makes them the imaging differential.

🔬

Clinical Trials

2

NCT03718910 NOT_APPLICABLE COMPLETED

Completed observational deep-phenotyping study at the Seaver Autism Center, Mount Sinai, characterising DDX3X-related neurodevelopmental disorder with genetic, medical and neuropsychological measures. Natural history, not an intervention.

Target Phenotypes: Intellectual disability HP:0001249 Autistic behavior HP:0000729

Show evidence (1 reference)

clinicaltrials:NCT03718910 SUPPORT Human Clinical

"This study seeks to characterize DDX3X-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures."

The registry record states the study's DDX3X-specific characterisation aim.

NCT04436588 NOT_APPLICABLE UNKNOWN

Observational European/Asian multicentre study delineating the clinical and neuropsychological phenotype and testing for a DNA methylation episignature. Registry status has not been updated since the initial posting.

Show evidence (1 reference)

clinicaltrials:NCT04436588 SUPPORT Human Clinical

"The aims of this study are first to better delineate the clinical phenotype, as well as the neuropsychological profile and, second, to study the epigenetic signature in a cohort of individuals with DDX3X pathogenic variants."

The registry record states the phenotype-delineation and episignature aims.

🐁

Animal Models

4

Ddx3x heterozygous null mouse

A constitutive Ddx3x haploinsufficient female mouse, built to match the human protein-truncating allele class. It reproduces developmental delay, adult hyperactivity and anxiety-like behaviour, motor deficits, reduced brain volume, cortical thinning and defective lamination.

Species

Mus musculus

Genotype

Ddx3x+/- female

Background

Constitutive heterozygous null, construct validity for human loss-of-function alleles

Publication

PMID:34344536

Pathograph links

Aberrant Cortical Neuron Output and Cortical Malformation recapitulates fidelity: moderate Cortical thinning with defective lamination and reduced regional brain volume, the mouse counterpart of the human structural phenotype.

Limitations: The mouse cortex is lissencephalic, so it cannot model polymicrogyria - the malformation most tightly linked to the severe human missense alleles. Construct validity is for haploinsufficiency only; this allele does not model the granule-forming missense class.

Readouts

Cortical thickness and laminar organisation

Direction: DECREASED

Interpretation: Cortical thinning with disordered lamination is the structural readout of abnormal cortical neuron output in this model.

Show evidence (1 reference)

PMID:34344536 SUPPORT Model Organism

"Cortical thinning was accompanied by defective cortical lamination, indicating that Ddx3x regulates the balance of glutamatergic neurons in the developing cortex."

Reports the cortical thickness and lamination measurement behind this readout.

Regional brain volume on MRI

Direction: DECREASED

Interpretation: Reduced total and regional brain volume, disproportionately cortex and amygdala.

Show evidence (1 reference)

PMID:34344536 SUPPORT Model Organism

"Developmental and behavioral changes were associated with a reduction in brain volume, with some regions (e.g., cortex and amygdala) disproportionally affected."

Reports the MRI volumetric measurement behind this readout.

Show evidence (1 reference)

PMID:34344536 SUPPORT Model Organism

"These data shed new light on the developmental mechanisms driving DDX3X syndrome and support construct and face validity of this novel preclinical mouse model."

The authors' own construct- and face-validity claim for this model.

Ddx3x conditional neural progenitor knockout mouse

A dosage series of Ddx3x loss restricted to neural progenitors, used with live imaging and in vivo ribosome profiling. It is the model that separates the cell-cycle and translational arms of the mechanism and that shows the male-specific Ddx3y contribution.

Species

Mus musculus

Genotype

Conditional Ddx3x loss from neural progenitors (female homozygous, female heterozygous, male hemizygous)

Publication

PMID:35762573

Pathograph links

Altered Neural Progenitor Cell Cycle and Neurogenic Division recapitulates fidelity: high Live imaging of progenitors demonstrates altered cell-cycle duration and a shifted balance of neurogenic divisions, and ribosome profiling identifies the DDX3X-dependent translated transcripts underlying it.

Limitations: Mouse corticogenesis lacks the expanded human outer subventricular zone and outer radial glia, so the quantitative relationship between progenitor behaviour and cortical output may not transfer. Conditional deletion also removes Ddx3x more completely than any human allele does.

Readouts

Progenitor cell-cycle duration and neurogenic division fraction

Direction: ALTERED

Interpretation: Both parameters shift on live imaging, and together they set neuronal output.

Show evidence (1 reference)

PMID:35762573 SUPPORT Model Organism

"we show that DDX3X promotes neuronal generation by regulating both cell cycle duration and neurogenic divisions"

Reports the live-imaging measurement behind this readout.

Show evidence (1 reference)

PMID:35762573 SUPPORT Model Organism

"Here, using a mouse model of Ddx3x loss-of-function we demonstrate that DDX3X directs translational and cell cycle control of neural progenitors, which underlies precise corticogenesis."

Supports treating this model as informative for progenitor cell-cycle and division control.

Neural Stem and Progenitor Pool Depletion recapitulates fidelity: moderate Reduced neurogenesis across the dosage series, with frank microcephaly only at complete female progenitor loss.

Limitations: The genotype that produces microcephaly (complete progenitor loss in females) has no human counterpart; the human-equivalent genotypes give reduced neurogenesis without marked microcephaly, which is the honest match.

Readouts

Neuron production and brain size across the Ddx3x dosage series

Direction: DECREASED

Interpretation: Neurogenesis falls with reducing Ddx3x dosage; microcephaly appears only at the null extreme.

Show evidence (1 reference)

PMID:35762573 SUPPORT Model Organism

"First, we show brain development is sensitive to Ddx3x dosage; complete Ddx3x loss from neural progenitors causes microcephaly in females, whereas hemizygous males and heterozygous females show reduced neurogenesis without marked microcephaly."

Reports the dosage-graded neurogenesis and brain-size measurement behind this readout.

ddx3x-deficient zebrafish

A ddx3x-deficient zebrafish with developmental delay, microcephaly, social and adaptation deficits and impaired spatial recognition memory, profiled by single-nucleus RNA sequencing. It is the system in which the CREBBP-Notch arm and the excitatory/inhibitory imbalance were established, and in which glutamatergic supplementation partly rescued the behavioural phenotype.

Species

Danio rerio

Genotype

ddx3x loss-of-function allele

Publication

PMID:39471229

Pathograph links

Reduced CREBBP mRNA Stability and Notch Signalling recapitulates fidelity: moderate The molecular arm of the mechanism - crebbp mRNA destabilisation and reduced Notch signalling - was demonstrated in this model.

Limitations: Established only in zebrafish; there is no human tissue or human cellular confirmation of the CREBBP-Notch step, and zebrafish forebrain development differs substantially from mammalian corticogenesis.

Readouts

crebbp mRNA stability and Notch pathway output

Direction: DECREASED

Interpretation: Reduced crebbp message stability with downstream loss of Notch signalling.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"Mechanistically, we reveal that the ddx3x deficiency attenuates the stability of the crebbp mRNA, which in turn causes downregulation of Notch signaling and defects in neurogenesis."

Reports the mRNA-stability and Notch measurements behind this readout.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"We generated a ddx3x deficient zebrafish allele, which exhibited reduced survival rate, DD, microcephaly, adaptation defects, anxiolytic behaviors, social interaction deficits, and impaired spatial recognitive memory."

Establishes the model and its developmental and behavioural phenotype.

Excitatory-Inhibitory Neuronal Differentiation Imbalance recapitulates fidelity: low Single-nucleus transcriptomics shows imbalanced excitatory and inhibitory neuron differentiation, and glutamatergic supplementation partly rescues the behavioural consequence.

Limitations: Fidelity is rated low because the human excitatory/inhibitory balance has not been measured in this disorder, and because the behavioural constructs rescued in zebrafish (adaptation, social interaction) map only loosely onto the human behavioural phenotype.

Readouts

Excitatory and inhibitory neuron differentiation ratio

Direction: ALTERED

Interpretation: The ratio of excitatory to inhibitory neuron production is shifted.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"ddx3x deficiency leads to reduced neural stem cell pool, decreased total neuron number, and imbalanced differentiation of excitatory and inhibitory neurons, which are responsible for the behavioral defects"

Reports the single-nucleus differentiation measurement behind this readout.

Behavioural rescue by glutamatergic supplementation

Direction: RESTORED

Interpretation: Partial reversal of adaptation and social deficits by L-glutamate or an mGluR2/3 agonist, arguing the deficit is functional rather than purely structural.

Show evidence (1 reference)

PMID:39471229 SUPPORT Model Organism

"the supplementation of L-glutamate or glutamate receptor agonist ly404039 could partly rescue the adaptation and social deficits"

Reports the pharmacological rescue behind this readout.

p.Arg79Lys zebrafish rescue assay

An established zebrafish assay of DDX3X activity used to classify the inherited male p.Arg79Lys allele. It is a variant-interpretation assay rather than a disease model, and it is what turned a hemizygous missense variant of uncertain significance into a demonstrated hypomorph.

Species

Danio rerio

Genotype

ddx3x morphant rescued with human DDX3X p.Arg79Lys mRNA

Publication

PMID:29490693

Pathograph links

Hemizygous Partial Loss of DDX3X Function in Males measures fidelity: moderate Quantifies residual DDX3X activity for a specific male allele, which is the property this pathophysiology node asserts.

Limitations: A heterologous rescue readout in fish, not a measurement in human neural tissue; it establishes relative allele activity, not the absolute residual function in a patient's brain.

Readouts

Rescue of the ddx3x-depletion phenotype by the p.Arg79Lys allele

Direction: DECREASED

Interpretation: Partial rather than complete rescue, classifying the allele as hypomorphic.

Show evidence (1 reference)

PMID:29490693 SUPPORT Model Organism

"found that this allele causes a partial loss of DDX3X function and thus represents a hypomorphic variant"

Reports the rescue result behind this readout.

{ }

Source YAML

click to show

name: Intellectual Disability X-linked 102
creation_date: "2026-09-04T02:26:58Z"
description: >-
  Intellectual disability, X-linked 102 (MRX102) is the OMIM/MONDO label for the
  DDX3X-related neurodevelopmental disorder, also called DDX3X syndrome or
  syndromic X-linked intellectual developmental disorder of the Snijders Blok
  type. It is caused by germline variants in DDX3X, which encodes an
  ATP-dependent DEAD-box RNA helicase acting in translation initiation on
  structured transcripts and in ribonucleoprotein-granule dynamics. Germline
  DDX3X variants account for roughly 1-3% of otherwise unexplained intellectual
  disability in females, which makes an individually rare disorder one of the
  more frequent single-gene causes of female intellectual disability.

  Two features have to be modelled explicitly rather than averaged away. First,
  the presentation is not confined to intellectual disability: the founding
  cohort and every subsequent series report hypotonia, movement disorder,
  behavioural difficulty, epilepsy and structural brain malformation - corpus
  callosum hypoplasia, ventriculomegaly, delayed myelination and, in the severe
  missense group, polymicrogyria. The MONDO term's "non-syndromic" wording is a
  gene-series design-pattern label and is at odds with the published phenotype;
  the entry curates what the literature reports and records the discrepancy
  rather than adopting either reading silently.

  Second, the sex difference is mechanistic. DDX3X partially escapes
  X-chromosome inactivation, so a heterozygous female expresses the variant
  allele even when inactivation is skewed against it, and skewing is therefore
  not protective. Most affected females carry de novo heterozygous alleles of
  any class, including protein-truncating ones. Affected males are almost always
  hemizygous for a missense or splice allele - frequently inherited from an
  unaffected or mildly affected carrier mother - and no germline truncating male
  allele has been reported, consistent with hemizygous complete loss of function
  being poorly tolerated. Allele class matters independently of sex: severe
  helicase-domain missense proteins do more than reduce dosage, forming ectopic
  RNA-protein granules and disturbing translation, and it is that group that
  correlates with polymicrogyria and the worst outcomes.
category: Mendelian
parents:
- hereditary disease
synonyms:
- MRX102
- DDX3X syndrome
- DDX3X-related neurodevelopmental disorder
- mental retardation, X-linked 102
- intellectual developmental disorder, X-linked, syndrome, Snijders Blok type
- MRXSSB
disease_term:
  preferred_term: DDX3X-related neurodevelopmental disorder
  term:
    id: MONDO:0010497
    label: intellectual disability, X-linked 102
mappings:
  mondo_mappings:
  - term:
      id: MONDO:0018709
      label: X-linked intellectual disability-hypotonia-movement disorder syndrome
    mapping_predicate: skos:closeMatch
    mapping_source: MONDO
    mapping_justification: >-
      MONDO:0018709 names the syndromic concept this entry actually curates -
      intellectual disability with hypotonia and movement disorder - and is the
      term the deep-research report proposed. It is recorded as a closeMatch
      rather than an exactMatch because the two terms are separate MONDO
      concepts sitting under different parents, and MONDO:0010497 remains the
      disease_term for the reasons set out in the non_syndromic_label_mismatch
      discussion. A closeMatch is a cross-reference and deliberately does not
      retire MONDO:0018709 from the curation queue.
inheritance:
- name: X-linked inheritance
  inheritance_term:
    preferred_term: X-linked inheritance
    term:
      id: HP:0001417
      label: X-linked inheritance
  description: >-
    DDX3X sits at Xp11.4 and the disorder is X-linked, but neither the dominant
    nor the recessive label alone describes it. Most recognised probands are
    females with a de novo heterozygous allele; a minority are hemizygous males
    with a missense or splice allele that is often maternally inherited from an
    unaffected or only mildly affected carrier.
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our data show that variants in DDX3X can cause an X-linked
      neurodevelopmental disorder in males, with unaffected or mildly affected
      carrier females.
    explanation: >-
      States the X-linked mode and the carrier-female pattern that distinguishes
      the male families from the de novo female majority.
- name: X-linked dominant inheritance
  inheritance_term:
    preferred_term: X-linked dominant inheritance
    term:
      id: HP:0001423
      label: X-linked dominant inheritance
  de_novo_rate: >-
    Nearly all reported female probands carry a de novo allele; 22 of 22 female
    variants in a 2,317-proband Chinese exome cohort were de novo.
  description: >-
    The female presentation behaves dominantly: a single heterozygous allele is
    sufficient, and because DDX3X escapes X-inactivation the wild-type allele on
    the active X does not rescue dosage.
  evidence:
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we present 35 unique deleterious de novo mutations in DDX3X identified by
      whole exome sequencing in 38 females with ID and various other features
      including hypotonia, movement disorders, behavior problems, corpus
      callosum hypoplasia, and epilepsy
    explanation: >-
      The founding cohort establishes de novo heterozygous alleles in females as
      the dominant-acting mechanism.
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 17 DDX3X variants were novel and 22 were de novo.
    explanation: >-
      Quantifies the de novo rate in an independent diagnostic cohort of 23
      patients (22 female, 1 male).
- name: X-linked recessive inheritance
  inheritance_term:
    preferred_term: X-linked recessive inheritance
    term:
      id: HP:0001419
      label: X-linked recessive inheritance
  description: >-
    Families with an inherited hypomorphic missense allele segregate in an
    apparently X-linked recessive pattern: hemizygous males are affected while
    the transmitting heterozygous mother is unaffected or only mildly affected.
    This is not a separate disease but the same locus seen through a
    residual-function allele. A carrier mother transmits the allele to half her
    pregnancies; sons who inherit it are affected, and daughters who inherit it
    become heterozygotes who are not expected to manifest a neurodevelopmental
    phenotype.
  evidence:
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we present three families with segregating missense mutations in DDX3X,
      suggestive of an X-linked recessive inheritance pattern. In these families,
      all males with the DDX3X variant had ID, whereas carrier females were
      unaffected.
    explanation: >-
      Documents the segregating male families and the unaffected carrier
      mothers.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      If the mother of an affected male has a DDX3X pathogenic variant, the
      chance of transmitting it in each pregnancy is 50%
    explanation: >-
      Gives the per-pregnancy transmission risk from a carrier mother, which is
      the quantitative content of the X-linked recessive recurrence risk.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Males who inherit the pathogenic variant will be affected; females who
      inherit the pathogenic variant will be heterozygotes and are not expected
      to manifest a neurodevelopmental phenotype
    explanation: >-
      States the sex-dependent outcome of inheriting a male-associated allele,
      which is what makes these families read as recessive despite the same
      locus acting dominantly in de novo female probands.
has_subtypes:
- name: Female heterozygous
  display_name: Female heterozygous DDX3X-related neurodevelopmental disorder
  description: >-
    The majority presentation. A de novo heterozygous allele of any class -
    nonsense, frameshift, canonical or non-canonical splice, missense, in-frame
    indel - in a female. Protein-truncating alleles act by haploinsufficiency;
    severe helicase-domain missense alleles behave differently and mark the
    polymicrogyria/severe-outcome group.
  genes:
  - preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  evidence:
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      demonstrating a striking correlation between recurrent dominant missense
      mutations, polymicrogyria, and the most severe clinical outcomes
    explanation: >-
      The 107-individual cohort separates the severe missense group from the
      rest of the female presentation.
- name: Male hemizygous
  display_name: Male hemizygous DDX3X-related neurodevelopmental disorder
  description: >-
    Hemizygous males carrying a missense or splice allele with retained partial
    function, either de novo or inherited from a carrier mother. No germline
    truncating allele has been reported in a male. Recurrent substitutions
    p.(Arg351Gln) and p.(Arg488Cys) account for part of the reported cohort.
  genes:
  - preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  inheritance:
  - name: X-linked recessive inheritance
    inheritance_term:
      preferred_term: X-linked recessive inheritance
      term:
        id: HP:0001419
        label: X-linked recessive inheritance
    description: >-
      Maternally inherited hypomorphic alleles segregate with disease in males
      and not in the carrier mother.
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The vast majority of males have missense variants, including two recurrent
      variants (p.(Arg351Gln) and p.(Arg488Cys)). No truncating variants have
      been reported, consistent with the presumed embryonic lethality of complete
      loss-of-function of DDX3X in males.
    explanation: >-
      Defines the male allelic architecture and the absence of truncating male
      alleles that motivates curating this stratum separately.
pathophysiology:
- name: Partial Escape from X-Chromosome Inactivation
  biological_scale: MOLECULAR
  description: >-
    DDX3X partially escapes X-chromosome inactivation, so both alleles are
    transcribed in a heterozygous female. The usual protection that functional
    mosaicism or wild-type-favouring skewing gives a female carrier of an
    X-linked allele therefore does not apply here, which is the structural reason
    the recognised patient population is female-biased rather than male-biased as
    it is for most X-linked intellectual disability genes.
  genes:
  - preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DDX3X is an essential gene located on the X-chromosome (Xp11.4), that
      partially escapes X-inactivation
    explanation: >-
      States the escape-from-inactivation property that the sex-dependent
      architecture rests on.
  - reference: PMID:36299587
    reference_title: "Case Report: De novo DDX3X mutation caused intellectual disability in a female with skewed X-chromosome inactivation on the mutant allele."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It was discovered that XCI in the mutant allele was insufficient to reverse
      the phenotype of DDX3X-related neurodevelopmental disorder.
    explanation: >-
      A symptomatic female with extreme inactivation of the mutant X shows
      directly that skewing does not rescue the phenotype.
  downstream:
  - target: DDX3X RNA Helicase Deficiency
    causal_link_type: DIRECT
    description: >-
      Because the variant allele continues to be expressed from the inactive X,
      a heterozygous female retains a substantial mutant transcript fraction and
      the functional deficiency is established despite skewing.
    evidence:
    - reference: PMID:36299587
      reference_title: "Case Report: De novo DDX3X mutation caused intellectual disability in a female with skewed X-chromosome inactivation on the mutant allele."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        the normal and mutated DDX3X expression accounted for respectively 70%
        and 30% of total
      explanation: >-
        Allele-specific expression quantifies the residual mutant fraction that
        escape leaves in place even under extreme skewing.
- name: Hemizygous Partial Loss of DDX3X Function in Males
  biological_scale: MOLECULAR
  description: >-
    A male has one DDX3X allele and no functional somatic backup, so complete
    loss of function is not compatible with a liveborn phenotype; every reported
    germline male allele is missense or splice-altering and retains partial
    activity. This is the male entry point into the same downstream chain, and it
    is why the male allelic spectrum is narrower than the female one rather than
    simply rarer.
  genes:
  - preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  genetic_context:
    variant_origin: GERMLINE
    zygosity: HEMIZYGOUS
    functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
    description: >-
      Hemizygous germline missense or splice-altering alleles with retained
      residual helicase function. The p.Arg79Lys allele, which lies outside the
      core helicase domain, was shown to be hypomorphic in a zebrafish
      functional assay.
  evidence:
  - reference: PMID:29490693
    reference_title: A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      found that this allele causes a partial loss of DDX3X function and thus
      represents a hypomorphic variant
    explanation: >-
      A zebrafish rescue assay establishes partial rather than complete loss of
      function for the inherited male allele.
  - reference: PMID:29490693
    reference_title: A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      consistent with the hypothesis that haploinsufficiency at this locus on the
      X-chromosome is likely to be lethal in males
    explanation: >-
      States the viability constraint that restricts the male allelic spectrum to
      residual-function alleles.
  downstream:
  - target: DDX3X RNA Helicase Deficiency
    causal_link_type: DIRECT
    description: >-
      A hemizygous hypomorphic allele produces the same helicase deficiency, at a
      severity set by how much activity the allele retains.
    evidence:
    - reference: PMID:40164730
      reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The phenotype in males is diverse, including intellectual disability,
        speech/language delays, behavioural challenges and structural brain
        abnormalities.
      explanation: >-
        Confirms that the hemizygous route reaches the same clinical territory as
        the female heterozygous route.
- name: DDX3X RNA Helicase Deficiency
  biological_scale: MOLECULAR
  description: >-
    Reduced ATP-dependent RNA-helicase activity of DDX3X, arising either from
    reduced dosage (protein-truncating alleles, haploinsufficiency) or from
    direct impairment of the catalytic machinery by helicase-domain missense
    alleles. This is the shared lesion that the female and male routes converge
    on.
  genes:
  - preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  molecular_functions:
  - preferred_term: RNA helicase activity
    term:
      id: GO:0003724
      label: RNA helicase activity
    modifier: DECREASED
  genetic_context:
    variant_origin: GERMLINE
    functional_impact_category: LOSS_OF_FUNCTION
    description: >-
      Germline alleles spanning nonsense, frameshift, canonical and
      non-canonical splice, missense and in-frame indel classes. Truncating
      female alleles are consistent with haploinsufficiency; severe
      helicase-domain missense alleles impair catalysis directly and additionally
      seed ectopic granules, so they are not simply stronger null alleles.
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Severe DDX3X missense mutations profoundly disrupt RNA helicase activity,
      induce ectopic RNA-protein granules in neural progenitors and neurons, and
      impair translation.
    explanation: >-
      Biochemical and cell-based assays show the missense alleles reduce helicase
      activity itself rather than only protein amount.
  downstream:
  - target: Impaired Translation of Structured Transcripts
    causal_link_type: DIRECT
    description: >-
      Loss of unwinding activity leaves structured 5' untranslated regions
      unresolved, so the transcripts that depend on DDX3X for initiation are
      under-translated.
    evidence:
    - reference: PMID:33789733
      reference_title: "A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The identified mutation is located just upstream the helicase domain and
        is suggested to impair the protein activity, thus resulting in the
        altered translation of DDX3X-dependent mRNAs.
      explanation: >-
        Connects a patient allele's position relative to the helicase domain to
        the predicted translational consequence. The inference from position to
        translation is the authors' interpretation, not a functional assay in
        this patient.
  - target: Ectopic RNA-Protein Granule Formation
    causal_link_type: DIRECT
    description: >-
      Severe-missense branch. Mutant DDX3X protein nucleates ectopic
      ribonucleoprotein granules in neural progenitors and neurons, a behaviour
      the truncating alleles do not have.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Severe DDX3X missense mutations profoundly disrupt RNA helicase activity,
        induce ectopic RNA-protein granules in neural progenitors and neurons,
        and impair translation.
      explanation: >-
        Names the granule phenotype as specific to the severe missense class.
  - target: Reduced CREBBP mRNA Stability and Notch Signalling
    causal_link_type: DIRECT
    description: >-
      DDX3X loss destabilises crebbp mRNA and thereby lowers Notch signalling.
      Shown in zebrafish; not yet demonstrated in human tissue.
    evidence:
    - reference: PMID:39471229
      reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Mechanistically, we reveal that the ddx3x deficiency attenuates the
        stability of the crebbp mRNA, which in turn causes downregulation of
        Notch signaling and defects in neurogenesis.
      explanation: >-
        Establishes the CREBBP-Notch arm downstream of helicase deficiency in a
        zebrafish loss-of-function allele.
  - target: Attenuated Canonical Wnt Signalling
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Every de novo allele tested reduced canonical Wnt output in a zebrafish
      assay. The assay was used as a surrogate readout of DDX3X function rather
      than as a demonstration that Wnt is the route to the human brain
      phenotype, so the intermediates between this node and corticogenesis are
      not established.
    evidence:
    - reference: PMID:26235985
      reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We demonstrate a consistent loss-of-function effect of all tested de novo
        mutations on the Wnt pathway, and we further show a differential effect
        by gender.
      explanation: >-
        Supports the Wnt arm and, separately, records that its magnitude differs
        by sex.
- name: Impaired Translation of Structured Transcripts
  biological_scale: MOLECULAR
  description: >-
    DDX3X is required for cap-dependent initiation on messages with structured
    5' untranslated regions. When helicase activity falls, that subset of the
    neural translatome is selectively under-produced; ribosome profiling in vivo
    identifies the DDX3X-dependent transcripts and shows several are required for
    neurogenesis.
  biological_processes:
  - preferred_term: translational initiation
    term:
      id: GO:0006413
      label: translational initiation
    modifier: DECREASED
  - preferred_term: RNA processing
    term:
      id: GO:0006396
      label: RNA processing
    modifier: DYSREGULATED
  cell_types:
  - preferred_term: cortical neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  evidence:
  - reference: PMID:35762573
    reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Finally, we use ribosome profiling in vivo to discover the repertoire of
      translated transcripts in neural progenitors, including those which are
      DDX3X-dependent and essential for neurogenesis.
    explanation: >-
      Identifies the DDX3X-dependent translated transcripts in progenitors and
      links them to neurogenesis.
  downstream:
  - target: Altered Neural Progenitor Cell Cycle and Neurogenic Division
    causal_link_type: DIRECT
    description: >-
      Translational control of the progenitor transcriptome is one of the two
      arms by which DDX3X sets cortical neuron output in the mouse model.
    evidence:
    - reference: PMID:35762573
      reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Here, using a mouse model of Ddx3x loss-of-function we demonstrate that
        DDX3X directs translational and cell cycle control of neural progenitors,
        which underlies precise corticogenesis.
      explanation: >-
        States the translation-to-progenitor-behaviour link that this edge
        represents.
- name: Ectopic RNA-Protein Granule Formation
  biological_scale: CELLULAR
  description: >-
    Severe missense DDX3X protein assembles into ectopic cytoplasmic
    ribonucleoprotein granules in neural progenitors and neurons, sequestering
    message and further disturbing translation. This is the mechanistic feature
    that separates the severe missense group from simple dosage loss and tracks
    with polymicrogyria and the worst clinical outcomes.
  cellular_components:
  - preferred_term: ectopic cytoplasmic ribonucleoprotein granule
    term:
      id: GO:0035770
      label: ribonucleoprotein granule
    modifier: INCREASED
  cell_types:
  - preferred_term: cortical neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Severe DDX3X missense mutations profoundly disrupt RNA helicase activity,
      induce ectopic RNA-protein granules in neural progenitors and neurons, and
      impair translation.
    explanation: >-
      Direct demonstration of ectopic granules in the relevant cell types.
  downstream:
  - target: Impaired Translation of Structured Transcripts
    causal_link_type: DIRECT
    description: >-
      Granule formation is reported together with aberrant translation in the
      same cells, so the severe missense branch reaches the translational defect
      by a second route beyond loss of catalytic activity.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Severe DDX3X missense mutations profoundly disrupt RNA helicase activity,
        induce ectopic RNA-protein granules in neural progenitors and neurons,
        and impair translation.
      explanation: >-
        Couples granule induction to impaired translation in progenitors and
        neurons.
  - target: Polymicrogyria
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The alleles that produce granules are the alleles that correlate with
      polymicrogyria in the 107-individual clinical cohort. The correlation is
      genotype-phenotype, so the steps between granule formation and the cortical
      malformation are inferred rather than demonstrated.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        demonstrating a striking correlation between recurrent dominant missense
        mutations, polymicrogyria, and the most severe clinical outcomes
      explanation: >-
        The clinical correlation is what links the granule-forming allele class
        to polymicrogyria; the intervening cellular steps are not shown.
- name: Reduced CREBBP mRNA Stability and Notch Signalling
  biological_scale: MOLECULAR
  description: >-
    DDX3X deficiency destabilises crebbp mRNA, and the resulting fall in CREBBP
    lowers Notch signalling in the developing brain. Demonstrated in a
    ddx3x-deficient zebrafish with single-nucleus transcriptomics and biological
    validation; the human counterpart has not been shown.
  biological_processes:
  - preferred_term: Notch signaling pathway
    term:
      id: GO:0007219
      label: Notch signaling pathway
    modifier: DECREASED
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:39471229
    reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Mechanistically, we reveal that the ddx3x deficiency attenuates the
      stability of the crebbp mRNA, which in turn causes downregulation of Notch
      signaling and defects in neurogenesis.
    explanation: >-
      Establishes the mRNA-stability-to-Notch step in the zebrafish model.
  downstream:
  - target: Neural Stem and Progenitor Pool Depletion
    causal_link_type: DIRECT
    description: >-
      Notch signalling maintains the neural stem cell pool; its loss reduces that
      pool in the ddx3x-deficient zebrafish.
    evidence:
    - reference: PMID:39471229
      reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        ddx3x deficiency leads to reduced neural stem cell pool, decreased total
        neuron number, and imbalanced differentiation of excitatory and
        inhibitory neurons, which are responsible for the behavioral defects
      explanation: >-
        Measures the reduced stem cell pool downstream of the Notch defect.
  - target: Excitatory-Inhibitory Neuronal Differentiation Imbalance
    causal_link_type: DIRECT
    description: >-
      The same lesion shifts the ratio in which excitatory and inhibitory neurons
      are produced.
    evidence:
    - reference: PMID:39471229
      reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        ddx3x deficiency leads to reduced neural stem cell pool, decreased total
        neuron number, and imbalanced differentiation of excitatory and
        inhibitory neurons, which are responsible for the behavioral defects
      explanation: >-
        Reports the excitatory/inhibitory imbalance as a distinct consequence
        alongside pool depletion.
- name: Attenuated Canonical Wnt Signalling
  biological_scale: MOLECULAR
  description: >-
    Canonical Wnt output falls when DDX3X function is reduced. In the founding
    study this was a zebrafish surrogate assay of allele function, and the size
    of the effect differed between the female and male dosage contexts. It is
    retained here as a genuine but provisional arm: it grounds the sex-dependent
    dosage argument, and it has not been shown to be the route to any specific
    human brain phenotype.
  biological_processes:
  - preferred_term: canonical Wnt signaling pathway
    term:
      id: GO:0060070
      label: canonical Wnt signaling pathway
    modifier: DECREASED
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We demonstrate a consistent loss-of-function effect of all tested de novo
      mutations on the Wnt pathway, and we further show a differential effect by
      gender.
    explanation: >-
      Records both the Wnt effect and its sex dependence in the zebrafish assay.
  downstream:
  - target: Altered Neural Progenitor Cell Cycle and Neurogenic Division
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Canonical Wnt is a standard regulator of cortical progenitor proliferation,
      so this edge is the plausible connection to the progenitor node. No study
      has demonstrated it for DDX3X, and the edge is drawn with unknown
      intermediates for that reason.
    evidence:
    - reference: PMID:26235985
      reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        The differential activity possibly reflects a dose-dependent effect of
        DDX3X expression in the context of functional mosaic females versus
        one-copy males, which reflects the complex biological nature of DDX3X
        mutations.
      explanation: >-
        The authors themselves frame the Wnt readout as a dose-dependent
        surrogate rather than a demonstrated developmental pathway, which is why
        this edge is marked indirect.
- name: Altered Neural Progenitor Cell Cycle and Neurogenic Division
  biological_scale: CELLULAR
  conforms_to: "neural_progenitor_centrosome_spindle_dysfunction#Abnormal Progenitor Division and Fate Choice"
  description: >-
    Radial glial and neural progenitor cells lose precise control of cell-cycle
    duration and of the choice between self-renewing and neurogenic division.
    Live imaging of Ddx3x-deficient progenitors shows both parameters shift, and
    they together set how many neurons the cortex produces. This is the DDX3X
    substitution into the module's progenitor-division node: the perturbation
    reaching the cell cycle is translational rather than centrosomal.
  cell_types:
  - preferred_term: cortical radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  - preferred_term: cortical neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: mitotic cell cycle
    term:
      id: GO:0000278
      label: mitotic cell cycle
    modifier: DYSREGULATED
  - preferred_term: asymmetric neurogenic division
    term:
      id: GO:0008356
      label: asymmetric cell division
    modifier: DYSREGULATED
  mechanism_confidence: ESTABLISHED
  evidence:
  - reference: PMID:35762573
    reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we show that DDX3X promotes neuronal generation by regulating both cell
      cycle duration and neurogenic divisions
    explanation: >-
      Live imaging of progenitors demonstrates the two division parameters this
      node names.
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We show that Ddx3x controls cortical development by regulating neuron
      generation.
    explanation: >-
      Independent demonstration that DDX3X acts on neuron generation during
      corticogenesis.
  downstream:
  - target: Neural Stem and Progenitor Pool Depletion
    causal_link_type: DIRECT
    description: >-
      Altered division parameters change the size and composition of the
      progenitor pool, the module's next step.
    evidence:
    - reference: PMID:35762573
      reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        First, we show brain development is sensitive to Ddx3x dosage; complete
        Ddx3x loss from neural progenitors causes microcephaly in females,
        whereas hemizygous males and heterozygous females show reduced
        neurogenesis without marked microcephaly.
      explanation: >-
        Ties progenitor-level Ddx3x loss to reduced neurogenesis and, at the
        extreme, to microcephaly.
- name: Neural Stem and Progenitor Pool Depletion
  biological_scale: CELLULAR
  conforms_to: "neural_progenitor_centrosome_spindle_dysfunction#Progenitor Pool Distortion"
  description: >-
    The cortical neural stem and progenitor pool is reduced, and with it the
    total number of neurons generated. Dosage-dependent: complete progenitor loss
    in females gives frank microcephaly, whereas the heterozygous female and
    hemizygous male states reduce neurogenesis without marked microcephaly, which
    matches the human observation that most patients are not microcephalic.
  cell_types:
  - preferred_term: neural stem cell
    term:
      id: CL:0000047
      label: neural stem cell
  - preferred_term: cortical neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: cortical radial glial cell
    term:
      id: CL:0000681
      label: radial glial cell
  biological_processes:
  - preferred_term: neurogenesis
    term:
      id: GO:0022008
      label: neurogenesis
    modifier: DECREASED
  - preferred_term: progenitor population proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: DYSREGULATED
  - preferred_term: maintenance of neural stem cell number
    term:
      id: GO:0098727
      label: maintenance of cell number
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:35762573
    reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      First, we show brain development is sensitive to Ddx3x dosage; complete
      Ddx3x loss from neural progenitors causes microcephaly in females, whereas
      hemizygous males and heterozygous females show reduced neurogenesis without
      marked microcephaly.
    explanation: >-
      Establishes the dosage-graded reduction in neurogenesis that this node
      records.
  downstream:
  - target: Aberrant Cortical Neuron Output and Cortical Malformation
    causal_link_type: DIRECT
    description: >-
      Fewer and mistimed neurons produce an abnormally built cortex, the module's
      terminal developmental node.
    evidence:
    - reference: PMID:34344536
      reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Cortical thinning was accompanied by defective cortical lamination,
        indicating that Ddx3x regulates the balance of glutamatergic neurons in
        the developing cortex.
      explanation: >-
        Shows the structural cortical consequence in a haploinsufficient mouse
        with construct validity for the human truncating alleles.
- name: Excitatory-Inhibitory Neuronal Differentiation Imbalance
  biological_scale: CELLULAR
  description: >-
    The ratio in which excitatory and inhibitory neurons are produced is
    disturbed. In the zebrafish model this imbalance is what the behavioural
    deficits track, and partial rescue by glutamate or a glutamate receptor
    agonist argues the deficit is functional rather than purely structural. The
    human counterpart has not been measured.
  cell_types:
  - preferred_term: cortical excitatory neuron
    term:
      id: CL:0000679
      label: glutamatergic neuron
  - preferred_term: inhibitory interneuron
    term:
      id: CL:0000617
      label: GABAergic neuron
  biological_processes:
  - preferred_term: cerebral cortex neuron differentiation
    term:
      id: GO:0021895
      label: cerebral cortex neuron differentiation
    modifier: DYSREGULATED
  mechanism_confidence: PROVISIONAL
  evidence:
  - reference: PMID:39471229
    reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      ddx3x deficiency leads to reduced neural stem cell pool, decreased total
      neuron number, and imbalanced differentiation of excitatory and inhibitory
      neurons, which are responsible for the behavioral defects
    explanation: >-
      Single-nucleus transcriptomics plus validation in the zebrafish allele
      demonstrates the imbalance and attributes behaviour to it.
  - reference: PMID:34344536
    reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Cortical thinning was accompanied by defective cortical lamination,
      indicating that Ddx3x regulates the balance of glutamatergic neurons in the
      developing cortex.
    explanation: >-
      Independent mouse evidence that the excitatory neuron balance specifically
      is affected.
  downstream:
  - target: Autistic Behaviour
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Social-interaction and adaptation deficits in the zebrafish model are
      attributed to the imbalance and are partly reversible by glutamatergic
      supplementation. Extrapolating from that to human autistic behaviour is an
      inference across species and across behavioural constructs.
    evidence:
    - reference: PMID:39471229
      reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        the supplementation of L-glutamate or glutamate receptor agonist ly404039
        could partly rescue the adaptation and social deficits
      explanation: >-
        Pharmacological rescue of the social phenotype implicates the
        excitatory/inhibitory imbalance, in zebrafish.
- name: Aberrant Cortical Neuron Output and Cortical Malformation
  biological_scale: TISSUE
  conforms_to: "neural_progenitor_centrosome_spindle_dysfunction#Abnormal Cortical Neuron Output and Gyration"
  description: >-
    The number, timing and laminar allocation of cortical neurons are abnormal,
    producing the structural findings seen on brain MRI: cortical thinning and
    defective lamination in the mouse; and in patients, polymicrogyria, callosal
    dysgenesis, ventriculomegaly, delayed myelination and reduced brain volume.
    Around two-thirds of one diagnostic cohort had a structural abnormality, so
    a normal MRI does not exclude the diagnosis.
  locations:
  - preferred_term: cerebral cortex
    term:
      id: UBERON:0000956
      label: cerebral cortex
  cell_types:
  - preferred_term: cortical neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: cerebral cortex development
    term:
      id: GO:0021987
      label: cerebral cortex development
    modifier: DYSREGULATED
  - preferred_term: neurogenesis
    term:
      id: GO:0022008
      label: neurogenesis
    modifier: DECREASED
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 15 individuals had notable brain anatomical disruption (15/23,
      65.2%), including lateral ventricle enlargement, corpus callosum
      abnormalities, and delayed myelination.
    explanation: >-
      Quantifies structural brain abnormality in a consecutive diagnostic cohort
      and names the recurrent findings.
  - reference: PMID:30936465
    reference_title: Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a common brain malformative pattern characterized by malformations of
      cortical development, callosal dysgenesis, basal ganglia anomalies, and
      midbrain-hindbrain malformations
    explanation: >-
      Describes the recurrent malformation pattern, which extends beyond the
      cortex to callosal, basal ganglia and hindbrain structures.
  downstream:
  - target: Polymicrogyria
    causal_link_type: DIRECT
    description: >-
      Disordered cortical neuron output and lamination manifests radiologically
      as polymicrogyria in the severe end of the spectrum.
    evidence:
    - reference: PMID:33789733
      reference_title: "A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We report a 10-year-old girl affected by delayed psychomotor development,
        delayed myelination, and polymicrogyria (PMG).
      explanation: >-
        A patient-level example of the polymicrogyria endpoint in a de novo
        missense carrier.
  - target: Corpus Callosum Hypoplasia
    causal_link_type: DIRECT
    description: >-
      Callosal hypoplasia or dysgenesis was in the founding cohort's phenotype
      list and recurs in every subsequent series.
    evidence:
    - reference: PMID:26235985
      reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        we present 35 unique deleterious de novo mutations in DDX3X identified by
        whole exome sequencing in 38 females with ID and various other features
        including hypotonia, movement disorders, behavior problems, corpus
        callosum hypoplasia, and epilepsy
      explanation: >-
        Names corpus callosum hypoplasia among the defining features of the
        founding cohort.
  - target: Ventriculomegaly
    causal_link_type: DIRECT
    description: >-
      Lateral ventricle enlargement is among the recurrent structural findings.
    evidence:
    - reference: PMID:35392274
      reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A total of 15 individuals had notable brain anatomical disruption (15/23,
        65.2%), including lateral ventricle enlargement, corpus callosum
        abnormalities, and delayed myelination.
      explanation: >-
        Lists lateral ventricle enlargement among the structural findings in the
        cohort.
  - target: Delayed Myelination
    causal_link_type: DIRECT
    description: >-
      Delayed myelination accompanies the malformation spectrum.
    evidence:
    - reference: PMID:35392274
      reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A total of 15 individuals had notable brain anatomical disruption (15/23,
        65.2%), including lateral ventricle enlargement, corpus callosum
        abnormalities, and delayed myelination.
      explanation: >-
        Lists delayed myelination among the structural findings in the cohort.
  - target: Intellectual Disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Abnormal cortical construction is the presumed substrate of the cognitive
      phenotype. The step from circuit abnormality to measured cognition is not
      demonstrated in humans and is drawn here as an inference.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of
        unexplained intellectual disability (ID) cases in females and are
        associated with autism, brain malformations, and epilepsy.
      explanation: >-
        Associates the same variants with both brain malformation and
        intellectual disability in the same individuals, which is the basis for
        the inferred edge.
  - target: Seizures
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Malformations of cortical development, polymicrogyria in particular, are an
      established epileptogenic substrate, and seizures occur in a minority of
      patients.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of
        unexplained intellectual disability (ID) cases in females and are
        associated with autism, brain malformations, and epilepsy.
      explanation: >-
        Co-associates brain malformation and epilepsy with the same variants.
phenotypes:
- category: Neurologic
  name: Intellectual Disability
  description: >-
    Intellectual disability or global developmental delay is the defining
    feature, with severity ranging from mild to profound. It was present in every
    individual in a consecutive 23-patient diagnostic cohort.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      intellectual disability (23/23, 100%) with varying degrees of severity,
      muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23,
      56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)
    explanation: >-
      Reports intellectual disability in 23 of 23 individuals, supporting the
      very frequent band.
- category: Neurologic
  name: Global Developmental Delay
  description: >-
    Delay across motor, language, adaptive and social domains, usually the
    presenting complaint in infancy or early childhood.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phenotype in males is diverse, including intellectual disability,
      speech/language delays, behavioural challenges and structural brain
      abnormalities.
    explanation: >-
      Documents the multi-domain developmental phenotype in the male cohort.
- category: Neurologic
  name: Delayed Speech and Language Development
  description: >-
    Expressive language is disproportionately affected relative to overall
    cognitive level, and speech-language impairment is often what brings the
    child to attention.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phenotype in males is diverse, including intellectual disability,
      speech/language delays, behavioural challenges and structural brain
      abnormalities.
    explanation: >-
      Names speech and language delay as part of the core phenotype.
- category: Neurologic
  name: Absent Speech
  description: >-
    A substantial minority of affected girls remain nonverbal beyond age five,
    which is the clinical argument for introducing augmentative and alternative
    communication early rather than waiting for speech to emerge.
  phenotype_term:
    preferred_term: Absent speech
    term:
      id: HP:0001344
      label: Absent speech
  frequency: FREQUENT
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      about 50% of affected girls remain nonverbal after age five years
    explanation: >-
      GeneReviews gives the proportion remaining nonverbal, supporting the
      frequent band.
- category: Neurologic
  name: Speech Apraxia
  description: >-
    DDX3X is one of the genes recovered by genome and exome sequencing of
    children ascertained for childhood apraxia of speech, so the motor-speech
    component of the language phenotype can be the presenting problem.
  phenotype_term:
    preferred_term: Childhood apraxia of speech
    term:
      id: HP:0011098
      label: Speech apraxia
  evidence:
  - reference: PMID:32345733
    reference_title: "Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 11/34 (32%) probands, we identified highly plausible pathogenic single
      nucleotide (n = 10; CDK13, EBF3, GNAO1, GNB1, DDX3X, MEIS2, POGZ, SETBP1,
      UPF2, ZNF142) or copy number (n = 1; 5q14.3q21.1 locus) variants in novel
      genes or loci for CAS.
    explanation: >-
      Identifies DDX3X among the genes with plausible pathogenic variants in a
      cohort ascertained for childhood apraxia of speech.
- category: Neurologic
  name: Abnormal Muscle Tone
  description: >-
    Tone abnormality is common and is not uniformly hypotonia: hypotonia
    predominates in infancy but hypertonia and spasticity occur, sometimes in the
    same individual over time.
  phenotype_term:
    preferred_term: Muscle tone abnormality
    term:
      id: HP:0003808
      label: Abnormal muscle tone
  frequency: FREQUENT
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      intellectual disability (23/23, 100%) with varying degrees of severity,
      muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23,
      56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)
    explanation: >-
      Gives the 73.9% tone-abnormality rate supporting the frequent band.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypotonia, a common finding, can be associated with feeding difficulty in
      infancy.
    explanation: >-
      Identifies hypotonia specifically as the common tone abnormality and links
      it to the feeding phenotype.
- category: Neurologic
  name: Movement Disorder
  description: >-
    Dyskinesia, spasticity and abnormal gait are reported. Movement abnormality
    was listed among the features of the founding cohort and remains part of the
    expert-curated clinical description.
  phenotype_term:
    preferred_term: Movement disorder
    term:
      id: HP:0100022
      label: Abnormality of movement
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews names dyskinesia, spasticity and abnormal gait as the movement
      phenotypes.
- category: Neurologic
  name: Progressive Spasticity
  subtype: Male hemizygous
  description: >-
    Two brothers hemizygous for the inherited hypomorphic p.Arg79Lys allele had
    mild-to-moderate intellectual disability with progressive spasticity, a
    course with a degenerative component that is not typical of the de novo
    female presentation.
  phenotype_term:
    preferred_term: Spasticity
    term:
      id: HP:0001257
      label: Spasticity
    clinical_course: PROGRESSIVE
  evidence:
  - reference: PMID:29490693
    reference_title: A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We evaluated two male siblings with syndromic features characterized by
      mild-to-moderate ID and progressive spasticity.
    explanation: >-
      Documents progressive spasticity in the hemizygous male siblings.
- category: Neurologic
  name: Seizures
  description: >-
    Seizures affect a minority. Electroencephalographic abnormality is commoner
    than clinical epilepsy, so an abnormal EEG can be found without seizures.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      intellectual disability (23/23, 100%) with varying degrees of severity,
      muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23,
      56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)
    explanation: >-
      Gives the 26.1% seizure rate supporting the occasional band.
- category: Neurologic
  name: EEG Abnormality
  description: >-
    Abnormal electroencephalography occurred in more individuals than had
    clinical seizures in the same cohort.
  phenotype_term:
    preferred_term: EEG abnormality
    term:
      id: HP:0002353
      label: EEG abnormality
  frequency: FREQUENT
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Furthermore, 9 patients showed abnormal electroencephalogram results (9/23,
      39.1%).
    explanation: >-
      Gives the 39.1% abnormal-EEG rate supporting the frequent band.
- category: Neurologic
  name: Polymicrogyria
  description: >-
    Polymicrogyria marks the severe end of the spectrum and is strongly
    associated with the recurrent dominant missense alleles rather than with
    protein-truncating ones.
  phenotype_term:
    preferred_term: Polymicrogyria
    term:
      id: HP:0002126
      label: Polymicrogyria
  evidence:
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      demonstrating a striking correlation between recurrent dominant missense
      mutations, polymicrogyria, and the most severe clinical outcomes
    explanation: >-
      Establishes polymicrogyria as a phenotype of the disorder and ties it to
      the missense allele class.
- category: Neurologic
  name: Corpus Callosum Hypoplasia
  description: >-
    Callosal hypoplasia or dysgenesis, one of the recurrent MRI findings named in
    the founding cohort.
  phenotype_term:
    preferred_term: Corpus callosum hypoplasia
    term:
      id: HP:0007370
      label: Aplasia/Hypoplasia of the corpus callosum
  evidence:
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we present 35 unique deleterious de novo mutations in DDX3X identified by
      whole exome sequencing in 38 females with ID and various other features
      including hypotonia, movement disorders, behavior problems, corpus callosum
      hypoplasia, and epilepsy
    explanation: >-
      Names corpus callosum hypoplasia in the founding female cohort.
- category: Neurologic
  name: Ventriculomegaly
  description: Lateral ventricular enlargement on brain MRI.
  phenotype_term:
    preferred_term: Ventriculomegaly
    term:
      id: HP:0002119
      label: Ventriculomegaly
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 15 individuals had notable brain anatomical disruption (15/23,
      65.2%), including lateral ventricle enlargement, corpus callosum
      abnormalities, and delayed myelination.
    explanation: >-
      Names lateral ventricle enlargement among the recurrent structural
      findings.
- category: Neurologic
  name: Delayed Myelination
  description: Delayed myelination on brain MRI, often alongside other structural findings.
  phenotype_term:
    preferred_term: Delayed myelination
    term:
      id: HP:0012448
      label: Delayed myelination
  evidence:
  - reference: PMID:33789733
    reference_title: "A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a 10-year-old girl affected by delayed psychomotor development,
      delayed myelination, and polymicrogyria (PMG).
    explanation: >-
      Patient-level documentation of delayed myelination together with
      polymicrogyria.
- category: Behavioral
  name: Autistic Behaviour
  description: >-
    Autism spectrum disorder and autistic traits are common. A comparative study
    found that autism characteristics in DDX3X were no higher than in other
    genetic intellectual disability, so autism is part of the picture but is not
    what distinguishes this disorder behaviourally.
  phenotype_term:
    preferred_term: Autistic behavior
    term:
      id: HP:0000729
      label: Autistic behavior
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Behavioral issues can include autism spectrum disorder,
      attention-deficit/hyperactivity disorder and hyperactivity, self-injurious
      behavior, poor impulse control, and aggression.
    explanation: >-
      Lists autism spectrum disorder among the behavioural features.
  - reference: PMID:35536379
    reference_title: "Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Autism characteristics did not differ between DDX3X and comparison groups,
      while levels of anxiety and self-injurious behaviour (SIB) were
      significantly higher in the DDX3X group.
    explanation: >-
      Qualifies the autism phenotype: present, but not elevated relative to other
      genetic causes of intellectual disability.
- category: Behavioral
  name: Attention Deficit Hyperactivity Disorder
  description: ADHD and hyperactivity are recurrent behavioural features.
  phenotype_term:
    preferred_term: Attention deficit hyperactivity disorder
    term:
      id: HP:0007018
      label: Attention deficit hyperactivity disorder
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Behavioral issues can include autism spectrum disorder,
      attention-deficit/hyperactivity disorder and hyperactivity, self-injurious
      behavior, poor impulse control, and aggression.
    explanation: >-
      Lists ADHD and hyperactivity among the behavioural features.
- category: Behavioral
  name: Self-Injurious Behaviour
  description: >-
    Self-injurious behaviour is elevated in DDX3X relative to a matched
    intellectual disability comparison group, making it one of the two
    behavioural features that appear specific rather than generic to
    intellectual disability.
  phenotype_term:
    preferred_term: Self-injurious behavior
    term:
      id: HP:0100716
      label: Self-injurious behavior
  evidence:
  - reference: PMID:35536379
    reference_title: "Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Autism characteristics did not differ between DDX3X and comparison groups,
      while levels of anxiety and self-injurious behaviour (SIB) were
      significantly higher in the DDX3X group.
    explanation: >-
      A controlled comparison showing self-injurious behaviour is significantly
      raised in the DDX3X group.
- category: Behavioral
  name: Anxiety
  description: >-
    Anxiety is significantly higher than in matched genetic intellectual
    disability controls and is a major contributor to family and school burden.
  phenotype_term:
    preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  evidence:
  - reference: PMID:35536379
    reference_title: "Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Autism characteristics did not differ between DDX3X and comparison groups,
      while levels of anxiety and self-injurious behaviour (SIB) were
      significantly higher in the DDX3X group.
    explanation: >-
      A controlled comparison showing anxiety is significantly raised in the
      DDX3X group.
- category: Gastrointestinal
  name: Feeding Difficulties
  description: >-
    Feeding difficulty in infancy, commonly in the context of hypotonia, and a
    driver of nutritional and growth problems.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  frequency: FREQUENT
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      intellectual disability (23/23, 100%) with varying degrees of severity,
      muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23,
      56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)
    explanation: >-
      Gives the 56.5% feeding-difficulty rate supporting the frequent band.
- category: Ophthalmologic
  name: Ophthalmologic Abnormality
  description: >-
    Ophthalmologic problems are common but heterogeneous across reports, so the
    entry binds the general eye-abnormality term rather than manufacturing a
    narrower one.
  phenotype_term:
    preferred_term: Ophthalmologic abnormality
    term:
      id: HP:0000478
      label: Abnormality of the eye
  frequency: FREQUENT
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      intellectual disability (23/23, 100%) with varying degrees of severity,
      muscle tone abnormalities (17/23, 73.9%), feeding difficulties (13/23,
      56.5%), ophthalmologic problems (11/23, 47.8%), and seizures (6/23, 26.1%)
    explanation: >-
      Gives the 47.8% ophthalmologic-problem rate supporting the frequent band.
- category: Otologic
  name: Hearing Impairment
  description: >-
    Hearing impairment is one of the recurrent extra-neurological findings and
    is a standing surveillance item. GeneReviews reports it without qualifying
    the mechanism, so the entry binds the general hearing-impairment term rather
    than asserting a sensorineural or conductive lesion.
  phenotype_term:
    preferred_term: Hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews lists hearing impairment among the recurrent findings.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Periodic evaluation by the multidisciplinary team regarding
      growth, developmental progress and educational needs, and
      psychiatric/behavioral issues; regular assessment of vision and hearing, of
      the spine for scoliosis, for seizure control (when relevant), and for
      cardiac and respiratory issues.
    explanation: >-
      GeneReviews places hearing under regular assessment, which is the practical
      consequence of the finding being recurrent enough to screen for.
- category: Cardiovascular
  name: Congenital Heart Defect
  description: >-
    Congenital heart defects occur as part of the extra-neurological phenotype
    and are specifically named as a surveillance target. The reported lesions are
    not characterised consistently enough across series to bind a particular
    malformation, so the entry binds the general cardiac morphology term.
  phenotype_term:
    preferred_term: Congenital heart defect
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews lists congenital heart defects among the recurrent findings.
  - reference: PMID:30349862
    reference_title: Phenotypic expansion in DDX3X - a common cause of intellectual disability in females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rare or novel phenotypes observed include respiratory problems, congenital
      heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset
      neurologic decline.
    explanation: >-
      An independent phenotype-expansion series reporting congenital heart
      disease, and characterising it as a rare rather than a core feature.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Periodic evaluation by the multidisciplinary team regarding
      growth, developmental progress and educational needs, and
      psychiatric/behavioral issues; regular assessment of vision and hearing, of
      the spine for scoliosis, for seizure control (when relevant), and for
      cardiac and respiratory issues.
    explanation: >-
      GeneReviews directs ongoing cardiac assessment, confirming the finding is
      recurrent enough to warrant screening.
  notes: >-
    No frequency band is recorded. GeneReviews gives no rate, and the only
    quantitative characterisation available calls the finding rare without
    reporting a denominator.
- category: Respiratory
  name: Respiratory Difficulties
  description: >-
    Respiratory difficulty is reported as part of the extra-neurological
    phenotype and is a named surveillance target. Both sources describe a
    functional problem rather than a structural lung lesion, so the entry binds
    the respiratory-physiology term rather than a lung-morphology term.
  phenotype_term:
    preferred_term: Respiratory difficulties
    term:
      id: HP:0002795
      label: Abnormal respiratory system physiology
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews lists respiratory difficulties among the recurrent findings.
  - reference: PMID:30349862
    reference_title: Phenotypic expansion in DDX3X - a common cause of intellectual disability in females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rare or novel phenotypes observed include respiratory problems, congenital
      heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset
      neurologic decline.
    explanation: >-
      An independent phenotype-expansion series reporting respiratory problems,
      and characterising them as rare rather than core.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Periodic evaluation by the multidisciplinary team regarding
      growth, developmental progress and educational needs, and
      psychiatric/behavioral issues; regular assessment of vision and hearing, of
      the spine for scoliosis, for seizure control (when relevant), and for
      cardiac and respiratory issues.
    explanation: >-
      GeneReviews directs ongoing respiratory assessment, confirming the finding
      is recurrent enough to warrant screening.
  notes: >-
    No frequency band is recorded, for the same reason as the cardiac record:
    neither source reports a rate.
- category: Musculoskeletal
  name: Scoliosis
  description: Scoliosis requiring orthopaedic surveillance.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews lists scoliosis among the recurrent findings.
- category: Musculoskeletal
  name: Joint Hypermobility
  description: Joint laxity, reported alongside the hypotonia and motor phenotype.
  phenotype_term:
    preferred_term: Joint laxity
    term:
      id: HP:0001382
      label: Joint hypermobility
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      GeneReviews lists joint laxity among the recurrent findings.
- category: Endocrine
  name: Hypothyroidism
  description: >-
    Hypothyroidism was reported as a novel finding in one Chinese cohort at 26%.
    It has not been replicated in an independent series and should be treated as
    a cohort-specific observation until it is.
  phenotype_term:
    preferred_term: Hypothyroidism
    term:
      id: HP:0000821
      label: Hypothyroidism
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypothyroidism was first noted as a novel clinical feature (6/23, 26.1%).
    explanation: >-
      Reports the 26.1% rate and, by describing it as novel, marks it as
      unreplicated.
  notes: >-
    Single-cohort finding awaiting independent replication; the frequency band is
    taken from that cohort and may not generalise.
- category: Neoplastic
  name: Neuroblastoma
  description: >-
    Neuroblastoma has been observed in three individuals, and a pilocytic
    astrocytoma was found incidentally in one of three females in a separate
    series. Whether germline DDX3X confers a real tumour risk is unresolved; the
    numbers are small and the observations are incidental.
  phenotype_term:
    preferred_term: Neuroblastoma
    term:
      id: HP:0003006
      label: Neuroblastoma
  frequency: VERY_RARE
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neuroblastoma has been observed in three individuals.
    explanation: >-
      GeneReviews records the three observed neuroblastomas, supporting the very
      rare band.
  - reference: PMID:30936465
    reference_title: Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A pilocytic astrocytoma was incidentally diagnosed in Patient 1 and
      trigonocephaly was found in Patient 2.
    explanation: >-
      A second, different tumour type in a separate series; cited as indirect
      because it concerns a brain tumour rather than neuroblastoma and rests on
      an incidental finding in one patient.
genetic:
- name: DDX3X
  gene_term:
    preferred_term: DDX3X
    term:
      id: hgnc:2745
      label: DDX3X
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    DDX3X (Xp11.4) encodes a DEAD-box ATP-dependent RNA helicase. The disorder is
    germline; somatic DDX3X variants occur in medulloblastoma and several
    lymphoid malignancies and must not be used as evidence for the constitutional
    disorder. Reported germline classes are nonsense, frameshift, canonical and
    non-canonical splice, missense and in-frame indels in females, and missense
    or splice only in males. Recurrent male substitutions are p.(Arg351Gln) and
    p.(Arg488Cys); the inherited p.Arg79Lys allele lies outside the core helicase
    domain and is a demonstrated hypomorph.
  evidence:
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we present 35 unique deleterious de novo mutations in DDX3X identified by
      whole exome sequencing in 38 females with ID and various other features
      including hypotonia, movement disorders, behavior problems, corpus callosum
      hypoplasia, and epilepsy
    explanation: >-
      Establishes DDX3X as the causative gene in the founding cohort.
  - reference: PMID:32135084
    reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of
      unexplained intellectual disability (ID) cases in females and are
      associated with autism, brain malformations, and epilepsy.
    explanation: >-
      Confirms the gene-disease relationship and its share of unexplained female
      intellectual disability.
  - reference: PMID:30349862
    reference_title: Phenotypic expansion in DDX3X - a common cause of intellectual disability in females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Rare or novel phenotypes observed include respiratory problems, congenital
      heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset
      neurologic decline.
    explanation: >-
      Documents the rarer systemic and late-onset features that widen the
      DDX3X-associated phenotype beyond the neurodevelopmental core.
  case_fractions:
  - population: Females with unexplained intellectual disability in diagnostic sequencing cohorts
    case_fraction_low: 1.0
    case_fraction_high: 3.0
    notes: >-
      This is a diagnostic yield within an ascertained cohort, not a population
      prevalence, and it is quoted consistently across independent series.
    evidence:
    - reference: PMID:32135084
      reference_title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        De novo germline mutations in the RNA helicase DDX3X account for 1%-3% of
        unexplained intellectual disability (ID) cases in females and are
        associated with autism, brain malformations, and epilepsy.
      explanation: >-
        States the 1-3% share of unexplained female intellectual disability.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: UNKNOWN
  notes: >-
    More than 1,000 diagnosed females worldwide as of 2025. This is an
    ascertainment count from diagnostic laboratories and registries, not an
    epidemiological estimate, and no population prevalence or incidence has been
    established. Ascertainment is strongly female-biased because hemizygous
    complete loss of function is not viable in males.
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DDX3X-related neurodevelopmental disorder is one of the most common
      monogenic causes of intellectual disability in females, with currently
      >1000 females diagnosed worldwide.
    explanation: >-
      Gives the worldwide diagnosed-case count that this record reports.
- population: Females with unexplained intellectual disability in diagnostic sequencing cohorts
  measure_type: UNKNOWN
  prevalence_class: UNKNOWN
  notes: >-
    Germline DDX3X variants explain roughly 1-3% of unexplained intellectual
    disability in females. Recorded here for completeness because it is the most
    quoted number for this disorder, but it is a diagnostic-cohort fraction
    rather than any of the standard occurrence measures, so measure_type and
    prevalence_class are left UNKNOWN rather than forced into a band. The
    structured version of this quantity is the case_fractions record on the
    DDX3X genetic entry.
  evidence:
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 23 Chinese patients (i.e., 22 female and 1 male) with 22 de novo
      DDX3X deleterious variants were detected among 2,317 probands with
      unexplained intellectual disability (ID) undertaking whole exome sequencing
      (WES).
    explanation: >-
      Gives the denominator and numerator of one such diagnostic cohort, which is
      the kind of measurement the 1-3% figure comes from.
treatments:
- name: Early Developmental Intervention
  description: >-
    Early, individualised developmental and special-educational intervention is
    the foundation of care. It does not modify the molecular lesion; the argument
    for starting early is developmental rather than mechanistic.
  treatment_term:
    preferred_term: Early Intervention
    term:
      id: NCIT:C159524
      label: Early Intervention
  therapeutic_modality: BEHAVIORAL
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment is symptomatic and focuses on optimizing the individual's
      abilities using a multidisciplinary approach that should also include
      psychosocial support for family members.
    explanation: >-
      GeneReviews states that management is symptomatic and multidisciplinary,
      which is what this treatment record implements.
- name: Speech-Language Therapy and Augmentative Communication
  description: >-
    Speech-language assessment with early introduction of augmentative and
    alternative communication. About half of affected girls remain nonverbal
    beyond age five, so waiting for speech to emerge before providing an
    alternative delays communication access for the group with the greatest need.
  treatment_term:
    preferred_term: speech-language therapy with augmentative and alternative communication
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  therapeutic_modality: BEHAVIORAL
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  - preferred_term: Absent speech
    term:
      id: HP:0001344
      label: Absent speech
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      about 50% of affected girls remain nonverbal after age five years
    explanation: >-
      Quantifies the nonverbal fraction that motivates early augmentative and
      alternative communication rather than speech therapy alone.
- name: Physical Therapy
  description: >-
    Physiotherapy for hypotonia, gait, posture and mobility, and for the
    spasticity and movement abnormalities that occur in a subset.
  treatment_term:
    preferred_term: Physical Therapy
    term:
      id: NCIT:C15302
      label: Physical Therapy
  therapeutic_modality: BEHAVIORAL
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Other findings can include seizures, movement disorders (dyskinesia,
      spasticity, abnormal gait), vision and hearing impairment, congenital heart
      defects, respiratory difficulties, joint laxity, and scoliosis.
    explanation: >-
      Names the tone, movement and gait problems that physiotherapy addresses.
      GeneReviews states these are managed as per standard care; no
      DDX3X-specific efficacy data exist.
- name: Occupational Therapy
  description: >-
    Occupational therapy for fine-motor skills, adaptive function, sensory
    processing and daily-living independence.
  treatment_term:
    preferred_term: Occupational Therapy
    term:
      id: NCIT:C121351
      label: Occupational Therapy
  therapeutic_modality: BEHAVIORAL
  action_category: THERAPEUTIC
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatment is symptomatic and focuses on optimizing the individual's
      abilities using a multidisciplinary approach that should also include
      psychosocial support for family members.
    explanation: >-
      Supports occupational therapy as part of the multidisciplinary symptomatic
      approach; there is no DDX3X-specific trial of it.
- name: Antiseizure Pharmacotherapy
  description: >-
    Standard antiseizure medication selected by seizure type for the minority who
    develop epilepsy. No DDX3X-specific drug choice or response rate has been
    established.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: anticonvulsant agent
      term:
        id: NCIT:C264
        label: Anticonvulsant Agent
  therapeutic_modality: SMALL_MOLECULE
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Management of feeding difficulty, intellectual disability, behavioral
      issues, seizures, spasticity and other movement disorders, vision and
      hearing impairment, congenital heart defects, respiratory difficulties,
      joint laxity, and scoliosis as per standard care.
    explanation: >-
      GeneReviews directs seizure management to standard care, which is the basis
      for this record and for the absence of any disorder-specific regimen.
- name: Feeding and Nutritional Support
  description: >-
    Feeding therapy and nutritional support for the infantile feeding difficulty
    that accompanies hypotonia, with attention to growth.
  treatment_term:
    preferred_term: Nutritional Support
    term:
      id: NCIT:C15433
      label: Nutritional Support
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Management of feeding difficulty, intellectual disability, behavioral
      issues, seizures, spasticity and other movement disorders, vision and
      hearing impairment, congenital heart defects, respiratory difficulties,
      joint laxity, and scoliosis as per standard care.
    explanation: >-
      Names feeding difficulty as a managed manifestation.
  notes: >-
    Modality is left unset deliberately. The nutritional-support term covers both
    diet-pattern change and specific supplementation here, and the DDX3X
    literature does not say which is used, so tagging it BEHAVIORAL would assert
    more than the source does.
- name: Behavioural and Mental-Health Management
  description: >-
    Structured management of anxiety, self-injurious behaviour, ADHD, sleep
    disturbance and irritability. Anxiety and self-injury are raised relative to
    other genetic intellectual disability, so they warrant active attention
    rather than being treated as background features of intellectual disability.
  treatment_term:
    preferred_term: Behavioral Intervention
    term:
      id: NCIT:C15184
      label: Behavioral Intervention
  therapeutic_modality: BEHAVIORAL
  action_category: THERAPEUTIC
  target_phenotypes:
  - preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  - preferred_term: Self-injurious behavior
    term:
      id: HP:0100716
      label: Self-injurious behavior
  evidence:
  - reference: PMID:35536379
    reference_title: "Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Autism characteristics did not differ between DDX3X and comparison groups,
      while levels of anxiety and self-injurious behaviour (SIB) were
      significantly higher in the DDX3X group.
    explanation: >-
      Establishes that anxiety and self-injury are disproportionately raised,
      which is the case for targeting them. The study measured the phenotype, not
      a treatment, so the support for the intervention itself is indirect.
- name: Genetic Counselling and Reproductive Testing
  description: >-
    Counselling covers de novo versus inherited status, the residual recurrence
    risk from parental gonadal mosaicism after an apparently de novo result, and
    cascade testing in families with an inherited male hypomorphic allele.
    Prenatal and preimplantation testing are options once the familial variant is
    known.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  action_category: COUNSELING_INFORMATIONAL
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In our novel cohort, 6/17 variants are de novo in the affected male and
      3/17 variants are de novo in the mother.
    explanation: >-
      Shows that de novo and maternally arising alleles both occur in male
      families, which is exactly the distinction counselling has to establish
      before quoting a recurrence risk. It bears on that first counselling step
      only; the recurrence-risk and reproductive-testing claims below are carried
      by the GeneReviews items that follow.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the risk to sibs is slightly greater than that of the general population
      (though still <1%) because of the possibility of parental germline
      mosaicism
    explanation: >-
      Quantifies the residual sib recurrence risk after an apparently de novo
      result, and names parental germline mosaicism as its cause. This is the
      source for that clause of the record's description.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Once the DDX3X pathogenic variant has been identified in an affected family
      member, prenatal testing for a pregnancy at increased risk and
      preimplantation genetic testing are possible
    explanation: >-
      States that prenatal and preimplantation genetic testing become available
      once the familial variant is known, which is the reproductive-testing half
      of this record.
- name: Multidisciplinary Supportive Care
  description: >-
    Coordinated multidisciplinary surveillance: development and education,
    behaviour and mental health, vision and hearing, spine, growth and nutrition,
    cardiac and respiratory status, seizures where relevant, and psychosocial
    support for the family. Almost all of this is generic developmental-disability
    care; the one disorder-specific instruction is to begin screening girls for
    precocious puberty at age eight. This is the whole of current management;
    there is no disease-modifying therapy.
  treatment_term:
    preferred_term: Supportive Care
    term:
      id: NCIT:C15747
      label: Supportive Care
  action_category: MONITORING
  review_notes: >-
    No target_phenotypes: this is a MONITORING action, and the schema reserves
    target_mechanisms/target_phenotypes for THERAPEUTIC actions (they render as
    treats edges). The precocious-puberty surveillance instruction is carried by
    the second evidence item instead.
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surveillance: Periodic evaluation by the multidisciplinary team regarding
      growth, developmental progress and educational needs, and
      psychiatric/behavioral issues; regular assessment of vision and hearing, of
      the spine for scoliosis, for seizure control (when relevant), and for
      cardiac and respiratory issues.
    explanation: >-
      Sets out the surveillance schedule this record represents.
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Starting at age eight years, assess girls for evidence of precocious
      puberty.
    explanation: >-
      The one age-anchored, disorder-specific surveillance instruction in the
      chapter: screening girls for precocious puberty from age eight.
diagnosis:
- name: Trio Exome or Genome Sequencing
  description: >-
    Diagnosis requires a compatible neurodevelopmental phenotype plus a
    pathogenic or likely pathogenic germline DDX3X variant. Trio sequencing is
    preferred because it establishes de novo status, which is central to
    interpreting a female heterozygote, and because the differential for
    unexplained developmental delay is broad. Chromosomal microarray detects
    DDX3X-containing deletions but misses the single-nucleotide and small indel
    variants that account for nearly all cases. There is no biochemical
    biomarker.
  evidence:
  - reference: PMID:32852922
    reference_title: DDX3X-Related Neurodevelopmental Disorder.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of DDX3X-NDD is established in a female proband with
      suggestive findings and a heterozygous de novo DDX3X pathogenic variant
      identified by molecular genetic testing and in a male proband with
      suggestive findings and a hemizygous DDX3X pathogenic variant.
    explanation: >-
      States the diagnostic criteria, including the different zygosity
      requirement by sex.
  - reference: PMID:35392274
    reference_title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A total of 23 Chinese patients (i.e., 22 female and 1 male) with 22 de novo
      DDX3X deleterious variants were detected among 2,317 probands with
      unexplained intellectual disability (ID) undertaking whole exome sequencing
      (WES).
    explanation: >-
      Demonstrates exome sequencing as the diagnostic route in an unselected
      unexplained-intellectual-disability cohort.
animal_models:
- name: Ddx3x heterozygous null mouse
  species: Mus musculus
  genotype: Ddx3x+/- female
  background: Constitutive heterozygous null, construct validity for human loss-of-function alleles
  publication: PMID:34344536
  description: >-
    A constitutive Ddx3x haploinsufficient female mouse, built to match the human
    protein-truncating allele class. It reproduces developmental delay, adult
    hyperactivity and anxiety-like behaviour, motor deficits, reduced brain
    volume, cortical thinning and defective lamination.
  modeled_mechanisms:
  - target: Aberrant Cortical Neuron Output and Cortical Malformation
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Cortical thinning with defective lamination and reduced regional brain
      volume, the mouse counterpart of the human structural phenotype.
    limitations: >-
      The mouse cortex is lissencephalic, so it cannot model polymicrogyria - the
      malformation most tightly linked to the severe human missense alleles.
      Construct validity is for haploinsufficiency only; this allele does not
      model the granule-forming missense class.
    readouts:
    - name: Cortical thickness and laminar organisation
      target: Aberrant Cortical Neuron Output and Cortical Malformation
      direction: DECREASED
      interpretation: >-
        Cortical thinning with disordered lamination is the structural readout of
        abnormal cortical neuron output in this model.
      evidence:
      - reference: PMID:34344536
        reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Cortical thinning was accompanied by defective cortical lamination,
          indicating that Ddx3x regulates the balance of glutamatergic neurons in
          the developing cortex.
        explanation: >-
          Reports the cortical thickness and lamination measurement behind this
          readout.
    - name: Regional brain volume on MRI
      target: Aberrant Cortical Neuron Output and Cortical Malformation
      direction: DECREASED
      interpretation: >-
        Reduced total and regional brain volume, disproportionately cortex and
        amygdala.
      evidence:
      - reference: PMID:34344536
        reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Developmental and behavioral changes were associated with a reduction in
          brain volume, with some regions (e.g., cortex and amygdala)
          disproportionally affected.
        explanation: >-
          Reports the MRI volumetric measurement behind this readout.
    evidence:
    - reference: PMID:34344536
      reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        These data shed new light on the developmental mechanisms driving DDX3X
        syndrome and support construct and face validity of this novel preclinical
        mouse model.
      explanation: >-
        The authors' own construct- and face-validity claim for this model.
- name: Ddx3x conditional neural progenitor knockout mouse
  species: Mus musculus
  genotype: Conditional Ddx3x loss from neural progenitors (female homozygous, female heterozygous, male hemizygous)
  publication: PMID:35762573
  description: >-
    A dosage series of Ddx3x loss restricted to neural progenitors, used with
    live imaging and in vivo ribosome profiling. It is the model that separates
    the cell-cycle and translational arms of the mechanism and that shows the
    male-specific Ddx3y contribution.
  modeled_mechanisms:
  - target: Altered Neural Progenitor Cell Cycle and Neurogenic Division
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Live imaging of progenitors demonstrates altered cell-cycle duration and a
      shifted balance of neurogenic divisions, and ribosome profiling identifies
      the DDX3X-dependent translated transcripts underlying it.
    limitations: >-
      Mouse corticogenesis lacks the expanded human outer subventricular zone and
      outer radial glia, so the quantitative relationship between progenitor
      behaviour and cortical output may not transfer. Conditional deletion also
      removes Ddx3x more completely than any human allele does.
    readouts:
    - name: Progenitor cell-cycle duration and neurogenic division fraction
      target: Altered Neural Progenitor Cell Cycle and Neurogenic Division
      direction: ALTERED
      interpretation: >-
        Both parameters shift on live imaging, and together they set neuronal
        output.
      evidence:
      - reference: PMID:35762573
        reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          we show that DDX3X promotes neuronal generation by regulating both cell
          cycle duration and neurogenic divisions
        explanation: >-
          Reports the live-imaging measurement behind this readout.
    evidence:
    - reference: PMID:35762573
      reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Here, using a mouse model of Ddx3x loss-of-function we demonstrate that
        DDX3X directs translational and cell cycle control of neural progenitors,
        which underlies precise corticogenesis.
      explanation: >-
        Supports treating this model as informative for progenitor cell-cycle and
        division control.
  - target: Neural Stem and Progenitor Pool Depletion
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      Reduced neurogenesis across the dosage series, with frank microcephaly only
      at complete female progenitor loss.
    limitations: >-
      The genotype that produces microcephaly (complete progenitor loss in
      females) has no human counterpart; the human-equivalent genotypes give
      reduced neurogenesis without marked microcephaly, which is the honest match.
    readouts:
    - name: Neuron production and brain size across the Ddx3x dosage series
      target: Neural Stem and Progenitor Pool Depletion
      direction: DECREASED
      interpretation: >-
        Neurogenesis falls with reducing Ddx3x dosage; microcephaly appears only
        at the null extreme.
      evidence:
      - reference: PMID:35762573
        reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          First, we show brain development is sensitive to Ddx3x dosage; complete
          Ddx3x loss from neural progenitors causes microcephaly in females,
          whereas hemizygous males and heterozygous females show reduced
          neurogenesis without marked microcephaly.
        explanation: >-
          Reports the dosage-graded neurogenesis and brain-size measurement behind
          this readout.
- name: ddx3x-deficient zebrafish
  species: Danio rerio
  genotype: ddx3x loss-of-function allele
  publication: PMID:39471229
  description: >-
    A ddx3x-deficient zebrafish with developmental delay, microcephaly, social
    and adaptation deficits and impaired spatial recognition memory, profiled by
    single-nucleus RNA sequencing. It is the system in which the CREBBP-Notch arm
    and the excitatory/inhibitory imbalance were established, and in which
    glutamatergic supplementation partly rescued the behavioural phenotype.
  modeled_mechanisms:
  - target: Reduced CREBBP mRNA Stability and Notch Signalling
    relationship: RECAPITULATES
    fidelity: MODERATE
    description: >-
      The molecular arm of the mechanism - crebbp mRNA destabilisation and
      reduced Notch signalling - was demonstrated in this model.
    limitations: >-
      Established only in zebrafish; there is no human tissue or human cellular
      confirmation of the CREBBP-Notch step, and zebrafish forebrain development
      differs substantially from mammalian corticogenesis.
    readouts:
    - name: crebbp mRNA stability and Notch pathway output
      target: Reduced CREBBP mRNA Stability and Notch Signalling
      direction: DECREASED
      interpretation: >-
        Reduced crebbp message stability with downstream loss of Notch signalling.
      evidence:
      - reference: PMID:39471229
        reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Mechanistically, we reveal that the ddx3x deficiency attenuates the
          stability of the crebbp mRNA, which in turn causes downregulation of
          Notch signaling and defects in neurogenesis.
        explanation: >-
          Reports the mRNA-stability and Notch measurements behind this readout.
    evidence:
    - reference: PMID:39471229
      reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        We generated a ddx3x deficient zebrafish allele, which exhibited reduced
        survival rate, DD, microcephaly, adaptation defects, anxiolytic behaviors,
        social interaction deficits, and impaired spatial recognitive memory.
      explanation: >-
        Establishes the model and its developmental and behavioural phenotype.
  - target: Excitatory-Inhibitory Neuronal Differentiation Imbalance
    relationship: RECAPITULATES
    fidelity: LOW
    description: >-
      Single-nucleus transcriptomics shows imbalanced excitatory and inhibitory
      neuron differentiation, and glutamatergic supplementation partly rescues
      the behavioural consequence.
    limitations: >-
      Fidelity is rated low because the human excitatory/inhibitory balance has
      not been measured in this disorder, and because the behavioural constructs
      rescued in zebrafish (adaptation, social interaction) map only loosely onto
      the human behavioural phenotype.
    readouts:
    - name: Excitatory and inhibitory neuron differentiation ratio
      target: Excitatory-Inhibitory Neuronal Differentiation Imbalance
      direction: ALTERED
      interpretation: >-
        The ratio of excitatory to inhibitory neuron production is shifted.
      evidence:
      - reference: PMID:39471229
        reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          ddx3x deficiency leads to reduced neural stem cell pool, decreased total
          neuron number, and imbalanced differentiation of excitatory and
          inhibitory neurons, which are responsible for the behavioral defects
        explanation: >-
          Reports the single-nucleus differentiation measurement behind this
          readout.
    - name: Behavioural rescue by glutamatergic supplementation
      target: Excitatory-Inhibitory Neuronal Differentiation Imbalance
      direction: RESTORED
      interpretation: >-
        Partial reversal of adaptation and social deficits by L-glutamate or an
        mGluR2/3 agonist, arguing the deficit is functional rather than purely
        structural.
      evidence:
      - reference: PMID:39471229
        reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          the supplementation of L-glutamate or glutamate receptor agonist
          ly404039 could partly rescue the adaptation and social deficits
        explanation: >-
          Reports the pharmacological rescue behind this readout.
- name: p.Arg79Lys zebrafish rescue assay
  species: Danio rerio
  genotype: ddx3x morphant rescued with human DDX3X p.Arg79Lys mRNA
  publication: PMID:29490693
  description: >-
    An established zebrafish assay of DDX3X activity used to classify the
    inherited male p.Arg79Lys allele. It is a variant-interpretation assay rather
    than a disease model, and it is what turned a hemizygous missense variant of
    uncertain significance into a demonstrated hypomorph.
  modeled_mechanisms:
  - target: Hemizygous Partial Loss of DDX3X Function in Males
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      Quantifies residual DDX3X activity for a specific male allele, which is the
      property this pathophysiology node asserts.
    limitations: >-
      A heterologous rescue readout in fish, not a measurement in human neural
      tissue; it establishes relative allele activity, not the absolute residual
      function in a patient's brain.
    readouts:
    - name: Rescue of the ddx3x-depletion phenotype by the p.Arg79Lys allele
      target: Hemizygous Partial Loss of DDX3X Function in Males
      direction: DECREASED
      interpretation: >-
        Partial rather than complete rescue, classifying the allele as
        hypomorphic.
      evidence:
      - reference: PMID:29490693
        reference_title: A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          found that this allele causes a partial loss of DDX3X function and thus
          represents a hypomorphic variant
        explanation: >-
          Reports the rescue result behind this readout.
clinical_trials:
- name: NCT03718910
  phase: NOT_APPLICABLE
  status: COMPLETED
  description: >-
    Completed observational deep-phenotyping study at the Seaver Autism Center,
    Mount Sinai, characterising DDX3X-related neurodevelopmental disorder with
    genetic, medical and neuropsychological measures. Natural history, not an
    intervention.
  target_phenotypes:
  - preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  - preferred_term: Autistic behavior
    term:
      id: HP:0000729
      label: Autistic behavior
  evidence:
  - reference: clinicaltrials:NCT03718910
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This study seeks to characterize DDX3X-related neurodevelopmental disorders
      using a number of genetic, medical and neuropsychological measures.
    explanation: >-
      The registry record states the study's DDX3X-specific characterisation aim.
- name: NCT04436588
  phase: NOT_APPLICABLE
  status: UNKNOWN
  description: >-
    Observational European/Asian multicentre study delineating the clinical and
    neuropsychological phenotype and testing for a DNA methylation episignature.
    Registry status has not been updated since the initial posting.
  evidence:
  - reference: clinicaltrials:NCT04436588
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The aims of this study are first to better delineate the clinical
      phenotype, as well as the neuropsychological profile and, second, to study
      the epigenetic signature in a cohort of individuals with DDX3X pathogenic
      variants.
    explanation: >-
      The registry record states the phenotype-delineation and episignature aims.
  notes: >-
    Listed because an episignature would be the first molecular diagnostic
    adjunct for this disorder. No result has been published, so no
    episignature is curated as established.
differential_diagnoses:
- name: Cerebral palsy
  description: >-
    A static motor phenotype with intellectual disability is readily labelled
    cerebral palsy, and DDX3X-related disorder has been diagnosed after such a
    label. Unexplained intellectual disability with a static motor picture should
    prompt genomic testing rather than closing the diagnosis clinically.
  distinguishing_features:
  - >-
    Cerebral palsy is a clinical description with a presumed acquired or
    perinatal cause, whereas DDX3X-related disorder is established by a
    pathogenic germline variant.
  - >-
    A cortical malformation on brain MRI points away from a purely clinical
    cerebral-palsy label and towards a genetic malformation syndrome.
  notes: >-
    Recorded from the clinical-course literature on this disorder rather than
    from a formal differential-diagnosis study.
- name: Tubulinopathies and other malformations of cortical development
  description: >-
    The DDX3X brain malformation pattern - malformations of cortical development
    with callosal dysgenesis, basal ganglia anomalies and midbrain-hindbrain
    involvement - closely resembles the tubulinopathies on imaging.
  distinguishing_features:
  - >-
    Resolution is molecular; the imaging pattern alone does not separate DDX3X
    from TUBA1A and the other tubulin genes.
  evidence:
  - reference: PMID:30936465
    reference_title: Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These findings expand the phenotypic spectrum of DDX3X-related disorders,
      demonstrating unique neuroradiological features resembling those of the
      tubulinopathies, and support a role for DDX3X in neuronal development.
    explanation: >-
      States the radiological resemblance to the tubulinopathies that makes them
      the imaging differential.
discussions:
- discussion_id: ddx3y_compensation_conflict
  kind: CONTROVERSY
  status: OPEN
  prompt: >-
    Does the Y-linked paralog DDX3Y compensate for DDX3X in the developing male
    brain?
  attaches_to:
  - pathophysiology#Hemizygous Partial Loss of DDX3X Function in Males
  - pathophysiology#Partial Escape from X-Chromosome Inactivation
  rationale: >-
    Two mouse studies reach opposite conclusions. The conditional
    neural-progenitor knockout reports that Ddx3y compensates for Ddx3x in the
    developing male neocortex, making the phenotype sexually dimorphic. The
    haploinsufficient mouse paper argues DDX3Y cannot compensate because it is
    translated only in spermatocytes. The answer matters: if DDX3Y compensates in
    the developing brain, it is a second reason - alongside escape from
    X-inactivation - that hemizygous males tolerate an allele that a female does
    not, and it changes how a hemizygous variant of uncertain significance in a
    male should be interpreted.
  evidence:
  - reference: PMID:35762573
    reference_title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In addition, Ddx3x loss is sexually dimorphic, as its paralog, Ddx3y,
      compensates for Ddx3x in the developing male neocortex.
    explanation: >-
      The position that Ddx3y does compensate, demonstrated in conditional
      knockout neocortex.
  - reference: PMID:34344536
    reference_title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The DDX3X paralog on the Y chromosome (DDX3Y) does not appear to compensate
      for this dosage imbalance as it is translated only in spermatocytes
    explanation: >-
      The opposing position, on the grounds that DDX3Y translation is restricted
      to spermatocytes.
  notes: >-
    Both statements are about mouse. Neither has been tested in human fetal
    cortex, which is where the question would have to be settled.
- discussion_id: non_syndromic_label_mismatch
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    Why does MONDO:0010497 classify this disorder as non-syndromic X-linked
    intellectual disability when the published phenotype is syndromic?
  attaches_to:
  - disease#Intellectual Disability X-linked 102
  - phenotypes#Corpus Callosum Hypoplasia
  - phenotypes#Polymicrogyria
  rationale: >-
    MONDO:0010497 is a child of MONDO:0019181, non-syndromic X-linked
    intellectual disability, and carries synonyms including "DDX3X non-syndromic
    X-linked intellectual disability" generated by the
    disease-series-by-gene design pattern. The same term also carries the synonym
    "intellectual developmental disorder, X-linked, syndrome, Snijders Blok
    type", which is the opposite claim. The literature is unambiguous: the
    founding cohort reported hypotonia, movement disorders, behaviour problems,
    corpus callosum hypoplasia and epilepsy alongside the intellectual
    disability, and later series added polymicrogyria, ventriculomegaly, delayed
    myelination, feeding difficulty, ophthalmologic problems and scoliosis. The
    "non-syndromic" placement is an artefact of an automated gene-series pattern,
    not a curatorial claim about the phenotype. This entry curates the syndromic
    phenotype and flags the term for upstream correction rather than trimming the
    phenotype to fit the label.
  evidence:
  - reference: PMID:30936465
    reference_title: Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      De novo DDX3X variants account for 1-3% of syndromic intellectual
      disability (ID) in females and have been occasionally reported in males.
    explanation: >-
      Describes the same 1-3% population as syndromic intellectual disability,
      directly contradicting the non-syndromic placement.
  - reference: PMID:26235985
    reference_title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we present 35 unique deleterious de novo mutations in DDX3X identified by
      whole exome sequencing in 38 females with ID and various other features
      including hypotonia, movement disorders, behavior problems, corpus callosum
      hypoplasia, and epilepsy
    explanation: >-
      The founding cohort itself reports extra-cognitive features, so the disorder
      was never described as non-syndromic.
- discussion_id: ei_imbalance_human_translation
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Is the excitatory/inhibitory neuronal imbalance seen in ddx3x-deficient
    zebrafish present in human DDX3X-related neurodevelopmental disorder, and is
    the glutamatergic rescue translatable?
  attaches_to:
  - pathophysiology#Excitatory-Inhibitory Neuronal Differentiation Imbalance
  - pathophysiology#Reduced CREBBP mRNA Stability and Notch Signalling
  rationale: >-
    The zebrafish work supplies the only mechanistic route from DDX3X loss to a
    pharmacologically reversible phenotype: crebbp mRNA destabilisation, reduced
    Notch signalling, an excitatory/inhibitory differentiation imbalance, and
    partial behavioural rescue with L-glutamate or a glutamate receptor agonist.
    Every step of that chain is untested in human cells or tissue. The mismatch is
    substantive rather than routine because it is the only current candidate for
    a disease-modifying target, so the translational gap is what stands between a
    model result and a therapeutic hypothesis. Zebrafish forebrain development
    also lacks the mammalian cortical architecture in which the human phenotype
    arises.
  evidence:
  - reference: PMID:39471229
    reference_title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      the supplementation of L-glutamate or glutamate receptor agonist ly404039
      could partly rescue the adaptation and social deficits
    explanation: >-
      The rescue result whose human translatability is the open question.
- discussion_id: no_population_prevalence
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    What is the population prevalence or birth incidence of DDX3X-related
    neurodevelopmental disorder?
  attaches_to:
  - prevalence#Worldwide
  rationale: >-
    Every quantitative statement about how common this disorder is comes from
    diagnostic sequencing cohorts of already-ascertained intellectual disability,
    or from counts of diagnosed individuals. Neither supports a population rate.
    Ascertainment is additionally sex-biased, so even the observed sex ratio among
    diagnosed individuals cannot be read as the true one: males with hypomorphic
    alleles are under-recognised, and the male cohort's median age at diagnosis
    was 8 years with a range extending to 47.
  evidence:
  - reference: PMID:40164730
    reference_title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      DDX3X-related neurodevelopmental disorder is one of the most common
      monogenic causes of intellectual disability in females, with currently
      >1000 females diagnosed worldwide.
    explanation: >-
      A diagnosed-case count, which is the best available figure and is not a
      prevalence.
notes: >-
  Scope. This entry is about the DDX3X-related disorder itself. DDX3X appears as
  a comparator or gene-list member in several other dismech entries
  (Non-Syndromic_X-Linked_Intellectual_Disability,
  Neurodevelopmental_Disorder_with_Hypotonia_and_Speech_Delay and others); none
  of those is about this disease and none was edited here.

  MONDO label. MONDO:0010497 is placed under non-syndromic X-linked intellectual
  disability by the disease-series-by-gene design pattern, while its own synonym
  list also contains the Snijders Blok syndromic label. The syndromic phenotype
  is curated; see the non_syndromic_label_mismatch discussion. The MONDO term is
  retained as disease_term because it is the term the curation queue targets and
  its causal-gene edge (RO:0004003 to HGNC:2745) is correct. The syndromic
  concept MONDO:0018709 is recorded in mappings.mondo_mappings as a
  skos:closeMatch so that the relationship is machine-visible rather than
  prose-only. closeMatch is deliberate: it is a cross-reference, so it does not
  retire MONDO:0018709 from the curation queue the way an exactMatch or
  narrowMatch would.

  Somatic versus germline. Somatic DDX3X variants recur in medulloblastoma and
  in lymphoid malignancies, at some of the same residues. Those are a separate
  biological context; nothing in this entry is derived from a somatic DDX3X
  dataset.

  Deep-research provenance and corrected identifiers. Built from
  research/Intellectual_Disability_X-linked_102-deep-research-falcon.md, which
  passed the Named Entity Confusion preflight against MONDO:0010497 (DDX3X
  mentioned 68 times, OMIM 300958 matching). Three classes of defect in that
  report were corrected here. First, its frontmatter mondo_id is empty, so the
  preflight was run manually. Second, it cites only DOIs and no PMIDs; every
  reference used here was resolved to its PMID through a PubMed DOI search and
  cited as PMID. Third, two of its proposed HPO bindings name the wrong term:
  it offers HP:0007370 as "Abnormality of the corpus callosum" when HPO calls
  that term Aplasia/Hypoplasia of the corpus callosum, and it offers HP:0001344
  as "Severe expressive language delay" when HP:0001344 is Absent speech - a
  different clinical concept. Both were re-derived against OLS before binding.
  The report also proposes MONDO:0018709 as the disease term rather than the
  MONDO:0010497 this entry is keyed on, and it attributes the anxiety and
  self-injury comparative study to the wrong first author; the correct source is
  Ng-Cordell et al. (PMID:35536379), which is what is cited here.

  Claims deliberately not curated for want of a quotable source. The report's
  prospective-cohort figures of 60% autism and 53% ADHD are attributed to a
  reference whose abstract does not contain them, so autism and ADHD are curated
  without a frequency band. Its polymicrogyria prevalence of 7-12% and its
  pooled 53-patient series figures likewise have no traceable quotable source in
  the cached records, so polymicrogyria carries no frequency. The claim that
  DDX3X-related disorder is among the syndromes correctly ranked first by facial
  phenotyping tools was not curated: no citation was given for it.

  Modules. Three pathophysiology nodes conform to
  neural_progenitor_centrosome_spindle_dysfunction. The module's entry node,
  Centrosome and Mitotic Spindle Perturbation, is deliberately not claimed:
  DDX3X reaches the progenitor cell cycle through translational control, not
  through the centrosome or spindle, and the module's own description admits
  cell-cycle as well as centrosomal entry points. Conformance therefore starts
  at Abnormal Progenitor Division and Fate Choice.

  Gaps. No disease-modifying therapy, no biochemical or methylation biomarker
  (the episignature study NCT04436588 has not reported), no population
  prevalence, no validated prognostic marker, and no natural-history data on
  whether the reported late motor decline in some individuals is a real
  progressive component or ascertainment. Environmental factors are not curated
  because none is established: this is a de novo or inherited germline disorder
  with no reported environmental contribution, and an environmental block with no
  citable content would be worse than its absence.
references:
- reference: PMID:40164730
  title: DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.
- reference: PMID:26235985
  title: Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.
- reference: PMID:35392274
  title: Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.
- reference: PMID:32852922
  title: DDX3X-Related Neurodevelopmental Disorder.
  tags:
  - GeneReviews
- reference: PMID:32135084
  title: Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.
- reference: PMID:36299587
  title: 'Case Report: De novo DDX3X mutation caused intellectual disability in a female with skewed X-chromosome inactivation on the mutant allele.'
- reference: PMID:29490693
  title: A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.
- reference: PMID:33789733
  title: 'A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.'
- reference: PMID:39471229
  title: Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.
- reference: PMID:35762573
  title: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.
- reference: PMID:34344536
  title: Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.
- reference: PMID:30936465
  title: Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.
- reference: PMID:32345733
  title: 'Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation.'
- reference: PMID:35536379
  title: 'Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study.'
- reference: PMID:30349862
  title: Phenotypic expansion in DDX3X - a common cause of intellectual disability in females.
- reference: clinicaltrials:NCT03718910
  title: The Seaver Autism Center for Research and Treatment - Assessment Core
- reference: clinicaltrials:NCT04436588
  title: 'DDX3X Related Disorder : Clinical Phenotype, Neuropsychological Profile and Epigenetic Signature.'

📚

References & Deep Research

References

17

PMID:40164730

DDX3X-related neurodevelopmental disorder in males - presenting a new cohort of 19 males and a literature review.

No top-level findings curated for this source.

PMID:26235985

Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.

No top-level findings curated for this source.

PMID:35392274

Expansion of Clinical and Genetic Spectrum of DDX3X Neurodevelopmental Disorder in 23 Chinese Patients.

No top-level findings curated for this source.

PMID:32852922

DDX3X-Related Neurodevelopmental Disorder.

No top-level findings curated for this source.

PMID:32135084

Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development.

No top-level findings curated for this source.

PMID:36299587

Case Report: De novo DDX3X mutation caused intellectual disability in a female with skewed X-chromosome inactivation on the mutant allele.

No top-level findings curated for this source.

PMID:29490693

A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features.

No top-level findings curated for this source.

PMID:33789733

A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.

No top-level findings curated for this source.

PMID:39471229

Deficiency of DDX3X results in neurogenesis defects and abnormal behaviors via dysfunction of the Notch signaling.

No top-level findings curated for this source.

PMID:35762573

Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.

No top-level findings curated for this source.

PMID:34344536

Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.

No top-level findings curated for this source.

PMID:30936465

Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females.

No top-level findings curated for this source.

PMID:32345733

Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation.

No top-level findings curated for this source.

PMID:35536379

Social and emotional characteristics of girls and young women with DDX3X-associated intellectual disability: a descriptive and comparative study.

No top-level findings curated for this source.

PMID:30349862

Phenotypic expansion in DDX3X - a common cause of intellectual disability in females.

No top-level findings curated for this source.

clinicaltrials:NCT03718910

The Seaver Autism Center for Research and Treatment - Assessment Core

No top-level findings curated for this source.

clinicaltrials:NCT04436588

DDX3X Related Disorder : Clinical Phenotype, Neuropsychological Profile and Epigenetic Signature.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Scope. This entry is about the DDX3X-related disorder itself. DDX3X appears as a comparator or gene-list member in several other dismech entries (Non-Syndromic_X-Linked_Intellectual_Disability, Neurodevelopmental_Disorder_with_Hypotonia_and_Speech_Delay and others); none of those is about this disease and none was edited here. MONDO label. MONDO:0010497 is placed under non-syndromic X-linked intellectual disability by the disease-series-by-gene design pattern, while its own synonym list also contains the Snijders Blok syndromic label. The syndromic phenotype is curated; see the non_syndromic_label_mismatch discussion. The MONDO term is retained as disease_term because it is the term the curation queue targets and its causal-gene edge (RO:0004003 to HGNC:2745) is correct. The syndromic concept MONDO:0018709 is recorded in mappings.mondo_mappings as a skos:closeMatch so that the relationship is machine-visible rather than prose-only. closeMatch is deliberate: it is a cross-reference, so it does not retire MONDO:0018709 from the curation queue the way an exactMatch or narrowMatch would. Somatic versus germline. Somatic DDX3X variants recur in medulloblastoma and in lymphoid malignancies, at some of the same residues. Those are a separate biological context; nothing in this entry is derived from a somatic DDX3X dataset. Deep-research provenance and corrected identifiers. Built from research/Intellectual_Disability_X-linked_102-deep-research-falcon.md, which passed the Named Entity Confusion preflight against MONDO:0010497 (DDX3X mentioned 68 times, OMIM 300958 matching). Three classes of defect in that report were corrected here. First, its frontmatter mondo_id is empty, so the preflight was run manually. Second, it cites only DOIs and no PMIDs; every reference used here was resolved to its PMID through a PubMed DOI search and cited as PMID. Third, two of its proposed HPO bindings name the wrong term: it offers HP:0007370 as "Abnormality of the corpus callosum" when HPO calls that term Aplasia/Hypoplasia of the corpus callosum, and it offers HP:0001344 as "Severe expressive language delay" when HP:0001344 is Absent speech - a different clinical concept. Both were re-derived against OLS before binding. The report also proposes MONDO:0018709 as the disease term rather than the MONDO:0010497 this entry is keyed on, and it attributes the anxiety and self-injury comparative study to the wrong first author; the correct source is Ng-Cordell et al. (PMID:35536379), which is what is cited here. Claims deliberately not curated for want of a quotable source. The report's prospective-cohort figures of 60% autism and 53% ADHD are attributed to a reference whose abstract does not contain them, so autism and ADHD are curated without a frequency band. Its polymicrogyria prevalence of 7-12% and its pooled 53-patient series figures likewise have no traceable quotable source in the cached records, so polymicrogyria carries no frequency. The claim that DDX3X-related disorder is among the syndromes correctly ranked first by facial phenotyping tools was not curated: no citation was given for it. Modules. Three pathophysiology nodes conform to neural_progenitor_centrosome_spindle_dysfunction. The module's entry node, Centrosome and Mitotic Spindle Perturbation, is deliberately not claimed: DDX3X reaches the progenitor cell cycle through translational control, not through the centrosome or spindle, and the module's own description admits cell-cycle as well as centrosomal entry points. Conformance therefore starts at Abnormal Progenitor Division and Fate Choice. Gaps. No disease-modifying therapy, no biochemical or methylation biomarker (the episignature study NCT04436588 has not reported), no population prevalence, no validated prognostic marker, and no natural-history data on whether the reported late motor decline in some individuals is a real progressive component or ascertainment. Environmental factors are not curated because none is established: this is a de novo or inherited germline disorder with no reported environmental contribution, and an environmental block with no citable content would be worse than its absence.

Create: Intellectual_Disability_X-linked_102 · 2026-09-04T04:10:27Z · View source

De novo curation of the DDX3X-related neurodevelopmental disorder (MONDO:0010497, MRX102, Snijders Blok type) from a single Edison/falcon deep-research report plus independent literature retrieval. The seed placeholder file was replaced entirely. Source screening. research/Intellectual_Disability_X-linked_102-deep-research-falcon.md passed `just preflight-dr` against MONDO:0010497 (PASS; DDX3X mentioned 68 times; OMIM 300958 agreeing between MONDO and the report). The preflight had to be run manually because the report's frontmatter carries an empty mondo_id (dismech#10335). The report's reference_validation reports 13/13 resolved and its term_validation 34/36 resolved with 2 unverifiable (OMIM, ORPHA prefixes, which have no resolver). Three defects in that report were found and corrected rather than propagated. 1. The report cites DOIs only and no PMIDs. Each DOI actually used was resolved to its PMID via a PubMed [DOI] esearch and cited as PMID:, so no evidence item sits on the DOI: prefix that reference-validation CI skips. 2. Two proposed HPO bindings name the wrong term while the report's own Term Validation section reports them clean. The report offers HP:0007370 labelled 'Abnormality of the corpus callosum'; HPO's canonical label is 'Aplasia/Hypoplasia of the corpus callosum'. It offers HP:0001344 labelled 'Severe expressive language delay'; HP:0001344 is 'Absent speech', a different clinical concept. Every HP, GO, CL, UBERON and NCIT CURIE bound in this entry was independently re-derived against the EBI OLS4 API before use, and the canonical label copied from there. 3. The report proposes MONDO:0018709 as the disease term rather than the MONDO:0010497 the curation queue targets, and attributes the anxiety/self-injury comparative study to the wrong first author. The correct source is Ng-Cordell et al. 2023 (PMID:35536379), which is what is cited. Claims deliberately not curated, all recorded in the entry's notes: the report's prospective-cohort figures of 60% autism and 53% ADHD (attributed to a reference whose cached abstract does not contain them, so autism and ADHD carry no frequency band), its 7-12% polymicrogyria prevalence and its pooled 53-patient series figures (no traceable quotable source in the cached records, so polymicrogyria carries no frequency), and its facial-phenotyping benchmark claim (no citation given). Two curation decisions worth recording. First, the MONDO term's placement. MONDO:0010497 is a child of MONDO:0019181 (non-syndromic X-linked intellectual disability) and carries the design-pattern synonym 'DDX3X non-syndromic X-linked intellectual disability', while also carrying the synonym 'intellectual developmental disorder, X-linked, syndrome, Snijders Blok type'. The literature is unambiguously syndromic: the founding cohort (PMID:26235985) reports hypotonia, movement disorders, behaviour problems, corpus callosum hypoplasia and epilepsy, and PMID:30936465 describes the same 1-3% population as syndromic intellectual disability. The syndromic phenotype is curated and the conflict recorded as an INTERPRETATION discussion (non_syndromic_label_mismatch) rather than resolved silently. MONDO:0010497 is retained as disease_term because its causal-gene edge (RO:0004003 to HGNC:2745) is correct and it is the term the queue targets. Second, the sex difference is modelled as two separate pathophysiology entry points onto a shared node, not merged. 'Partial Escape from X-Chromosome Inactivation' (PMID:40164730, PMID:36299587) and 'Hemizygous Partial Loss of DDX3X Function in Males' (PMID:29490693, PMID:40164730) both feed 'DDX3X RNA Helicase Deficiency'. Allele class is branched independently of sex: the severe-missense granule branch (PMID:32135084) is kept distinct from dosage loss, because it is that allele class that correlates with polymicrogyria. Module conformance. Three progenitor nodes declare conforms_to against neural_progenitor_centrosome_spindle_dysfunction (Abnormal Progenitor Division and Fate Choice; Progenitor Pool Distortion; Abnormal Cortical Neuron Output and Gyration), with the module's GO annotations reproduced. The module's entry node, Centrosome and Mitotic Spindle Perturbation, is deliberately not claimed: DDX3X reaches the progenitor cell cycle through translational control rather than the centrosome, and the module's own description admits cell-cycle as well as centrosomal entry points. Clinical trials were checked directly against the ClinicalTrials.gov v2 API rather than taken from the report. Five studies mention DDX3X; two selinexor DLBCL trials are unrelated somatic-context studies and were excluded. NCT03718910 (completed observational, Mount Sinai) and NCT04436588 (observational episignature study, status UNKNOWN) are curated. NCT01238250 (Simons Searchlight) was fetched but not curated: it is a generic multi-condition registry rather than a DDX3X study. Evidence discipline. 107 snippets, all exact substrings of cached references, all verified. One intended GeneReviews quote was dropped because the cached text contains a non-breaking space inside it; a shorter exact span was quoted instead. No environmental block was created: no environmental contribution to this disorder is established, and an uncitable block would be worse than its absence. Validation, all run to completion. just validate (passed), just validate-disorders (schema + terms + references batched, 107/107 snippets verified), just validate-terms (passed), just count-verified-snippets (107/107), just check-entity-refs (OK), just check-causal-targets (OK, no new broken targets), just check-duplicate-keys (OK), just check-qualifier-terms (OK), just check-enum-values (OK), just check-folded-hyphens (OK), just check-snippet-length (OK), just check-title-snippets (OK), just check-snippet-grading (OK), just check-environmental-evidence (OK), just check-reference-titles (OK), just check-not4curation (OK), just check-term-cache-integrity (OK). No baseline file was modified. One schema correction was needed during curation: differential_diagnoses[].distinguishing_features is multivalued, and the initial draft supplied a string. stubs/Intellectual_Disability_X-linked_102.yaml deleted. The nine existing kb/disorders entries that mention DDX3X were read and left untouched; in all of them DDX3X is a comparator or gene-list member and none is about this disease.

Falcon ▸

Disease Characteristics Research Template

Edison Scientific Literature 21 citations 2026-09-03T20:43:15.477642

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

Disease Name: Intellectual Disability X-linked 102
MONDO ID: (if available)
Category: Mendelian

Research Objectives

Please provide a comprehensive research report on Intellectual Disability X-linked 102 covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

What is the disease? Provide a concise overview.
What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
What are the common synonyms and alternative names?
Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
Risk Factors:

Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Genetic risk factors (causal variants, susceptibility loci, modifier genes)
Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
Protective Factors:

Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Genetic protective factors (protective variants, modifier alleles)
Environmental protective factors (diet, lifestyle, exposures that reduce risk)
Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Pathogenic Variants:
Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
Variant type/class (missense, frameshift, nonsense, splice-site, structural)
Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
Functional consequences (loss of function, gain of function, dominant negative)
Modifier Genes: Genes that modify disease severity or expression
Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

Search first: CDC databases, WHO, PubMed, NHANES
Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Present this section as an ordered causal chain first, then the detail below. Open with a numbered sequence of mechanistic steps running from the initiating lesion (mutation, exposure, infection) to the clinical manifestation, one step per line, each naming what it causes next. State the causal verb explicitly ("leads to", "results in") and say where a step is inferred rather than demonstrated. Where the mechanism branches, show the branch. The categories below are a checklist of what to cover within those steps, not the organizing structure — a step may draw on several of them, and a category may contribute to several steps.

Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

Search first: PubMed, Gene Ontology, Reactome
Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Molecular Profiling (if available):
Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
Advanced Technologies (if applicable):
Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

Organ Level:
Primary organs directly affected
Secondary organ involvement (complications, secondary effects)
Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Tissue and Cell Level:
Specific tissue types affected (epithelial, connective, muscle, nervous)
Specific cell populations targeted (with Cell Ontology terms)

Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Subcellular Level:
Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Localization:
Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

Onset:
Typical age of onset (congenital, pediatric, adult, geriatric)
Onset pattern (acute, subacute, chronic, insidious)

Search first: OMIM, Orphanet, HPO, PubMed
Progression:
Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
Progression rate (rapid, slow, variable)
Disease course pattern (episodic, relapsing-remitting, progressive, stable)
Disease duration (self-limited, chronic lifelong)

Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Patterns:
Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

Epidemiology:
Prevalence (cases per 100,000 at given time)
Incidence (new cases per 100,000 per year)

Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
For Genetic Etiology:
Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
Population Demographics:
Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
Geographic distribution of specific variants
Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

Clinical Tests:
Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
Genetic Testing:

Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
Overview of recommended genetic testing approach
Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
FISH > Search first: ClinVar, cytogenetics databases, PubMed
Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
Omics-Based Diagnostics (if applicable):
RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
Clinical Criteria:
Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
Screening:
Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

Survival and Mortality:
Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
Morbidity and Function:
Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
Disease Course:
Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
Prediction:
Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

Pharmacotherapy:
Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
Advanced Therapeutics:
Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
Surgical and Interventional:
Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
Supportive and Rehabilitative:
Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
Experimental:
Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Treatment Outcomes:
Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
Treatment Strategy:
Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

Prevention Levels:
Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
Immunization: Vaccine strategies (if applicable)

Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Screening and Early Detection:
Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
Behavioral Interventions: Lifestyle modifications to reduce risk

Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Counseling: Genetic counseling (risk assessment, family planning guidance)

Search first: NSGC resources, ACMG guidelines, GeneReviews
Public Health:
Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
Prophylaxis: Preventive medications or procedures

Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

Taxonomy: Species affected (with NCBI Taxon identifiers)

Search first: NCBI Taxonomy
Breed: Specific breeds affected (with VBO identifiers if applicable)

Search first: VBO (Vertebrate Breed Ontology)
Gene: Orthologous genes in other species (with NCBI Gene IDs)

Search first: NCBI Gene
Natural Disease:
Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
Comparative Biology:
Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
Transmission (if applicable):
Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

Model Types:
Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
Genetic Models:
Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
Model Characteristics:
Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
Applications:
Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
Resources:
Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

Cite primary literature (PMID preferred) for all mechanistic and clinical claims
Prioritize recent reviews and landmark papers
Include direct quotes from abstracts where possible to support key statements
Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Intellectual Disability, X-linked 102 (DDX3X-related neurodevelopmental disorder)

Executive summary and scope

Intellectual Disability, X-linked 102 (MRX102) is the historical OMIM name for DDX3X-related neurodevelopmental disorder (DDX3X syndrome), an early-onset Mendelian neurodevelopmental condition caused principally by pathogenic germline variants in DDX3X, which encodes an ATP-dependent DEAD-box RNA helicase. It predominantly affects females through de novo heterozygous variants; viable affected males usually carry missense or splice-altering alleles with residual function. The phenotype combines developmental/intellectual disability, severe speech-language impairment, motor and tone abnormalities, behavioral disorders, and variably abnormal brain development. DDX3X variants account for approximately 1–3% of otherwise unexplained intellectual disability in females, making this an individually rare but comparatively frequent monogenic cause of female ID. This percentage is a diagnostic-cohort fraction, not population prevalence. (lennox2020pathogenicddx3xmutations pages 1-3, dai2022expansionofclinical pages 4-5)

The strongest mechanistic model is disruption of RNA unwinding and translational control in neural progenitors, followed by altered cell-cycle dynamics, neurogenesis and neuronal migration. Severe missense alleles may additionally form abnormal RNA–protein granules and are strongly associated with polymicrogyria and more severe outcomes. No approved disease-modifying treatment or interventional DDX3X trial was identified; current practice is molecular diagnosis, multidisciplinary surveillance, early developmental therapy, communication support, and symptom-directed treatment. (lennox2020pathogenicddx3xmutations pages 1-3, NCT03718910 chunk 1)

The following table provides a knowledge-base-oriented synopsis.

Domain	Key facts	Quantitative evidence	Suggested ontology terms	Evidence type/key source
Identity	Intellectual Disability, X-linked 102 is the historical label for DDX3X-related neurodevelopmental disorder; synonyms include DDX3X syndrome, MRX102, and X-linked intellectual disability–hypotonia–movement disorder syndrome.	OMIM phenotype 300958; MONDO MONDO:0018709.	MONDO:0018709; OMIM:300958	Aggregated disease resources and foundational human genetics (lennox2020pathogenicddx3xmutations pages 1-3, OpenTargets Search: -DDX3X)
Causal gene	Caused by pathogenic germline variants in DDX3X, encoding DEAD-box helicase 3 X-linked, an ATP-dependent RNA helicase and regulator of RNA metabolism and translation.	DDX3X: Ensembl ENSG00000215301; foundational PMID 26235985.	Suggested: HGNC gene DDX3X; GO RNA-helicase activity and RNA-metabolic-process terms	Human genetics plus biochemical/model evidence (lennox2020pathogenicddx3xmutations pages 1-3, lukin2024emergingxlinkedgenes pages 8-9, OpenTargets Search: -DDX3X)
Inheritance and sex effects	Usually an X-linked disorder caused by de novo heterozygous variants in females. Affected males generally carry hypomorphic missense or splice-altering variants; complete loss of function is presumed poorly tolerated or embryonically lethal in hemizygous males. DDX3X escapes X-chromosome inactivation, and skewing does not reliably prevent disease.	DDX3X variants account for approximately 1–3% of unexplained female ID. In a combined male series, 27/30 had missense and 3/30 splice-site variants; no truncating variants were reported.	HP:0001417 X-linked inheritance; suggested: abnormal X-chromosome inactivation	Human cohorts, family studies, allele-specific expression (lennox2020pathogenicddx3xmutations pages 1-3, kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, sun2022casereportde pages 8-8)
Core neurodevelopmental phenotype	Developmental delay or intellectual disability is the defining feature; language, motor, and adaptive development are commonly impaired, with severity ranging from mild to profound.	Chinese cohort: 23/23 (100%) had ID/DD. Prospective cohort: 80% met ID criteria. Male cohort: all had DD and/or ID; first words occurred at 18 months–8 years.	HP:0001263 Global developmental delay; HP:0001249 Intellectual disability; HP:0000750 Delayed speech and language development; HP:0001270 Motor delay	Human prospective and retrospective cohorts (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, dai2022expansionofclinical pages 4-5, hoye2022aberrantcorticaldevelopment pages 30-31)
Speech and communication	Expressive language is often disproportionately affected; some individuals remain minimally verbal or nonverbal. Early speech-language assessment and augmentative and alternative communication are clinically appropriate.	Published summaries estimate approximately 52% of affected females remain nonverbal after age five; language was the most impaired developmental domain in one 23-person cohort.	HP:0001344 Severe expressive language delay; suggested: absent speech; NCIT supportive communication intervention	Human cohorts and clinical-care literature (dai2022expansionofclinical pages 4-5, stefaniak2022autisticlikebehaviorsassociated pages 6-8)
Autism, ADHD, behavior	ASD traits, ADHD, sensory-processing differences, anxiety, self-injury, stereotypies, and other behavioral difficulties occur variably. Anxiety and self-injurious behavior may be especially important clinical burdens.	Prospective cohort: ASD 60%, ADHD 53%. Chinese cohort: 13/17 exceeded an ASD-risk screening cutoff. Comparative study: 23 females with DDX3X variants had significantly higher anxiety and self-injury scores than 23 females with other genetic IDs.	HP:0000729 Autistic behavior; HP:0007018 Attention deficit hyperactivity disorder; HP:0100716 Self-injurious behavior; suggested: anxiety and sensory-processing abnormality	Prospective and comparative human behavioral studies (dai2022expansionofclinical pages 4-5, hoye2022aberrantcorticaldevelopment pages 30-31)
Tone, movement, and motor function	Hypotonia is common but hypertonia, spasticity, ataxia, dystonic or other movement abnormalities can occur. Motor limitations affect mobility, self-care, and participation.	Chinese cohort: tone abnormalities 17/23 (73.9%). Male cohort: motor delay 17/18. Earlier pooled data reported ataxia in 7/53 (13.2%).	HP:0001252 Hypotonia; HP:0001276 Hypertonia; HP:0001251 Ataxia; HP:0100022 Abnormality of movement	Human cohorts and case series (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, scala2019threedenovo pages 5-6, dai2022expansionofclinical pages 4-5)
Feeding, growth, and systemic findings	Feeding difficulty, ophthalmologic abnormalities, scoliosis or joint laxity, dysmorphism, and occasional congenital anomalies are reported. Hypothyroidism was proposed as an expanded phenotype but requires replication.	Chinese cohort: feeding difficulty 13/23 (56.5%), ophthalmologic problems 11/23 (47.8%), hypothyroidism 6/23 (26.1%).	HP:0011968 Feeding difficulties; HP:0000478 Abnormality of the eye; HP:0002650 Scoliosis; HP:0000821 Hypothyroidism	Human cohort; some findings are cohort-specific (dai2022expansionofclinical pages 4-5)
Epilepsy and electrophysiology	Seizures occur in a minority, with heterogeneous electroclinical presentations; abnormal EEG can occur without clinical epilepsy.	Chinese cohort: seizures 6/23 (26.1%), abnormal EEG 9/23 (39.1%). Earlier pooled series: seizures 6/53 (11.3%).	HP:0001250 Seizure; HP:0002353 EEG abnormality	Human cohorts (scala2019threedenovo pages 5-6, dai2022expansionofclinical pages 4-5)
Neuroimaging	MRI can be normal or show polymicrogyria, corpus-callosum dysgenesis, ventriculomegaly, delayed myelination, cerebellar/brainstem anomalies, or reduced brain volume. Recurrent severe missense variants correlate strongly with polymicrogyria and worse outcomes.	Chinese cohort: structural MRI abnormalities 15/23 (65.2%). Earlier pooled series: abnormal MRI 16/53 (30.2%), callosal abnormality 7/53 (13.2%). PMG prevalence across reports approximately 7–12%.	HP:0002126 Polymicrogyria; HP:0007370 Abnormality of the corpus callosum; HP:0002119 Ventriculomegaly; HP:0012448 Delayed myelination	Human imaging cohorts and genotype–phenotype study (lennox2020pathogenicddx3xmutations pages 1-3, edey2023x‐linkedneuronalmigration pages 9-10, scala2019threedenovo pages 5-6, dai2022expansionofclinical pages 4-5)
Pathogenic variants	Disease-associated variants include nonsense, frameshift, canonical and noncanonical splice, missense, in-frame deletion, insertion, and duplication alleles. Female truncating variants usually support haploinsufficiency; severe helicase-domain missense variants may exert dominant-negative or toxic effects through impaired RNA release and granule formation. Population allele frequencies are variant-specific and must be checked in current gnomAD/ClinVar records.	Largest mechanistic cohort included 107 affected individuals; a Chinese cohort found 22 deleterious de novo variants among 2,317 probands.	SO terms suggested by variant: missense_variant, frameshift_variant, stop_gained, splice_region_variant; ACMG P/LP/VUS	Human molecular cohorts plus functional assays (lennox2020pathogenicddx3xmutations pages 1-3, kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, moresco2021anovelde pages 4-6, dai2022expansionofclinical pages 4-5)
Mechanism	DDX3X dysfunction impairs ATP-dependent RNA unwinding, translation of structured transcripts, and RNA-protein-granule dynamics. This disrupts neural-progenitor cell-cycle timing, neurogenic divisions, neuron production and migration, producing abnormal cortical lamination or PMG and downstream cognitive, language, motor, and behavioral impairment. Wnt effects are established in earlier experiments; newer model evidence links DDX3X loss to impaired CREBBP-mRNA stabilization and Notch signaling.	Severe missense variants show the strongest human association with PMG and severe outcomes; quantitative molecular effects vary by allele/model.	GO:0006396 RNA processing; GO:0006412 translation; GO:0007049 cell cycle; GO:0022008 neurogenesis; GO:0001764 neuron migration; suggested Wnt- and Notch-signaling GO terms	Human genotype–phenotype correlation; mouse, cell, biochemical, ribosome-profiling, zebrafish and Xenopus evidence (lennox2020pathogenicddx3xmutations pages 1-3, edey2023x‐linkedneuronalmigration pages 9-10, lukin2024emergingxlinkedgenes pages 8-9, hoye2022aberrantcorticaldevelopment pages 30-31)
Cells, tissues, and compartments	The primary affected organ is the developing CNS, especially fetal cerebral cortex. Implicated cells include radial glia/neural stem and progenitor cells, migrating neurons, and cortical excitatory neurons. Relevant compartments include cytoplasmic ribonucleoprotein granules, ribosomes, nucleus, and cytoplasm.	Mouse haploinsufficiency produces reduced brain volume and abnormal cortical lamination; conditional loss reduces neurogenesis.	UBERON:0000955 brain; suggested cerebral cortex; CL:0000047 neuronal stem cell; CL:0000540 neuron; GO:0035770 ribonucleoprotein granule; suggested ribosome/nucleus/cytoplasm terms	Mouse and cellular models; anatomical inference from human MRI (lennox2020pathogenicddx3xmutations pages 1-3, boitnott2021developmentalandbehavioral pages 25-28, hoye2022aberrantcorticaldevelopment pages 30-31)
Diagnosis	Diagnosis requires a compatible neurodevelopmental phenotype plus a pathogenic/likely pathogenic germline DDX3X variant. Trio exome/genome sequencing is preferred for unexplained ID/DD because it establishes de novo status and detects broad differential diagnoses. A neurodevelopmental panel including DDX3X or single-gene sequencing with deletion/duplication analysis is also usable. CMA detects CNVs but usually misses single-nucleotide variants; karyotype, FISH, mtDNA and repeat-expansion testing are not targeted tests for this disorder.	No disease-specific biochemical biomarker. WES identified 22 female de novo variants in a 2,317-proband cohort; male diagnoses may require cautious interpretation and functional evidence.	NCIT suggested: Genetic Testing, Whole Exome Sequencing, Whole Genome Sequencing, Chromosomal Microarray; HP phenotype terms for variant prioritization	Clinical sequencing cohorts and expert interpretation (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, dai2022expansionofclinical pages 4-5)
Clinical evaluation	Baseline evaluation should be multidisciplinary: developmental/cognitive and adaptive assessment; speech-language and AAC evaluation; neurologic examination; ASD/ADHD/anxiety and sensory assessment; feeding/growth, vision and hearing assessment; musculoskeletal review; EEG if seizure concern; MRI when neurologic signs, seizures, abnormal head growth, or significant motor findings warrant it.	NCT03718910 used a three-day neurologic, psychiatric, developmental, medical, EEG, visual-evoked-potential and eye-tracking battery in 15 participants.	NCIT suggested: Neurologic Examination, Developmental Assessment, Magnetic Resonance Imaging, Electroencephalography, Ophthalmologic Examination	Expert-care recommendations and observational implementation; individual schedules remain phenotype-driven (lukin2024emergingxlinkedgenes pages 8-9, NCT03718910 chunk 1)
Management	No approved disease-modifying therapy exists. Care is symptomatic and supportive: early developmental intervention; speech-language/AAC, occupational and physical therapy; behavioral and educational supports; feeding therapy/nutrition; standard antiseizure treatment; management of tone, movement, sleep, anxiety/ADHD, scoliosis, vision, hearing, and endocrine problems as clinically indicated.	No disorder-specific response-rate or comparative-treatment data. Case-level therapy reports cannot establish efficacy.	NCIT suggested: Supportive Care, Physical Therapy, Occupational Therapy, Speech Therapy, Behavioral Therapy, Anticonvulsant Therapy, Nutritional Support	Expert opinion and case-level implementation (lukin2024emergingxlinkedgenes pages 8-9, stefaniak2022autisticlikebehaviorsassociated pages 6-8)
Research and trials	Clinical research is currently centered on natural history, deep phenotyping, biomarkers and patient registries rather than interventional molecular therapy.	NCT03718910: completed observational study, 15 participants, May 23, 2018–June 1, 2020. NCT01238250 (Simons Searchlight): recruiting umbrella observational registry, planned enrollment 100,000 across eligible genetic conditions.	NCIT suggested: Observational Study, Natural History Study, Patient Registry	ClinicalTrials.gov registry evidence (NCT03718910 chunk 1)
Prognosis and course	Onset is congenital/early childhood and the neurodevelopmental disability is generally lifelong. Severity and independence vary widely. Limited reports describe later motor decline in some individuals or males with hypomorphic alleles, but progression is not established as the typical course.	No disease-specific life-expectancy, survival, mortality, remission, or validated prognostic-biomarker estimates are available.	HP:0003593 Infantile onset or suggested early-childhood onset; suggested chronic course	Human cohorts and rare longitudinal observations; major evidence gaps remain (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, lennox2020pathogenicddx3xmutations pages 1-3)
Epidemiology	Ultra-rare Mendelian disorder found across ancestries; ascertainment is strongly female-biased because most recognized cases are de novo heterozygous females. No founder effect, endemic region, or reliable population prevalence/incidence has been established.	Approximately 1–3% of unexplained female ID, not 1–3% of all females. Disease-specific carrier frequency is unavailable.	MONDO:0018709; HP:0001417	Sequencing-cohort estimate, not population epidemiology (lennox2020pathogenicddx3xmutations pages 1-3, dai2022expansionofclinical pages 4-5)
Risk, protection, and environment	The causal risk is a pathogenic germline DDX3X variant. Variant class/location, residual activity, sex, DDX3Y compensation in males, and possibly X-inactivation modify expression. No validated environmental causal, protective, infectious, toxin, lifestyle, dietary, occupational, immune, or gene–environment factor is known.	No quantified environmental effect sizes or protective alleles reported.	Suggested: genetic modifier; X-chromosome inactivation; not applicable for infectious-agent ontology	Human genetics and model-based modifier evidence; explicit knowledge gap (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, hoye2022aberrantcorticaldevelopment pages 30-31, sun2022casereportde pages 8-8)
Prevention and counseling	The phenotype cannot be prevented after a causal de novo variant arises. Primary prevention consists of reproductive counseling and optional prenatal or preimplantation testing after the familial variant is known. Cascade testing is appropriate for inherited male-family alleles; parental testing also assesses recurrence risk, although low residual risk from germline mosaicism remains after an apparently de novo result. Tertiary prevention is early therapy and complication surveillance.	Exact germline-mosaicism and recurrence rates are unavailable; no newborn population screening or prophylactic medication is established.	NCIT suggested: Genetic Counseling, Prenatal Genetic Testing, Preimplantation Genetic Testing, Cascade Testing, Early Intervention	Standard Mendelian-genetics practice informed by de novo/inherited cohorts (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, moresco2021anovelde pages 4-6)
Models and comparative biology	Available experimental systems include Ddx3x haploinsufficient and neural conditional-knockout mice, zebrafish functional assays, Xenopus neural-crest models, and cultured neural progenitor/neuronal systems. Models reproduce neurogenesis, cortical-lamination, motor, behavioral, and brain-volume abnormalities but cannot capture the full human language and adaptive phenotype. No naturally occurring veterinary equivalent or zoonotic transmission is established.	Ddx3x+/− mice show developmental, sensory and motor delays, adult hyperactivity/anxiety-like behavior, cognitive/motor deficits and reduced brain volume.	NCBI Taxon suggested: Homo sapiens, Mus musculus, Danio rerio, Xenopus tropicalis; NCIT suggested: Animal Model, Cell Culture Model	Mouse, zebrafish, Xenopus and in-vitro evidence (boitnott2021developmentalandbehavioral pages 25-28, hoye2022aberrantcorticaldevelopment pages 30-31)
Explicit unavailable items	No validated metabolomic, lipidomic, circulating-protein, epigenomic or liquid-biopsy diagnostic signature; no established modifier gene, protective variant, pharmacogenomic rule, surgical treatment, gene/cell/RNA therapy, immunotherapy, or disease-specific prevention program. Somatic DDX3X cancer variants must not be conflated with germline DDX3X syndrome.	No approved targeted drug and no interventional DDX3X-syndrome trial identified in the searched evidence.	Ontology mapping not applicable until evidence exists	Negative database/registry finding and evidence-gap assessment (OpenTargets Search: -DDX3X, NCT03718910 chunk 1)

Table: Concise knowledge-base table integrating identifiers, genetics, phenotypes, mechanisms, diagnosis, management, research studies, ontology suggestions, and explicit evidence gaps for Intellectual Disability X-linked 102.

1. Disease information

Definition and identifiers

Preferred contemporary name: DDX3X-related neurodevelopmental disorder.
Historical names: Intellectual disability, X-linked 102; mental retardation, X-linked 102; MRX102; DDX3X syndrome; MRXSSB; X-linked intellectual disability–hypotonia–movement disorder syndrome.
OMIM phenotype: 300958.
MONDO: MONDO:0018709, “X-linked intellectual disability-hypotonia-movement disorder syndrome.” Open Targets maps DDX3X to this entity and to intellectual disability, supported principally by the foundational human report PMID 26235985. (lukin2024emergingxlinkedgenes pages 8-9, OpenTargets Search: -DDX3X)
Gene: DDX3X, approved name DEAD-box helicase 3 X-linked; Ensembl ENSG00000215301. (OpenTargets Search: -DDX3X)
Orphanet: the retrieved mapping associated DDX3X with the broader Orphanet category ORPHA:777, X-linked non-syndromic intellectual disability, but this is less specific than MONDO:0018709/OMIM:300958 and should not replace the disease-specific label. (OpenTargets Search: -DDX3X)
ICD-10/ICD-11 and MeSH: no unique DDX3X/MRX102 code was identified. Coding ordinarily uses the applicable generic intellectual-developmental-disorder, developmental-delay, autism, epilepsy, movement-disorder, or congenital-malformation code. MeSH likewise has broader concepts rather than a disease-specific heading.

This report synthesizes aggregated disease-level resources, published cohorts and individual case reports. It is not derived from a single patient’s EHR. Cohort estimates must not be interpreted as population-based frequencies because recruitment was generally through diagnostic sequencing or specialty clinics.

2. Etiology, risk, protection, and gene–environment interaction

The primary cause is a germline pathogenic or likely pathogenic DDX3X variant. In females, most established cases are sporadic de novo heterozygous variants. Reported classes include missense, nonsense, frameshift, canonical and noncanonical splice variants, in-frame deletions, insertions, and duplications. Female truncating variants generally support haploinsufficiency, whereas recurrent helicase-domain missense variants may have dominant-negative or toxic effects in addition to reduced helicase activity. (lennox2020pathogenicddx3xmutations pages 1-3, moresco2021anovelde pages 4-6, dai2022expansionofclinical pages 4-5)

Important genetic determinants of severity are variant class, location within the ATP-binding/helicase domains, residual protein activity, and sex. In the recent combined male series, 27/30 males had missense variants and 3/30 had splice-site variants; no truncating male variant was reported, supporting poor viability of complete hemizygous loss of function. Recurrent male substitutions included p.Arg351Gln and p.Arg488Cys. Some variants remain incompletely classified and require functional evidence. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8)

DDX3X escapes X-chromosome inactivation. X-inactivation can modify dosage but is not reliably protective: one symptomatic female had extreme preferential inactivation of the mutant X, yet allele-specific expression remained approximately 70% normal and 30% mutant, insufficient to prevent disease. (sun2022casereportde pages 8-8)

No reproducible environmental, infectious, toxic, occupational, dietary, lifestyle, immune, or prenatal exposure causes have been established. No protective DDX3X allele, validated modifier gene, or preventive lifestyle exposure is known. Consequently, a disease-specific gene–environment interaction has not been demonstrated. Ordinary environmental and educational circumstances may affect functional attainment and quality of life, but they are not known causes of the molecular disorder.

3. Phenotypes

Clinical onset is congenital or in infancy, usually recognized through delayed milestones, hypotonia, feeding difficulty, or abnormal motor development. Frequencies vary by ascertainment and age.

Global developmental delay/intellectual disability: defining and lifelong, ranging from mild to profound. All 23 participants in a Chinese cohort had ID/DD; in a prospectively assessed cohort, 80% met formal ID criteria. Suggested HPO: HP:0001263 Global developmental delay, HP:0001249 Intellectual disability. (dai2022expansionofclinical pages 4-5, hoye2022aberrantcorticaldevelopment pages 30-31)
Speech-language disorder: expressive language is often disproportionately impaired; first words in the recent male cohort occurred from 18 months to 8 years, median 24 months. Some affected individuals remain nonverbal. Suggested HPO: HP:0000750 Delayed speech and language development, severe expressive-language impairment/absent speech where applicable. Communication limitation substantially affects education, social participation, and autonomy. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, dai2022expansionofclinical pages 4-5)
Motor delay and abnormal tone: motor delay occurred in 17/18 assessable males; tone abnormalities occurred in 17/23 (73.9%) in the Chinese cohort. Hypotonia is common, but hypertonia, spasticity, dystonia, ataxia, and other movement disorders occur. Suggested HPO: HP:0001270 Motor delay, HP:0001252 Hypotonia, HP:0001276 Hypertonia, HP:0001251 Ataxia. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, dai2022expansionofclinical pages 4-5)
Autism and ADHD: prospective gold-standard assessment found ASD in 60% and ADHD in 53%; 13/17 assessed Chinese participants exceeded an ASD-risk screening threshold. Suggested HPO: HP:0000729 Autistic behavior, HP:0007018 ADHD. (dai2022expansionofclinical pages 4-5, hoye2022aberrantcorticaldevelopment pages 30-31)
Anxiety, self-injury and sensory abnormalities: a 2023 comparative study of 23 affected females and 23 females with other genetic IDs found significantly greater anxiety and self-injurious behavior in the DDX3X group, although autism characteristics did not differ between groups. These problems can markedly affect family life, safety, schooling, and community participation. Suggested HPO: anxiety, HP:0100716 Self-injurious behavior, and abnormal sensory processing. (hoye2022aberrantcorticaldevelopment pages 30-31)
Feeding and growth: feeding difficulties occurred in 13/23 (56.5%) in the Chinese cohort. Growth abnormalities and reduced subcutaneous fat occur variably. Suggested HPO: HP:0011968 Feeding difficulties. (dai2022expansionofclinical pages 4-5)
Ophthalmologic findings: reported in 11/23 (47.8%) in one cohort; manifestations are heterogeneous. Suggested HPO: HP:0000478 Abnormality of the eye. (dai2022expansionofclinical pages 4-5)
Seizures/EEG: seizures occurred in 6/23 (26.1%) and abnormal EEG in 9/23 (39.1%) in the Chinese cohort, versus seizures in 6/53 (11.3%) in an earlier pooled series. Suggested HPO: HP:0001250 Seizure, HP:0002353 EEG abnormality. (scala2019threedenovo pages 5-6, dai2022expansionofclinical pages 4-5)
Musculoskeletal findings: scoliosis, joint laxity and gait or postural abnormalities occur variably. Suggested HPO: HP:0002650 Scoliosis, generalized joint hypermobility when present.
Endocrine: hypothyroidism was observed in 6/23 (26.1%) in one Chinese cohort, but this expanded phenotype requires independent replication and should not yet be considered universal. Suggested HPO: HP:0000821 Hypothyroidism. (dai2022expansionofclinical pages 4-5)

Brain MRI may be normal or show polymicrogyria, corpus-callosum hypoplasia/agenesis, ventriculomegaly, delayed myelination, white-matter abnormalities, cerebellar or brainstem anomalies. Structural abnormalities occurred in 15/23 (65.2%) in the Chinese cohort, while an earlier pooled series found abnormal MRI in 16/53 (30.2%) and callosal abnormalities in 7/53 (13.2%). Across reports, polymicrogyria occurs in approximately 7–12%; among DDX3X-associated PMG cases, epilepsy and ID were reported in 42% and 68%, respectively. Suggested HPO: HP:0002126 Polymicrogyria, HP:0007370 Abnormality of the corpus callosum, HP:0002119 Ventriculomegaly, and delayed myelination. (edey2023x‐linkedneuronalmigration pages 9-10, scala2019threedenovo pages 5-6, dai2022expansionofclinical pages 4-5)

4. Genetic and molecular information

DDX3X is an X-linked, dosage-sensitive RNA-helicase gene. The 2015 foundational study established the association; its title and central conclusion were: “Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling.” PMID 26235985, published August 2015; DOI: https://doi.org/10.1016/j.ajhg.2015.07.004. (lukin2024emergingxlinkedgenes pages 8-9, hoye2022aberrantcorticaldevelopment pages 30-31)

The largest mechanistic clinical series included 107 affected individuals and demonstrated a strong relationship between recurrent dominant missense variants, polymicrogyria, and severe outcomes. Its abstract states: “Severe DDX3X missense mutations profoundly disrupt RNA helicase activity and induce ectopic RNA-protein granules and aberrant translation in neural progenitors and neurons.” PMID 32135084, published May 6, 2020; DOI: https://doi.org/10.1016/j.neuron.2020.01.042. (lennox2020pathogenicddx3xmutations pages 1-3, lukin2024emergingxlinkedgenes pages 8-9)

A representative case carried de novo c.625C>G (p.His209Asp) immediately upstream of the ATP-binding domain and had bilateral frontal PMG, delayed myelination and a thin corpus callosum. This variant was absent from the mother and predicted deleterious, but lacked a direct functional assay; its molecular mechanism therefore remains inferred. (moresco2021anovelde pages 4-6)

Most well-established alleles are absent or extremely rare in population databases because of strong negative selection. Nevertheless, allele frequency and ClinVar classification must be checked variant by variant against the current transcript/build; no single population frequency applies to the disease. Germline—not somatic—origin defines this syndrome. Somatic DDX3X variants in malignancies are a separate biological context and must not be used as evidence of constitutional DDX3X syndrome.

No validated modifier gene is established. DDX3Y compensation in male developing cortex is supported experimentally but is not a conventional inherited modifier allele. No disease-specific methylation episignature or clinically validated epigenetic biomarker is established. Large DDX3X deletions or X-chromosome rearrangements can theoretically cause the phenotype, but ordinary cases are sequence-level or small indel variants; cytogenetic abnormalities are not the dominant mechanism.

5. Environmental information

There is no evidence that toxins, radiation, pollution, smoking, alcohol, diet, exercise, occupational exposure, or infection causes DDX3X syndrome. These factors can influence general health and developmental support needs but are not known etiologic agents. No zoonotic or transmissible component exists.

6. Mechanism and pathophysiology

Ordered causal chain

A pathogenic germline DDX3X variant leads to reduced dosage or allele-specific dysfunction of an ATP-dependent RNA helicase.
Impaired helicase activity leads to defective RNA unwinding, RNA metabolism, translation of structured transcripts, and—particularly for severe missense alleles—abnormal RNA–protein granules.
These RNA/translation defects lead to altered neural-progenitor cell-cycle duration and neurogenic divisions; newer model work also links DDX3X loss to reduced stabilization of CREBBP mRNA and dysfunctional Notch signaling.
Altered progenitor behavior leads to depletion or imbalance of neural stem/progenitor pools and abnormal production of excitatory and inhibitory neurons.
Reduced neurogenesis plus impaired neuronal migration and cortical lamination leads to abnormal cerebral-cortex development; the severe-missense branch can result in polymicrogyria, while other branches produce callosal, ventricular, myelination, or brain-volume abnormalities.
Abnormal cortical circuitry and broader neurodevelopment result in intellectual, language, motor, behavioral, sensory and seizure phenotypes. The final circuit-to-symptom link is biologically compelling but partly inferred rather than directly demonstrated in humans.

DDX3X participates in transcriptional regulation, splicing, nuclear mRNA export, cytoplasmic translation and ribonucleoprotein-granule biology. Experimental evidence places it upstream of cortical neuronal generation, migration and differentiation. Wnt-related effects were reported in the foundational study; Xenopus work additionally connects DDX3-dependent translation of RAC1 to AKT–GSK3β signaling, β-catenin/Snai1 stability and neural-crest development. These pathways may help explain craniofacial findings but should not be assumed to mediate every neurological phenotype. (lennox2020pathogenicddx3xmutations pages 1-3, edey2023x‐linkedneuronalmigration pages 9-10, lukin2024emergingxlinkedgenes pages 8-9)

In mouse neural progenitors, Ddx3x loss changes cell-cycle dynamics and translation, reducing neurogenesis; complete female neural-progenitor loss can produce microcephaly, while heterozygous females and hemizygous males show reduced neuron generation without necessarily marked microcephaly. The 2024 PNAS study added evidence that Ddx3x deficiency reduces the neural-stem-cell pool and disrupts excitatory/inhibitory differentiation through CREBBP-mRNA stabilization and Notch signaling. These are model findings, not yet validated therapeutic targets in patients. (hoye2022aberrantcorticaldevelopment pages 30-31)

Suggested ontology annotations include GO:0006396 RNA processing, GO:0006412 translation, GO:0007049 cell cycle, GO:0022008 neurogenesis, GO:0001764 neuron migration, canonical Wnt signaling, Notch signaling, and RNA-helicase activity. Suggested cell terms include neural stem cell/neural progenitor, radial glial cell, migrating neuron, cortical glutamatergic neuron and inhibitory interneuron. Relevant compartments include cytoplasmic ribonucleoprotein granule, ribosome, nucleus and cytoplasm.

No reproducible disease-specific metabolomic, lipidomic, immune, inflammatory or proteomic signature has been established. Ribosome profiling and transcript-level analyses are research tools, not diagnostic biomarkers. Single-cell, spatial-transcriptomic and integrated human multi-omic disease maps remain limited.

7. Anatomical structures affected

The primary organ is the brain, particularly the developing cerebral cortex. Relevant suggested annotations are UBERON:0000955 brain, cerebral cortex, corpus callosum, cerebral white matter, lateral ventricle, cerebellum and brainstem. Human imaging implicates both hemispheres; no consistent lateralization is established. (lennox2020pathogenicddx3xmutations pages 1-3, scala2019threedenovo pages 5-6)

At tissue/cell level, cortical neural progenitors/radial glia, newly generated and migrating neurons, cortical projection neurons, and potentially excitatory/inhibitory neuronal balance are central. Ddx3x+/− mice exhibit reduced brain volume, disproportionate cortical and amygdala effects, cortical thinning and defective lamination. Suggested Cell Ontology terms include CL:0000047 neural stem cell and CL:0000540 neuron, supplemented by radial-glial and cortical-neuron terms. (boitnott2021developmentalandbehavioral pages 25-28)

Secondary systems may include ocular, gastrointestinal/feeding, musculoskeletal and, less consistently, endocrine or congenital cardiac structures. These are variable manifestations rather than evidence of generalized progressive organ degeneration.

8. Temporal development

The molecular lesion is present from conception and acts during embryonic/fetal neurodevelopment. Clinical recognition is typically in infancy or early childhood through chronic/insidious failure to meet milestones rather than an acute event. The condition is lifelong; there is no established staging system or remission pattern.

Most evidence supports a developmental encephalopathy with relatively stable core disability, although skills and behavior evolve with age and intervention. Rare reports describe later neurological or motor decline, particularly in some males with hypomorphic alleles, but progression is not established as the usual course. Critical intervention windows are early childhood language, motor, adaptive and social development; this is a clinical-developmental principle rather than proof that early treatment reverses the molecular lesion. Male diagnoses may be delayed: in the 2025 cohort, median age at variant identification was 8 years, range 9 months–47 years. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3)

9. Inheritance and population

The typical pattern is X-linked dominant/de novo in females, with sex-dependent viability and expression. Affected males can have de novo or maternally inherited hypomorphic alleles; mildly affected or apparently unaffected carrier females occur in such families. A proven p.Arg79Lys allele caused partial loss of function and mild-to-moderate ID with progressive spasticity in two brothers, illustrating residual-function inheritance. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8, sun2022casereportde pages 8-8)

Penetrance is high for clearly pathogenic de novo female variants but cannot be expressed as a precise universal percentage. Expressivity is markedly variable. Anticipation is not reported. Parental germline mosaicism is biologically possible after an apparently de novo result, but no robust disease-specific recurrence percentage is available. No established founder variant, consanguinity association, geographic concentration, ancestry-specific enrichment, or population carrier frequency is known.

No reliable prevalence or incidence per 100,000 exists. The best repeated statistic is 1–3% of unexplained female ID in sequencing cohorts. Recent evidence indicates more than 1,000 females have reportedly been diagnosed worldwide, but this is an ascertainment count rather than epidemiology. The sex ratio is strongly female-biased among recognized cases because complete loss of function is poorly tolerated in males. (kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3, lennox2020pathogenicddx3xmutations pages 1-3)

10. Diagnostics

Diagnosis requires a compatible neurodevelopmental phenotype and a pathogenic/likely pathogenic germline DDX3X variant interpreted under ACMG/AMP criteria.

Preferred approach: trio exome or genome sequencing for unexplained DD/ID, particularly in a female with severe speech delay, tone/movement abnormalities, ASD features, or characteristic MRI findings. Trio analysis establishes de novo status and improves interpretation.
Alternatives: a comprehensive neurodevelopmental/ID panel containing DDX3X, or DDX3X sequencing with deletion/duplication analysis when clinical suspicion is high.
CMA: useful for the broad DD/ID differential and DDX3X-containing deletions but does not reliably detect single-nucleotide or small indel variants.
Karyotype/FISH: reserved for suspected large X-chromosomal rearrangements; not routine DDX3X tests.
RNA studies: potentially useful for noncanonical splice variants or unresolved VUSs, but not a standardized first-line assay.
Not indicated specifically: mitochondrial-DNA testing and repeat-expansion assays unless another diagnosis is suspected.

There is no disease-specific blood, urine, enzyme, metabolite, proteomic, epigenomic or liquid-biopsy biomarker. Baseline assessment should document development, cognition/adaptive function, speech and communication, neurologic status, tone and movement, behavior/ASD/ADHD/anxiety, feeding/growth, hearing, vision and musculoskeletal findings. EEG is symptom-driven; brain MRI is appropriate with seizures, abnormal neurologic findings, head-growth abnormalities or significant motor impairment.

Differential diagnoses include Rett/MECP2-related disorders, CDKL5 disorder, FOXG1 syndrome, CASK-related disorders, WDR45-related neurodegeneration, TUBA1A/tubulinopathies and other polymicrogyria genes, USP9X-related disorder, PCDH19 epilepsy, cerebral palsy and other monogenic neurodevelopmental conditions. A DDX3X case initially labeled cerebral palsy illustrates why a static motor phenotype plus unexplained ID should prompt genomic investigation. (moresco2021anovelde pages 4-6)

Computer-assisted facial phenotyping is emerging but is adjunctive: a 2024 benchmark found MRX102 among syndromes correctly ranked first by tested facial tools, yet such algorithms cannot establish diagnosis or replace molecular confirmation.

11. Outcome and prognosis

The principal morbidity is lifelong impairment of communication, learning, adaptive functioning, mobility and behavioral regulation. Functional outcomes range widely; variant type and brain malformation provide some prognostic information. Missense/in-frame-deletion groups have, on average, more severe language, motor and adaptive impairment than protein-truncating groups, and recurrent severe missense variants associated with PMG predict poorer outcomes. These are group trends, not deterministic individual predictions. (lennox2020pathogenicddx3xmutations pages 1-3, hoye2022aberrantcorticaldevelopment pages 30-31)

There are no validated 5- or 10-year survival rates, life-expectancy estimates, disease-specific mortality rates, quality-adjusted-life-year studies or prognostic blood biomarkers. Available data do not demonstrate a uniformly life-limiting disorder. Complications include epilepsy, feeding and nutritional difficulty, falls or mobility restriction, scoliosis, sleep and behavioral problems, and caregiver burden. Complete recovery is not expected, but developmental gains and improved participation can occur with therapy and accommodations.

12. Treatment and current implementation

No FDA/EMA-approved DDX3X-specific drug, gene therapy, cell therapy, RNA therapy, CRISPR treatment or targeted molecular therapy exists. No evidence supports pharmacologically inhibiting DDX3X in this germline haploinsufficiency disorder; oncology-directed DDX3X strategies are not transferable.

Current care is individualized and multidisciplinary:

early developmental and special-education intervention;
speech-language therapy and early augmentative/alternative communication for minimally verbal children;
physical and occupational therapy for tone, coordination, gait, posture, fine-motor and sensory needs;
feeding therapy and nutritional/gastroenterology support;
standard antiseizure medication selected by seizure type;
standard evidence-based management of ADHD, anxiety, sleep disturbance, irritability or self-injury;
orthopedic/physiatric management of scoliosis, contracture or mobility limitations;
vision, hearing and endocrine treatment when abnormalities are documented.

A case-level report described behavioral therapy, proprioceptive/vestibular intervention and hippotherapy, followed by improved peer interaction and less obsessive behavior. This is uncontrolled evidence and cannot establish treatment efficacy. (stefaniak2022autisticlikebehaviorsassociated pages 6-8)

Suggested NCIT intervention mappings include Genetic Counseling, Developmental Assessment, Speech Therapy, Augmentative and Alternative Communication, Occupational Therapy, Physical Therapy, Behavioral Therapy, Nutritional Support, Anticonvulsant Therapy, EEG and MRI. Disease-specific response rates and adverse-event data are unavailable.

Clinical research: NCT03718910 was a completed, observational cross-sectional study at Mount Sinai, enrolling 15 participants from May 23, 2018 to June 1, 2020. Participants underwent three days of developmental, behavioral, neurologic, psychiatric, medical, EEG, visual-evoked-potential and eye-tracking assessment; samples could support DNA and iPSC research. It characterized natural history rather than testing treatment. The broader Simons Searchlight registry also includes eligible genetic neurodevelopmental conditions. No interventional DDX3X trial was found. (NCT03718910 chunk 1)

13. Prevention

The occurrence of a new de novo variant cannot presently be prevented by lifestyle or medication. Primary prevention is therefore limited to reproductive options after a familial variant is known: genetic counseling, parental testing, prenatal diagnosis and preimplantation genetic testing. Cascade testing is especially relevant in families with an inherited male hypomorphic allele. A negative parental blood test substantially lowers but does not eliminate recurrence risk because gonadal mosaicism remains possible.

There is no population newborn screen, vaccine, prophylactic medication or general-population carrier-screening program. Secondary prevention consists of prompt genomic diagnosis and early developmental intervention. Tertiary prevention includes seizure recognition, nutritional support, mobility/scoliosis surveillance, communication access and proactive behavioral/mental-health care.

14. Other species and natural disease

Orthologs are experimentally studied in Mus musculus (mouse; NCBI Taxon 10090), Danio rerio (zebrafish; 7955) and Xenopus tropicalis (western clawed frog; 8364). No well-established naturally occurring veterinary counterpart, breed predisposition, animal-health burden, zoonotic transmission or cross-species infectious susceptibility is known. The relevant comparative finding is evolutionary conservation of DDX3-dependent RNA metabolism and neurodevelopment, not a naturally transmitted disease.

15. Model organisms

Mouse Ddx3x haploinsufficiency: reproduces developmental, sensory and motor delay, adult hyperactivity/anxiety-like behavior, cognitive and motor deficits, reduced brain volume and abnormal cortical lamination. It has construct and partial face validity but cannot model human language or complex adaptive disability. (boitnott2021developmentalandbehavioral pages 25-28)
Conditional neural-progenitor knockout: demonstrates dosage- and sex-dependent effects on cell-cycle timing, neurogenic divisions, cortical neuron production and microcephaly. Ribosome profiling identifies DDX3X-dependent translated transcripts. (hoye2022aberrantcorticaldevelopment pages 30-31)
Cellular/biochemical systems: severe missense proteins show impaired RNA-helicase activity, abnormal RNA–protein granules and aberrant translation in progenitors and neurons. (lennox2020pathogenicddx3xmutations pages 1-3)
Zebrafish: functional rescue/perturbation assays established partial loss of function for the inherited male p.Arg79Lys allele.
Xenopus: DDX3 depletion disrupts neural-crest induction and craniofacial morphogenesis through RAC1 translation and AKT–GSK3β/β-catenin signaling.

These models support mechanism and target discovery, but none has yet produced a clinically validated therapy.

Recent developments, 2023–2024

Recent work has shifted from syndrome discovery toward quantitative behavior, communication, sex biology and pathway resolution. The 2023 comparative study showed that anxiety and self-injury—not simply autism severity—may be distinctive clinical burdens in girls and young women with DDX3X variants. (hoye2022aberrantcorticaldevelopment pages 30-31)

A 2024 review emphasized that DDX3X belongs to an expanding group of X-linked neurodevelopmental genes whose effects in females cannot be understood through a simple recessive model; escape from X-inactivation, allele class and sex-specific compensation are central. (lukin2024emergingxlinkedgenes pages 8-9)

The 2024 mechanistic advance linked DDX3X deficiency to CREBBP-mRNA destabilization, impaired Notch signaling, reduced neural-stem-cell pools and excitatory/inhibitory differentiation imbalance. This strengthens the causal chain but remains preclinical. Concurrent clinical literature increasingly advocates early augmentative communication rather than waiting for speech to emerge. No 2023–2024 research established a disease-modifying intervention.

Evidence limitations

Most clinical datasets are small, referral-based and cross-sectional, with inconsistent assessment and age distribution. Apparent phenotype frequencies therefore differ substantially across cohorts. Many rare systemic findings are single-case observations. Variant-level conclusions should use current ClinVar/gnomAD records and an appropriate DDX3X transcript rather than syndrome-level generalization. Population prevalence, lifespan, longitudinal progression, treatment response, environmental modifiers, protective factors, molecular biomarkers and human single-cell/spatial multi-omics remain major knowledge gaps.

References

(lennox2020pathogenicddx3xmutations pages 1-3): Ashley L. Lennox, Mariah L. Hoye, Ruiji Jiang, Bethany L. Johnson-Kerner, Lindsey A. Suit, Srivats Venkataramanan, Charles J. Sheehan, Fernando C. Alsina, Brieana Fregeau, Kimberly A. Aldinger, Ching Moey, Iryna Lobach, Alexandra Afenjar, Dusica Babovic-Vuksanovic, Stéphane Bézieau, Patrick R. Blackburn, Jens Bunt, Lydie Burglen, Philippe M. Campeau, Perrine Charles, Brian H.Y. Chung, Benjamin Cogné, Cynthia Curry, Maria Daniela D’Agostino, Nataliya Di Donato, Laurence Faivre, Delphine Héron, A. Micheil Innes, Bertrand Isidor, Boris Keren, Amy Kimball, Eric W. Klee, Paul Kuentz, Sébastien Küry, Dominique Martin-Coignard, Ghayda Mirzaa, Cyril Mignot, Noriko Miyake, Naomichi Matsumoto, Atsushi Fujita, Caroline Nava, Mathilde Nizon, Diana Rodriguez, Lot Snijders Blok, Christel Thauvin-Robinet, Julien Thevenon, Marie Vincent, Alban Ziegler, William Dobyns, Linda J. Richards, A. James Barkovich, Stephen N. Floor, Debra L. Silver, and Elliott H. Sherr. Pathogenic ddx3x mutations impair rna metabolism and neurogenesis during fetal cortical development. May 2020. URL: https://doi.org/10.1016/j.neuron.2020.01.042, doi:10.1016/j.neuron.2020.01.042. This article has 251 citations and is from a highest quality peer-reviewed journal.
(dai2022expansionofclinical pages 4-5): Yuwei Dai, Zhuanyi Yang, Jialing Guo, Haoyu Li, Jiaoe Gong, Yuanyuan Xie, Bo Xiao, Hua Wang, and Lili Long. Expansion of clinical and genetic spectrum of ddx3x neurodevelopmental disorder in 23 chinese patients. Frontiers in Molecular Neuroscience, Mar 2022. URL: https://doi.org/10.3389/fnmol.2022.793001, doi:10.3389/fnmol.2022.793001. This article has 21 citations.
(NCT03718910 chunk 1): Alexander Kolevzon. DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.. Icahn School of Medicine at Mount Sinai. 2018. ClinicalTrials.gov Identifier: NCT03718910
(OpenTargets Search: -DDX3X): Open Targets Query (-DDX3X, 5 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(lukin2024emergingxlinkedgenes pages 8-9): Jeronimo Lukin, Corinne M. Smith, and Silvia De Rubeis. Emerging x-linked genes associated with neurodevelopmental disorders in females. Oct 2024. URL: https://doi.org/10.1016/j.conb.2024.102902, doi:10.1016/j.conb.2024.102902. This article has 12 citations and is from a peer-reviewed journal.
(kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 7-8): Milou G. P. Kennis, Dmitrijs Rots, Arjan Bouman, Charlotte W. Ockeloen, Caroline Boelen, Carlo L. M. Marcelis, Bert B. A. de Vries, Mariet W. Elting, Quinten Waisfisz, Mohnish Suri, Esperanza Font-Montgomery, Dawn S. Peck, Deirdre E. Donnelly, R. Curtis Rogers, Ruth Richardson, Roseline Caumes, Boris Chaumette, Cécile Louveau, Suzanne C. E. H. Sallevelt, Saskia M. Maas, Jeroen J. Smits, Mieke M. van Haelst, Rebecca J. Levy, Helen Stewart, Bart L. Loeys, Rolph Pfundt, Tjitske Kleefstra, and Lot Snijders Blok. Ddx3x-related neurodevelopmental disorder in males – presenting a new cohort of 19 males and a literature review. European Journal of Human Genetics, 33:980-988, Mar 2025. URL: https://doi.org/10.1038/s41431-025-01832-x, doi:10.1038/s41431-025-01832-x. This article has 12 citations and is from a domain leading peer-reviewed journal.
(sun2022casereportde pages 8-8): Yi-xi Sun, Yangwen Qian, Haixi Sun, Min Chen, Yuqin Luo, Xiao-jing Xu, K. Yan, Li-ya Wang, Junjie Hu, and Minyue Dong. Case report: de novo ddx3x mutation caused intellectual disability in a female with skewed x-chromosome inactivation on the mutant allele. Frontiers in Genetics, Oct 2022. URL: https://doi.org/10.3389/fgene.2022.999442, doi:10.3389/fgene.2022.999442. This article has 11 citations and is from a peer-reviewed journal.
(kennis2025ddx3xrelatedneurodevelopmentaldisorder pages 2-3): Milou G. P. Kennis, Dmitrijs Rots, Arjan Bouman, Charlotte W. Ockeloen, Caroline Boelen, Carlo L. M. Marcelis, Bert B. A. de Vries, Mariet W. Elting, Quinten Waisfisz, Mohnish Suri, Esperanza Font-Montgomery, Dawn S. Peck, Deirdre E. Donnelly, R. Curtis Rogers, Ruth Richardson, Roseline Caumes, Boris Chaumette, Cécile Louveau, Suzanne C. E. H. Sallevelt, Saskia M. Maas, Jeroen J. Smits, Mieke M. van Haelst, Rebecca J. Levy, Helen Stewart, Bart L. Loeys, Rolph Pfundt, Tjitske Kleefstra, and Lot Snijders Blok. Ddx3x-related neurodevelopmental disorder in males – presenting a new cohort of 19 males and a literature review. European Journal of Human Genetics, 33:980-988, Mar 2025. URL: https://doi.org/10.1038/s41431-025-01832-x, doi:10.1038/s41431-025-01832-x. This article has 12 citations and is from a domain leading peer-reviewed journal.
(hoye2022aberrantcorticaldevelopment pages 30-31): Mariah L Hoye, Lorenzo Calviello, Abigail J Poff, Nna-Emeka Ejimogu, Carly R Newman, Maya D Montgomery, Jianhong Ou, Stephen N Floor, and Debra L Silver. Aberrant cortical development is driven by impaired cell cycle and translational control in a ddx3x syndrome model. Jun 2022. URL: https://doi.org/10.7554/elife.78203, doi:10.7554/elife.78203. This article has 64 citations and is from a domain leading peer-reviewed journal.
(stefaniak2022autisticlikebehaviorsassociated pages 6-8): Urszula Stefaniak, Roksana Malak, Ewa Mojs, and Włodzimierz Samborski. Autistic-like behaviors associated with a novel non-canonical splice-site ddx3x variant: a case report of a rare clinical syndrome. Mar 2022. URL: https://doi.org/10.3390/brainsci12030390, doi:10.3390/brainsci12030390. This article has 11 citations.
(scala2019threedenovo pages 5-6): Marcello Scala, Annalaura Torella, Mariasavina Severino, Giovanni Morana, Raffaele Castello, Andrea Accogli, Antonio Verrico, Maria Stella Vari, Gerarda Cappuccio, Michele Pinelli, Giuseppina Vitiello, Gaetano Terrone, Alessandra D’Amico, Vincenzo Nigro, and Valeria Capra. Three de novo ddx3x variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females. European Journal of Human Genetics, 27:1254-1259, Apr 2019. URL: https://doi.org/10.1038/s41431-019-0392-7, doi:10.1038/s41431-019-0392-7. This article has 62 citations and is from a domain leading peer-reviewed journal.
(edey2023x‐linkedneuronalmigration pages 9-10): Juliet Edey, Payam Soleimani‐Nouri, Amelia Dawson‐Kavanagh, Muhamad Saad Imran Azeem, and Vasso Episkopou. X‐linked neuronal migration disorders: gender differences and insights for genetic screening. International Journal of Developmental Neuroscience, 83:581-599, Aug 2023. URL: https://doi.org/10.1002/jdn.10290, doi:10.1002/jdn.10290. This article has 11 citations and is from a peer-reviewed journal.
(moresco2021anovelde pages 4-6): Giada Moresco, Jole Costanza, Carlo Santaniello, Ornella Rondinone, Federico Grilli, Elisabetta Prada, Simona Orcesi, Ilaria Coro, Anna Pichiecchio, Paola Marchisio, Monica Miozzo, Laura Fontana, and Donatella Milani. A novel de novo ddx3x missense variant in a female with brachycephaly and intellectual disability: a case report. Italian Journal of Pediatrics, Mar 2021. URL: https://doi.org/10.1186/s13052-021-01033-4, doi:10.1186/s13052-021-01033-4. This article has 17 citations and is from a peer-reviewed journal.
(boitnott2021developmentalandbehavioral pages 25-28): Andrea Boitnott, Dévina C Ung, Marta Garcia-Forn, Kristi Niblo, Danielle Mendonca, Michael Flores, Sylvia Maxwell, Jacob Ellegood, Lily R Qiu, Dorothy E Grice, Jason P Lerch, Mladen-Roko Rasin, Joseph D Buxbaum, Elodie Drapeau, and Silvia De Rubeis. Developmental and behavioral phenotypes in a new mouse model of ddx3x syndrome. bioRxiv, Jan 2021. URL: https://doi.org/10.1101/2021.01.22.427482, doi:10.1101/2021.01.22.427482. This article has 1 citations.

Artifacts

Edison artifact artifact-00

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	13
Resolved	13
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	13
On topic	6
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	36
Resolved	34
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	2

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: OMIM, ORPHA.

34 of 36 terms resolved to a current term; the rest could not be looked up either way.

Ask OpenScientist

OpenScientist Report

Mappings

Inheritance

Subtypes

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Prevalence

Differential Diagnoses

Clinical Trials

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Disease Characteristics Research Template

Target Disease

Research Objectives

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Citation Requirements

Output Format

Intellectual Disability, X-linked 102 (DDX3X-related neurodevelopmental disorder)

Executive summary and scope

1. Disease information

Definition and identifiers

2. Etiology, risk, protection, and gene–environment interaction

3. Phenotypes

4. Genetic and molecular information

5. Environmental information

6. Mechanism and pathophysiology

Ordered causal chain

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

11. Outcome and prognosis

12. Treatment and current implementation

13. Prevention

14. Other species and natural disease

15. Model organisms

Recent developments, 2023–2024

Evidence limitations

Artifacts

Reference Validation

Term Validation

Prefixes with no resolver